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ABSTRACT 
 Peripheral arterial disease (PAD) is a manifestation of the systemic disease of 
atherosclerosis that results in arterial stenoses of the lower extremities.  Patients with 
PAD demonstrate slowed dynamics of pulmonary oxygen uptake ( O2 kinetics) 
following the onset of exercise and a profound reduction in peak oxygen uptake and work 
capacity.  However, whereas the primary pathophysiology of PAD results from the lower 
extremity hemodynamic limitation, there are abnormalities distal to the arterial stenoses 
in PAD-affected skeletal muscle that may also contribute to the impaired exercise 
responses. Thus, the potential contributions of abnormal muscle metabolism versus local 
circulatory defects in the PAD exercise impairment remains unclear. In this context, the 
purpose of the dissertation was to advance our understanding of the abnormal pulmonary 
O2 kinetics in PAD and characterize the local muscle deoxygenation responses during 
the rest-exercise transition exercise in health and PAD.  The present series of 
investigations were designed to: 1. localize the abnormal pulmonary O2 kinetics in PAD 
to the affected lower extremities, 2. characterize the kinetics of calf muscle 
deoxygenation during walking in PAD and healthy subjects, 3. describe muscle 
deoxygenation kinetics in relation to exercise work rate and blood flow in PAD and 
health, and 4. evaluate the effect of arterial revascularization on pulmonary O2 kinetics 
in PAD.  These investigations revealed a persistent abnormality in muscle oxygen 
utilization in PAD-affected skeletal muscle that was not associated with the severity of 
hemodynamic compromise.  In particular, we observed slowed pulmonary O2 kinetics 
in PAD only during exercise of the PAD-affected skeletal muscles.  Moreover, muscle 
deoxygenation kinetics following the onset of walking and lower intensity calf exercise 
were prolonged in PAD subjects while leg blood flow responses were normal.   However, 
at higher work rates, PAD muscle deoxygenation kinetics accelerated, demonstrating a 
work rate and presumably blood flow dependence.  Lastly, arterial revascularization 
tended to improve, but not consistently normalize, pulmonary O2 kinetics in PAD 
subjects.  Thus, these investigations demonstrate abnormal oxygen uptake kinetics in 
PAD and provide evidence that local abnormalities of the affected skeletal muscle may 
contribute to the abnormal O2 kinetics and exercise intolerance of patients with PAD. 
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capacity.  However, whereas the primary pathophysiology of PAD results from the lower 
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in PAD-affected skeletal muscle that may also contribute to the impaired exercise 
responses. Thus, the potential contributions of abnormal muscle metabolism versus local 
circulatory defects in the PAD exercise impairment remains unclear. In this context, the 
purpose of the dissertation was to advance our understanding of the abnormal pulmonary 
O2 kinetics in PAD and characterize the local muscle deoxygenation responses during 
the rest-exercise transition exercise in health and PAD.  The present series of 
investigations were designed to: 1. localize the abnormal pulmonary O2 kinetics in PAD 
to the affected lower extremities, 2. characterize the kinetics of calf muscle 
deoxygenation during walking in PAD and healthy subjects, 3. describe muscle 
deoxygenation kinetics in relation to exercise work rate and blood flow in PAD and 
health, and 4. evaluate the effect of arterial revascularization on pulmonary O2 kinetics 
in PAD.  These investigations revealed a persistent abnormality in muscle oxygen 
utilization in PAD-affected skeletal muscle that was not associated with the severity of 
hemodynamic compromise.  In particular, we observed slowed pulmonary O2 kinetics 
in PAD only during exercise of the PAD-affected skeletal muscles.  Moreover, muscle 
deoxygenation kinetics following the onset of walking and lower intensity calf exercise 
were prolonged in PAD subjects while leg blood flow responses were normal.   However, 
at higher work rates, PAD muscle deoxygenation kinetics accelerated, demonstrating a 
work rate and presumably blood flow dependence.  Lastly, arterial revascularization 
tended to improve, but not consistently normalize, pulmonary O2 kinetics in PAD 
subjects.  Thus, these investigations demonstrate abnormal oxygen uptake kinetics in 
PAD and provide evidence that local abnormalities of the affected skeletal muscle may 
contribute to the abnormal O2 kinetics and exercise intolerance of patients with PAD. 
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Chapter 1.  
Peripheral Arterial Disease: Pathophysiology and Response to Exercise 
Introduction 
Peripheral arterial disease (PAD) is a manifestation of the systemic disease of 
atherosclerosis that results in arterial stenoses in the lower extremity.   Peripheral arterial 
disease has an estimated prevalence of 12% in the general United States population 
affecting nearly 20% of those over the age of 70 years (Criqui et al. 1985).  Importantly, 
the presence of PAD confers significant cardiovascular morbidity and mortality roughly 
equivalent to people with prior myocardial infarction or stroke (Leng et al. 1996).  The 
characteristic symptom of PAD is intermittent claudication: a cramping leg pain that 
occurs in the affected limbs during exercise and that causes the patient to stop and rest 
until the pain subsides.  Secondary to intermittent claudication, PAD is associated with a 
significant functional impairment, and peak exercise capacity is reduced approximately 
50% compared with healthy subjects (Hiatt et al. 1994).  Thus, PAD is associated with 
serious health consequences related to reduced exercise tolerance and increased risk for 
cardiovascular events.   
The pathophysiology of PAD is associated with the lower extremity 
hemodynamic compromise.  During exercise arterial stenoses constrain increases in 
lower limb blood flow resulting in reversible muscle ischemia.  However, whereas the 
primary pathophysiology of PAD results from the lower extremity hemodynamic 
limitation, there are a spectrum of abnormalities distal to the arterial stenoses in PAD-
affected skeletal muscle that may also contribute to the impaired exercise responses 
(Hiatt et al. 1992, Bhat et al. 1999, Brass et al. 2001). For example, there is an inverse 
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correlation between the accumulation of metabolic intermediates (e.g. short-chain 
[acylcarnitine]) in PAD-affected skeletal muscle and peak exercise performance in PAD 
suggesting abnormal oxidative metabolism (Hiatt et al. 1992).  This contrasts with the 
poor correlations observed between performance and hemodynamic measures (Dahllof et 
al. 1976, Ekroth et al. 1978, Hiatt et al. 1987, Steinacker et al. 2000).  Additionally, there 
are specific defects in mitochondrial electron chain complexes I and III (Brass et al. 
2001), and altered control of mitochondrial respiration during exercise that may impair 
skeletal muscle oxygen utilization (Kemp et al. 1995, Kemp et al. 2001).  Thus, it has 
been suggested that a portion of the PAD exercise impairment may be related to 
abnormal oxidative metabolism as well as the local circulatory defects in PAD-affected 
skeletal muscle (Brass and Hiatt 2000).      
Insight into the PAD exercise impairment may be gained from investigations that 
examine the dynamic increase of oxygen uptake (pulmonary oxygen uptake kinetics, O2 
kinetics) during the transition from rest-to-constant work rate exercise. Accounting for a 
circulatory transit delay from exercising muscle to lung, pulmonary O2 kinetics 
following the onset of exercise closely resembles the time course of oxygen utilization 
measured at the level of the exercising muscle (Grassi et al. 1996).  Thus, pulmonary 
O2 kinetics provides a window into the dynamics of muscle O2 that are ultimately 
dependent upon the complex interaction between oxygen delivery, blood flow 
distribution, oxygen diffusion, and the rate of mitochondrial oxygen utilization.   
Previous investigations have described slowed pulmonary O2 kinetics in a variety of 
cardiovascular diseases, including PAD (Sietsema et al. 1986, Koike et al. 1994, 
Sietsema et al. 1994, Bauer et al. 1999).  The significance of slowed O2 kinetics in 
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disease rests with a greater perturbation of intracellular metabolism and prolonged 
adjustments to increases in work rate such as those encountered in daily life.  As a result, 
slowed O2 kinetics may be related to the exercise intolerance observed in diseased 
populations.   For example, in some cardiovascular diseases the slowed O2 kinetics may 
result from a central impairment of oxygen delivery (e.g. cyanotic congenital heart 
disease (Sietsema et al. 1986)) whereas others may result from combined impairments of 
both cardiac output and peripheral skeletal muscle metabolic function (e.g. chronic heart 
failure) (Sietsema et al. 1994, Hepple et al. 1999).  In PAD, early observations of slowed 
O2 kinetics were attributed to the local mechanisms of blood flow limitation 
(Auchincloss et al. 1980, Haouzi et al. 1997) and/or to their abnormal skeletal muscle 
metabolism (Bauer et al. 1999, Barker et al. 2003).  However, there remain potential 
systemic abnormalities secondary to atherosclerosis in addition to the local circulatory 
and metabolic abnormalities associated with PAD that could not be entirely excluded.  
Thus, the relative contributions of impaired limb blood flow and abnormal muscle 
oxidative metabolism to the impaired oxygen uptake responses in PAD have not been 
systematically addressed.   
In this context, the following series of investigations sought to further characterize 
the systemic oxygen uptake kinetics during exercise in patients with intermittent 
claudication secondary to PAD and extend these observations to local muscle 
deoxygenation (e.g. oxygen extraction) measured at the level of the PAD-affected 
exercising muscle.  Localization of the PAD-associated oxygen uptake abnormalities and 
evaluation of the dynamic responses of muscle deoxygenation in the transition from rest 
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to exercise would provide further insight into the pathophysiology of exercise intolerance 
and functional disability in patients with peripheral arterial disease.   
The aims of these investigations were four-fold: 
1. Evaluate whether the abnormal pulmonary O2 kinetics in PAD are reflective of 
the systemic sequelae of atherosclerosis or can be attributed to peripheral factors 
local to the affected limbs in the PAD condition. 
2. Characterize the dynamics of calf muscle deoxygenation across the rest-exercise 
transition during treadmill walking in PAD and healthy control subjects.    
3. Evaluate muscle deoxygenation dynamics during single-leg, isolated calf muscle 
exercise in PAD and control subjects in relation to exercise work rate and limb 
blood flow responses.  
4. Describe the effects of revascularization and the resulting improvement in 
peripheral blood flow capacity on the abnormal pulmonary O2 kinetics and peak 
exercise response in patients with PAD. 
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 Background and Review of Literature: 
1.1  Peripheral Arterial Disease: History and Prevalence.  
Peripheral arterial occlusive disease (PAD) refers to a common atherosclerotic 
condition that impairs arterial blood flow to the lower extremities.  The primary symptom 
of PAD, intermittent claudication described as a cramping leg pain that occurs during 
exercise, has been recognized since the time of the Roman Empire.  However, it wasn’t 
until the early 19th century that the etiology of chronic peripheral arterial disease and the 
clinical symptoms of claudication were more clearly understood (Vascular Surgery: A 
Comprehensive Review1998).  Indeed, the term ‘claudication’ is derived from the Latin 
word ‘claudicatio’, meaning to limp, which accurately describes the gait pattern of 
patients affected by PAD.    
The first medical description of intermittent claudication involved carriage horses 
and was made by Jean-Francois Bouley jeune in 1831 in an oral report regarding 
claudication and subsequent collapse of a trotting horse (Sugar 1994).   The autopsy 
revealed the “obliteration of the femoral arteries” caused by fibrinous clots and led to 
Bouley jeune’s interpretation that muscle perfusion, even through the numerous 
anastomoses, was insufficient to support the demands of exercise (Bollinger et al. 2000).   
However, the modern characterization of intermittent claudication in human patients may 
well be credited to Jean-Martin Charcot in his 1858 report on the arterial obstruction and 
intermittent claudication in horse and man (Charcot 1858).  Charcot’s first human patient 
was a former soldier of the French conquest of Algeria who suffered an abdominal bullet 
wound that became embedded in his right iliac artery.   The patient presented with loss of 
peripheral arterial pulses, cool extremity, and exercise intolerance resulting from the 
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reduced arterial lumen.  This initial description of arterial stenosis, although of traumatic 
origin, formed the basis for what he and his students would later realize could also be 
caused by peripheral atherosclerosis (Bollinger et al. 2000).  Charcot’s characterization of 
the etiology of intermittent claudication in human patients remains accurate to the present 
day.   
Interest into the surgical management of PAD soon followed, and new surgical 
techniques were developed to address the hemodynamics of acute and chronic peripheral 
arterial problems.  The hemodynamics of PAD were characterized using both invasive 
and non-invasive methods, and by the late 20th century, evidence of the perturbed 
morphological and metabolic status of the PAD-affected skeletal muscle had been 
described.  More recently, descriptions of PAD-induced tissue injury and in vivo muscle 
bioenergetic abnormalities have spread research interest into the potential mechanisms of 
functional limitation in PAD and potential for non-surgical alternatives in the treatment 
of patients with claudication.  
Today, the prevalence of PAD comprises a significant health concern affecting an 
estimated 10-15 million adults in the general United States population and nearly 20% of 
those aged 70 years or greater (Criqui et al. 1985).  While the natural history of PAD is 
generally stable, up to 25% of patients may have progression of symptoms (Weitz et al. 
1996) and less than 5% will progress to the level requiring lower limb amputation (Leng 
et al. 1996).  Symptomatic PAD causes a significant functional impairment (Regensteiner 
et al. 1990), and patients report an adverse effect of PAD on health-related quality of life 
(Arfvidsson et al. 1993). The presence of PAD is equally distributed between women and 
men, and importantly, the presence of PAD confers a similar level of cardiovascular 
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morbidity and mortality due to cardiovascular events as people with prior myocardial 
infarction or stroke (Leng et al. 1996).  The increased risk of cardiovascular events 
extends to those patients with PAD but who remain asymptomatic (e.g. experiencing no 
claudication symptoms or pain at rest).  Thus, PAD confers a significant functional 
impairment due to the symptoms of intermittent claudication and, whether symptomatic 
or not, is associated with serious cardiovascular consequences.  
1.2 Atherosclerosis of the lower limbs  
Peripheral arterial disease is a common manifestation of atherosclerosis that 
causes narrowing and stenoses of the large and medium sized arteries of the body.  The 
risk factors for PAD are similar to those for other atherosclerotic diseases including: 
hypertension, hyperlipidemia, history of smoking, and elevated blood fibrinogen 
(Murabito et al. 2002). Due to its systemic nature, atherosclerosis is rarely confined to a 
specific circulatory region, and may often be present in the coronary, cerebral as well as 
the lower extremity peripheral arterial circulations in patients with PAD (Hertzer et al. 
1984, Ness and Aronow 1999).  Central to the disease process of atherosclerosis is the 
injury and dysfunction of the vascular endothelium.  Patients with atherosclerosis 
(including PAD) have a systemic abnormality in endothelial function that is associated 
with impaired flow-mediated vasodilation, reduced vascular reactivity, and enhanced 
platelet aggregation (Anderson et al. 1995, Lieberman et al. 1996).  A primary mediator 
of endothelial injury is considered to be oxidant stress from the generation of superoxide 
anion, an oxygen-derived free radical (Ohara et al. 1993, Tsao et al. 1995).  Indeed, 
elevated markers of oxidant stress and endothelial dysfunction are observed systemically 
in PAD and increase acutely with claudication-producing exercises (Liao et al. 1991, 
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Hickman et al. 1994, Belch et al. 1995, Brendle et al. 2001).  Importantly, this is 
consistent with the increased oxidative stress found in models of ischemia and ischemia-
reperfusion (Karmazyn 1991, Turrens et al. 1991).  Thus, in PAD systemic oxidant stress 
is elevated due to both the local muscle ischemic episodes occurring with exercise and 
the systemic disease process of atherosclerosis.   
The pathogenesis of atherosclerosis relates to the alterations in the vascular 
biology of the endothelium, such as the effects of oxidant stress and decreased bioactivity 
of nitric oxide (NO) and its synthesis (Tesfamariam and Cohen 1992, Tsao et al. 1995).  
Atherosclerotic arterial stenoses develop as a consequence of the local injury and 
inflammation of the affected endothelium.  Monocytes, attracted to the area of endothelial 
injury, infiltrate the sub-endothelial layers becoming engorged with oxidized low density 
lipoproteins (LDL) trapped below the endothelial surface (Ross 1997). The local immune 
and inflammatory responses promote further accumulation of macrophages and release 
reactive oxygen species that increase regional oxidative stress.  Over time, the 
accumulations of fatty macrophages (foam cells) form fatty streaks and ultimately 
atherosclerotic plaques in the arteries that may impinge upon the lumen and effectively 
reduce arterial diameter.  In PAD, atherosclerotic plaques form stenoses in the arterial 
circulation supplying the lower extremities, generally occurring in the femoral-popliteal 
arteries and aortoiliac arteries although distal tibial and pedal arteries may also be 
involved.   
1.3  Arterial hemodynamics and leg blood flow in peripheral arterial disease 
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The narrowing of arterial diameter due to atherosclerotic lesions alters arterial 
hemodynamics.  The changes in arterial hemodynamics can be described by Pouseille’s 
Law:  
P1 – P2 = · 8L0/r2 = Q · 8Ln/%r4     (1) 
where P1 – P2 represents the change in potential energy (e.g. mean arterial pressure) 
between two points separated by a distance, L, and where Q is blood flow,  is the mean 
blood velocity along a tube (or vessel) with an inside radius of r and n represents the 
coefficient of blood viscosity.  From this equation, it is clear that the internal radius of the 
artery plays a dominating role in determining arterial hemodynamics as blood flow and 
vessel resistance, R, are inversely proportional to the fourth power of the radius of the 
arterial vessel.  Resistance is described as : 
 R = P1 – P2/Q and R ∝ Ln/r4      (2) 
This has important effects on the lower extremity arterial hemodynamics in 
patients with PAD.  For example, over time as the radius of the artery is gradually 
reduced by an arterial stenosis, there is little change in the pressure gradient and blood 
flow across a stenosis until at least a 50% reduction in arterial diameter is attained 
(Vascular Surgery: A Comprehensive Review1998).  With further narrowing of the 
artery, the pressure gradient across the stenosis increases and blood flow may only be 
maintained as long as the peripheral resistance of distal vascular beds can continue to fall.  
Once peripheral resistance can no longer compensate, further decreases in arterial 
diameter cause flow and mean arterial pressure distal to the stenosis to decline towards 
zero.  The degree of stenosis at which mean arterial pressure and flow initially become 
affected is termed the critical stenosis.  In peripheral, high resistance circulations (such as 
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the resting lower limbs), a 90% stenosis may be required to observe a significant decrease 
in mean arterial pressure and blood flow at rest.  However, an increased velocity of blood 
flow such as with exercise may lower the threshold for a critical stenosis resulting from 
the loss of energy and apparent increase in resistance across the stenosis.  For example, a 
single low grade iliac stenosis may have no effect on resting limb blood flow at low 
resting blood velocities because of a compensatory decrease in peripheral resistance.  
However with the increased blood velocities during exercise, resistance increases across 
the stenosis requiring a greater drop in mean distal peripheral resistance to maintain 
and/or increase flow.  Thus, under the condition of high blood velocity, the same (non-
critical) resting stenosis may become hemodynamically limiting.  A decrease in mean 
arterial pressure distal to the stenosis with exercise may thus reflect the failure of blood 
flow to adequately increase to match the fall in peripheral resistance.   
The hemodynamic changes in the affected lower limbs of patients with PAD 
provide a useful index to assess hemodynamic severity.  Measured in the supine position 
using Doppler ultrasonography, the ankle-brachial index (ABI) is calculated as the ratio 
of systolic blood pressure of the artery in the ankle (dorsalis pedis or posterior tibialis) to 
that of the upper arm (Stoffers et al. 1996).   In healthy subjects the mean arterial pressure 
from the heart to the ankle decreases by only a few millimeters of mercury.  As the pulse 
travels distally from the heart, the pulse pressure widens and systolic pressure increases 
due to the reflection of waves from the high resistance arteriolar beds.  Thus, at rest in 
normal subjects, the ankle systolic pressure will generally exceed that of the arm yielding 
an ABI of 1.0 or greater.  As discussed above, arterial stenoses require a drop in 
peripheral resistance to maintain a normal resting limb blood flow.  The main result is the 
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reduction of systolic pressure distal to the stenosis (e.g. ankle arteries).  An ABI of 0.90 
or less is diagnostic for PAD.  Importantly, the hemodynamic severity of peripheral 
arterial disease is correlated with the maximal increase in limb blood flow following 
exercise (Sumner and Strandness, Jr. 1969).  
The hemodynamics of the lower limb in patients with intermittent claudication 
disease are altered.  At rest, patients with intermittent claudication have normal lower 
limb blood flow and no ischemic symptoms (Hillestad 1963a, Hillestad 1963b, Folse 
1965, Hlavova et al. 1965, Hlavova et al. 1966, Pernow and Zetterquist 1968, Wahren et 
al. 1973, Pernow et al. 1975, Sorlie and Myhre 1978, Bernink et al. 1982, Pentecost 2003, 
Strandell and Wain 2003).  Resting blood flow is maintained due to the compensatory 
decrease in peripheral resistance distal to the arterial occlusions.  With exercise and the 
demand for an increase in leg blood flow, intramuscular arterioles dilate in the working 
muscles causing a further decrease in peripheral resistance and a proportional increase in 
leg blood flow (Sumner and Strandness, Jr. 1970).  Thus, patients with intermittent 
claudication may demonstrate a normal increase in leg blood flow with initial step 
increases in work rate (Folse 1965, Hlavova et al. 1965, Hlavova et al. 1966, Pernow and 
Zetterquist 1968, Wahren et al. 1973, Pernow et al. 1975, Sorlie and Myhre 1978, 
Bernink et al. 1982, Pentecost 2003).  However, with further increases in exercise work 
rate, leg blood flow may reach a plateau (Folse 1965, Hlavova et al. 1965, Wahren et al. 
1973, Pernow et al. 1975, Sorlie and Myhre 1978) secondary to the failure of peripheral 
resistance to further decrease.  With additional increases in exercise work rate, the blood 
flow limitation results in a supply-demand mismatch of oxygen delivery to meet the 
metabolic demands of the working muscle.  This mismatch results in muscle ischemia 
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(defined by a reduction in blood flow and oxygen delivery), the symptoms of claudication 
pain, and presumably the abnormally low peak exercise capacity characteristic of this 
patient population.  
1.4  Skeletal muscle histology in peripheral arterial disease 
Distal to the arterial stenoses, the skeletal muscle of patients with PAD is 
associated with a spectrum of histological changes compared with healthy, normal 
muscle.  Grossly, skeletal muscle fibers in patients with PAD are generally smaller (e.g. 
have a smaller fiber area) than in healthy subjects (Teravainen and Makitie 1977, 
Henriksson et al. 1980, Clyne et al. 1982, Clyne et al. 1985, Regensteiner et al. 1993, 
McGuigan et al. 2001), and muscle capillarization (number of capillaries per fiber) is 
often increased in PAD-affected skeletal muscle (Makitie 1977, Hammarsten et al. 1980, 
Henriksson et al. 1980, Clyne et al. 1985, McGuigan et al. 2001).  In severe ischemic 
disease, inflammation, necrosis, fiber atrophy, and fiber regeneration have been observed 
in affected skeletal muscle (Henriksson et al. 1980, Clyne et al. 1985).  These 
observations are consistent with the pathology of muscle damage and denervation due to 
chronic ischemia (Sjostrom et al. 1980).  Similar but less severe abnormalities have been 
described in the affected skeletal muscles of patients with moderate ischemic disease.  
Sjostrom et al. (1980) described a shift of nuclei from peripheral to central locations 
within skeletal muscle (Sjostrom et al. 1980).  There may also be infiltration of 
inflammatory cells into the affected skeletal muscle of patients with PAD (Sjostrom et al. 
1980).  The skeletal muscles of patients with PAD have a greater proportion of angular 
muscle fibers than healthy muscle suggesting fiber denervation, and large groupings of 
muscle fibers by fiber type suggesting the subsequent re-innervation of denervated 
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muscle in the affected legs (Teravainen and Makitie 1977, Sjostrom et al. 1980, 
Regensteiner et al. 1993).  Within the muscle cells, myofibrillar abnormalities (e.g. Z-
band deviations) have been observed (Sjostrom et al. 1980).  Additionally, mitochondrial 
content is often increased (Elander et al. 1985, Jansson et al. 1988, Lundgren et al. 1989, 
Hiatt et al. 1996) but mitochondria may appear abnormal (Teravainen and Makitie 1977, 
Sjostrom et al. 1980), and the arrangement of the sarcoplasmic reticulum may be poorly 
organized (Sjostrom et al. 1980).  Indeed, based upon the histological changes alone, 
PAD skeletal muscle has been termed an arteriovasculo-occlusive myopathy (Sjostrom et 
al. 1980).   
Human skeletal muscles are heterogeneously composed of fibers with distinct 
twitch (slow versus fast) and metabolic (oxidative versus glycolytic) characteristics.  The 
classical description of skeletal muscle divides muscle fibers into two primary types 
defined histochemically by ATPase activity or by immunohistochemistry specific for 
distinct myosin heavy chain isoforms.  Type I muscle fibers are slowly contracting, non-
fatigable muscle fibers with a high content of mitochondria and oxidative enzymes.  Type 
II fibers are fast contracting, fatigable muscle fibers with a high content of glycolytic 
enzymes.  Type II fibers can be further divided into at least two subclasses: type IIa, a 
fast, oxidative fiber with modest to high mitochondrial content and type IIb, a fast, 
primarily glycolytic fiber with very low mitochondrial content.  More recently, a third 
type II muscle fiber, IIx, has been described with an intermediate oxidative capacity to IIa 
and IIb fibers and a distinct myosin heavy chain isoform (Smerdu et al. 1994).  Early 
studies of fiber type populations and proportions in PAD muscle are confusing but 
indicate similar relative percentages of type I  and type II muscle fibers in PAD-affected 
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muscle compared with control (Hammarsten et al. 1980, Henriksson et al. 1980, Sjostrom 
et al. 1980).  With increasing hemodynamic severity, the percentage of type I fibers and 
expression of the myosin heavy chain I isoform may become reduced (McGuigan et al. 
2001) although this has not been universally observed (Makitie and Teravainen 1977, 
Steinacker et al. 2000).  Reports of the proportion of type II fibers in PAD muscle are 
conflicting with observations of an increased (Henriksson et al. 1980) or decreased 
(Hammarsten et al. 1980) percentage of type IIb fibers.  These inconsistencies likely 
result from the diverse hemodynamic severity and small numbers of patients typically 
studied.  Steinacker et al. (2000) described no differences in myosin heavy chain isoform 
expression between patients with mild PAD (e.g. ABI ~ 0.82) compared with control 
subjects.  However, there was a reduced percentage of the IIb myosin heavy chain 
isoform in patients with moderate PAD (ABI ~ 0.59) and reductions in both IIa and IIb 
isoforms in cases of severe PAD (e.g. chronic leg ischemia, ABI ~ 0.36) (Steinacker et al. 
2000).  In a larger trial, McGuigan et al. (2001) found an increased percentage of type IIx 
fibers in the muscle of intermittent claudicants (ABI ~ 0.62) compared with controls 
(McGuigan et al. 2001).   
Though unresolved, these data suggest that type I and II fibers are generally 
reduced in size and the expression of myosin heavy chain IIx isoform increases with the 
presence of PAD.  Further, the skeletal muscles of intermittent claudicants show greater 
capillarization compared with control muscle, and there is a spectrum of other 
histological abnormalities consistent with significant skeletal muscle damage.  Whether 
these observations indicate a general shift in the relative proportions of type I to type II 
fibers or within type II fiber subpopulations in PAD-affected skeletal muscle (Henriksson 
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et al. 1980, Clyne et al. 1985, Regensteiner et al. 1993, McGuigan et al. 2001) remains to 
be determined.  Fiber atrophy, ischemic injury, and disuse secondary to the sedentary 
nature of patients with intermittent claudication remain significant confounders to the 
questions of skeletal muscle damage and histological changes in patients with PAD.   
1.5    Skeletal muscle metabolism in intermittent claudication 
Secondary to the arterial occlusions and ischemic episodes with exercise in 
patients with PAD are abnormalities in the metabolism of affected skeletal muscle.  As a 
general observation, there appear to be increases in the activities of important individual 
enzymes of glycolysis, the citric acid cycle, and oxidative phosphorylation with mild to 
moderate peripheral arterial disease.  For example, hexokinase tends to be elevated 
(Pastoris et al. 1996), and the rate limiting enzymes of glycolysis, phosphofructokinase 
and pyruvate kinase, have higher activities in PAD-affected muscle compared with 
controls (Bylund et al. 1976, Clyne et al. 1985).  Lactate dehydrogenase is also elevated 
in PAD muscle (Clyne et al. 1985, Schweiger 1991, Pastoris et al. 1996).  In the citric 
acid cycle, the rate limiting enzymes of citrate synthase and isocitrate dehydrogenase are 
also elevated in PAD-affected skeletal muscle compared with healthy, sedentary subjects 
(Bylund et al. 1976, Elander et al. 1985, Jansson et al. 1988, Lundgren et al. 1989, 
Schweiger 1991, Schersten et al. 2001) as are other non-rate limiting enzymes (fumarase 
and malate dehydrogenase) (Schweiger 1991).  Cytochrome c oxidase, a key enzyme in 
the oxidation of NADH and FADH by electron transport, is also elevated in PAD skeletal 
muscle (Bylund et al. 1976, Elander et al. 1985, Lundgren et al. 1989, Schweiger 1991, 
Schersten et al. 2001).  Additionally, increases in enzyme activities associated with beta-
oxidation (3 OH, acyl-Coenzyme A dehydrogenase) and amino acid metabolism (alanine 
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amino transferase) are observed in PAD (Bylund et al. 1976, Lundgren et al. 1989, 
Schweiger 1991).  Thus, the capacity for glycolytic and oxidative reactions generally 
appears to be elevated in the skeletal muscle of patients with PAD.   
However, there is also evidence that several key enzyme activities appear to be 
reduced in PAD.  The pyruvate dehydrogenase (PDH) complex converts pyruvate into 
acetyl-Coenzyme A for subsequent metabolism by the citric acid cycle.  The control of 
this enzyme is complicated, being inhibited directly by the accumulation of its products 
(NADH and acetyl-Coenzyme A) and well as by phosphorylation by individual enzymes 
loosely bound to it’s core (PDH phosphatase, and PDH kinase)(Voet and Voet 1995).  In 
resting PAD muscle, the activity of the pyruvate dehydrogenase complex may be reduced 
(Barker et al. 2003) suggesting a potential abnormality in regulating the entry of glucose 
subunits into the citric acid cycle.  Moreover, there are abnormalities in electron transport 
chain complexes I and III in skeletal muscle (Brass et al. 2001).  Normalized to 
mitochondrial content, the activities of NADH dehydrogenase (complex I) and ubiquinol- 
cytochrome c oxidoreductase (complex III) are reduced in PAD muscle compared with 
control subjects.  Thus, there appear to be potential differences from normal muscle in the 
regulation of key enzymes and activity of the fundamental electron transport processes 
necessary to convert the free energy conserved from upstream reactions to ATP in PAD 
skeletal muscle.   
These changes may explain the accumulation of intermediates of metabolism in 
the affected skeletal muscle in PAD.  At rest, lactate concentration is higher in the 
skeletal muscle and the venous effluent of the affected limbs (Hiatt et al. 1992, Pastoris et 
al. 1996, Maass and Alexander 2001). This could result from an ischemic state due to a 
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low oxygen delivery or a preferential shunt away from pyruvate oxidation secondary to 
an inactive PDH activation state.  Acylcarnitine concentrations are also increased in the 
affected skeletal muscle and plasma of PAD patients (Hiatt et al. 1987, Hiatt et al. 1992).  
Because acylcarnitine concentration is in equilibrium with acyl-Coenzyme A 
concentrations (via the reversible acyl-transferase reaction), this accumulation indicates 
incomplete substrate oxidation, and particularly that of acetyl-Coenzyme A.  Importantly, 
the accumulation of acylcarnitines in PAD skeletal muscle is inversely related to peak 
exercise capacity suggesting that the abnormal metabolism was related to the observed 
limitation in PAD exercise performance (Hiatt et al. 1992).  Indeed, acetyl-Coenzyme A 
tends to be increased in PAD skeletal muscle (Barker et al. 2003) a factor which could 
independently reduce PDH activity.   As acetyl-Coenzyme A groups form the common 
substrate for entry into the citric acid cycle, this reflects a downstream obstruction in 
substrate oxidation.   This is consistent with the observed increase in concentration of the 
citric acid cycle substrate, alpha-ketoglutarate, in PAD skeletal muscle (Pastoris et al. 
1996).  Alpha-ketoglutarate is the intermediate product of two rate limiting citric acid 
cycle enzymes: isocitrate dehydrogenase and alpha-ketoglutarate dehydrogenase.  The 
accumulation of these products could suggest a common mechanism of altered enzymatic 
control in PAD skeletal muscle.  For example, ischemia as well as an independent 
impairment in electron transport can abnormally increase the cellular redox potential 
(NADH/NAD+).  Increases in the redox potential inhibit the activity of pyruvate 
dehydrogenase, isocitrate dehydrogenase, as well as alpha-ketoglutarate dehydrogenase.  
As a result, the substrates of these reactions increase.  Thus, the accumulation of 
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metabolic intermediates are suggestive that alterations in enzymatic control and function 
in PAD muscle may have functional metabolic consequences.   
As mentioned earlier and consistent with the observations of elevated activities of 
some individual oxidative enzymes, the mitochondrial content of PAD-affected skeletal 
muscle is elevated compared with control muscle (Elander et al. 1985). In healthy 
subjects, mitochondrial content and oxidative enzyme activities positively correlate with 
peak exercise capacity (Wang et al. 1999).  As increases in mitochondrial activities are 
associated with exercise training and become reduced following detraining or bed rest, 
there is a relationship between muscle oxidative capacity and exercise performance in 
healthy individuals (Holloszy and Coyle 1984, Wibom et al. 1992).  This relationship is 
absent in patients with intermittent claudication who have paradoxically increased 
activities of oxidative enzymes (Bylund et al. 1976, Elander et al. 1985, Gerdle et al. 
1986, Lundgren et al. 1989, Schweiger 1991, Schersten et al. 2001) despite their limited 
walking ability and sedentary behavior.  Because the increased mitochondrial expression 
is proportionate to the severity of impaired leg hemodynamics in mild to moderate (but 
not severe) PAD patients (Jansson et al. 1988), these changes have been interpreted as 
compensatory adaptations to the primary exercise impairment in oxygen delivery and 
resulting low muscle PO2 in patients (Bylund et al. 1976, Bylund-Fellenius et al. 1984a, 
Bylund-Fellenius et al. 1984b, Elander et al. 1985, Jansson et al. 1988).  Thus, the 
increased skeletal muscle mitochondria and expression of oxidative enzymes of these 
patients appear to reflect the severity of the lower limb hemodynamic impairment.  The 
metabolic significance of these increases with PAD may be attributed to improved 
control of oxidative ATP synthesis.  For example, an increased mitochondrial content and 
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oxidative capacity would require less of an increase in the potential controllers of 
mitochondrial respiration (e.g. free [ADP]) to maintain a particular rate of oxidative ATP 
production (Elander et al. 1985, Wang et al. 1999).  Thus, an increase in mitochondrial 
content and oxidative enzyme activities in PAD muscle could minimize the perturbation 
of intracellular energy stores and improve the control of oxidative ATP generation.  
Indeed, some studies of isolated mitochondria from PAD-affected skeletal muscle have 
suggested normal oxidative function in PAD (Elander et al. 1985, Hou et al. 2002).   
However, normal oxidative function in PAD affected skeletal muscle measured in vivo is 
not universally observed (Hands et al. 1986, Hands et al. 1990, Pipinos et al. 2000).   
Whether these conflicting data are due to differences between in vivo versus in vitro 
preparations remains unclear.  However, it should be noted that neither total 
mitochondrial content nor in vitro oxidative function predicts functional exercise capacity 
in patients with intermittent claudication.  Moreover, there is a methodological concern of 
mitochondria isolation techniques particularly regarding the isolation of mitochondrial 
sub-populations that further confuse these data.  Thus, at present there is no compelling 
evidence that changes in total mitochondrial content or maximal oxidative enzyme 
activities are directly related to the functional exercise limitation in patients with PAD. 
Increases in mitochondrial content and oxidative enzymes could also reflect a 
compensatory mechanism for an intrinsic abnormality in mitochondrial oxidative 
capacity (DiMauro 2004).  The production of proteins destined for oxidative synthesis 
from mitochondrial and nuclear sources are not well coordinated (Duborjal et al. 2002).  
Thus, increases in the activity of nuclear versus mitochondrial encoded oxidative 
enzymes are a classic characteristic of mitochondrial diseases.  Moreover, there is 
 19
evidence that mitochondria are the target of oxidative injury in PAD patients.  For 
example, there is an accumulation of somatic mitochondrial DNA deletions in the 
affected skeletal muscle of PAD patients compared with age-matched control muscle 
(Bhat et al. 1999).  The mitochondrial DNA encodes for 13 peptide subunits involved in 
oxidative phosphorylation: seven subunits for complex I, one for complex III, three for 
complex IV, and two for the ATPase of complex V.  Thus, one basis for the development 
of an acquired mitochondrial myopathy may reside with the deletion of important 
mitochondrial DNA base pairs.   These deletions can adversely affect the transcription of 
peptide subunits necessary for normal enzyme synthesis and oxidative phosphorylation 
with functional consequences (DiMauro 2004).  In PAD, the documented abnormalities 
in electron transport function, particularly of NADH dehydrogenase of complex I and 
ubiquinol-cytochrome c oxidoreductase of complex III in PAD-affected muscle (Brass et 
al. 2001), are consistent with the mitochondrial DNA injury and electron transport 
dysfunction observed in ischemic myocardium (Rouslin 1983, Rouslin and Ranganathan 
1983).  Because mitochondria are also a major producer of oxygen free radicals, this 
injury may lead to further generation of reactive oxygen species resulting in a feed-
forward system of oxidative injury and mitochondrial dysfunction.   Collectively, 
mitochondrial DNA deletions, abnormal electron transport function, as well as the 
pronounced increase in activities of nuclear encoded oxidative enzymes are characteristic 
of heteroplasmic and inherited mitochondrial diseases (e.g. mitochondrial 
myopathy)(DiMauro 2004). Thus, the changes in mitochondrial content and oxidative 
enzymes may reflect a partial compensation for an acquired mitochondrial myopathy that 
could impair oxidative function in patients with PAD.   
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1.6  Response to exercise in intermittent claudication 
Systemic measures of exercise performance are generally assessed by oxygen 
consumption measured non-invasively at the level of the mouth (e.g. pulmonary O2) 
which encompasses the total changes in oxygen uptake by exercising muscle and non-
active tissues.  Because pulmonary O2 is coupled to tissue oxygen uptake via the 
circulation (and providing pulmonary gas exchange is not limited), increases in 
pulmonary O2 during exercise predominantly reflect the increases in oxygen uptake 
occurring at the level of the working skeletal muscles.  Thus, peak O2 can be calculated 
as the product of systemic oxygen extraction (a-vO2 difference) and cardiac output (Q, 
blood flow) at peak exercise as described by the Fick principle: 
O2 = Q · a-vO2 difference     (4) 
Exercise tolerance is profoundly reduced secondary to claudication symptoms in 
patients with peripheral arterial disease.  With the onset of claudication symptoms 
walking ability is reduced in PAD, limiting exercise performance to merely a few city 
blocks in the typical patient.   This free-living exercise impairment can be reproducibly 
demonstrated in the laboratory during graded exercise testing in patients with 
claudication.   For example, peak O2 is reduced during incremental treadmill exercise 
by approximately 50% in PAD patients compared with healthy subjects of similar age 
(Hiatt et al. 1987, Hiatt et al. 1988, Hiatt et al. 1992, Regensteiner et al. 1993, Bauer et al. 
1999, Askew et al. 2002).  Because patients with PAD stop exercising prematurely due to 
the local symptoms of claudication pain rather than from generalized fatigue, peak heart 
rate, blood pressure, and respiratory exchange ratio rarely approach the peak values 
observed in healthy control subjects (Eldridge and Hossack 1987, Hiatt et al. 1988, Bauer 
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et al. 1999).  Moreover, PAD patients do not generally demonstrate evidence of a 
systemic lactate threshold by estimates from pulmonary gas exchange (V-slope) or from 
measures of venous lactate (Hiatt et al. 1988, Bauer et al. 1999, Maass and Alexander 
2001).  Thus, the primary hemodynamic compromise leading to muscle ischemia and 
claudication pain during incremental exercise in PAD is a likely determinant to their peak 
exercise impairment.   
In healthy subjects, blood flow is a major determinant of peak O2, particularly 
during exercise of exercise-trained muscle (Andersen and Saltin 1985, Richardson et al. 
1995, Wagner 1996, Richardson et al. 1998, Richardson et al. 1999a).  In patients with 
PAD, many histological (increased capillarization and mitochondrial content) and 
metabolic (increased activities of most oxidative enzyme) changes that occur in PAD-
affected skeletal muscle are similar to that observed in exercise-trained healthy muscle.  
Thus, the simple conclusion is that the lower limb hemodynamic limitation is the primary 
determinant of exercise performance.  However, as muscle oxygen extraction at peak 
exercise may approach a diffusion-limited maximum in PAD (Zetterquist 1970), the 
capacity for oxygen extraction at peak exercise may be an equally important determinant  
(Pernow et al. 1975).  This may explain how exercise blood flow sometimes (Alpert et al. 
1969, Green 2002), but not always (Pernow and Zetterquist 1968, Zetterquist 1970, Hiatt 
et al. 1992, Gardner et al. 1992) correlates with peak exercise performance.  In contrast to 
hemodynamic measures, there is a significant inverse correlation between the abnormal 
metabolism of affected skeletal muscle (accumulation of acylcarnitines) and peak 
exercise capacity (Hiatt et al. 1992).  This fact emphasizes the relative importance of both 
impaired leg blood flow responses and muscle metabolism in the determination of PAD 
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exercise performance.  Thus, while the primary pathophysiology of patients with 
intermittent claudication is the hemodynamic compromise that occurs with exercise, 
abnormal muscle oxidative metabolism may also explain a portion of the exercise 
impairment in patients with peripheral arterial disease.   
1.7   Exercise Bioenergetics 
Following the onset of exercise, total muscle ATP turnover increases with 
negligible delay relative to the ATP demand of the skeletal muscle contractile elements.  
The re-generation of ATP to sustain the near-invariant intracellular [ATP] with exercise 
initially arises from the depletion of phosphocreatine (PCr) via the Lohman reaction and 
from glycolysis.  Oxidative resynthesis of ATP increases following exercise onset but 
follows a slower and more finite time course dictated by the control of mitochondrial 
respiration in the physiological range of intracellular pH and PO2 (Whipp and Mahler M. 
1980, Barstow et al. 1994, Kemp et al. 2002, Kemp 2005).  While the precise 
determinants in the control of oxidative metabolism remain unclear, oxidative resynthesis 
of ATP appears to follow a monoexponential rise that may be related to changes in [PCr], 
free[ADP], [Pi], and the free energy change of [ATP] as described by first order 
Michaelis-Menten kinetics (Barstow et al. 1994, Behnke et al. 2002, Grassi et al. 2002).   
In healthy subjects, following the onset of moderate exercise, the decrease in 
[PCr] can be described by an exponential function without a delay to a new steady state 
(Barstow et al. 1994, Rossiter et al. 1999).  The depletion of [PCr] acts as a buffer (and 
perhaps a signal) for the maintenance (via oxidative resynthesis) of cellular [ATP] such 
that the temporary mismatch between oxidative ATP synthesis and ATP use is reflected 
by the change in [PCr].   The time course and magnitude of [PCr] decrease following 
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exercise onset thus reflect the relationship between the acceleration of oxidative 
metabolism and ATP utilization.  Thus, the intramuscular processes (or limitations) that 
control the rate of increase of mitochondrial oxygen utilization may be expressed in the 
dynamic increase of muscle O2 (e.g. the accumulation/action of potential controllers of 
mitochondrial respiration and O2 availability).   
Following the onset of claudication-producing exercise in patients with PAD,  
[PCr] decreases to a greater extent and with a slower time course (time constant) 
compared with control subjects at a similar exercise work rate (G.J. Kemp, personal 
communication 12/2004)(Hands et al. 1986, Kemp et al. 1995, Kemp et al. 2001).  The 
change in [PCr] is associated with an increased [ADP] needed to sustain a given increase 
in oxidative ATP resynthesis at end-exercise (Kemp et al. 1993).  A greater fall in [PCr] 
during ischemia-producing exercise in PAD is also observed in healthy humans during 
exercise while breathing a hypoxic mixture (Haseler et al. 1998, Haseler et al. 2004), 
which is consistent with the changes in [PCr] during ischemia and hypoxemia in 
contracting canine skeletal muscle (Hogan et al. 1992).  However, it should be noted that 
in healthy skeletal muscle the greater fall of [PCr] under hypoxic conditions is not 
associated with a slower time course of [PCr] depletion (Haseler et al. 2004).  In PAD, 
the slowed dynamics of [PCr] depletion may be related with a slowed time course of the 
rise in oxidative ATP synthesis requiring a greater contribution of ATP synthesis from 
glycolysis and glycogenolysis early in the exercise transition, thus reflecting a potential 
abnormality in the control of or function of oxidative metabolism in exercising PAD 
skeletal muscle (Kemp et al. 2002). The slow increase of oxidative metabolism in PAD 
muscle may cause the adverse result of a greater perturbation of intracellular homeostasis 
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by the alterations in [PCr], free [ADP] and increasing H+ secondary to the increased 
reliance on glycolytic ATP production.  Thus, the intracellular accumulation of 
metabolites and depletion of preferred metabolic substrates (e.g. glycogen) associated 
with slowed dynamics of oxidative metabolism may contribute to muscle dysfunction and 
the exercise intolerance observed in PAD.  
The recovery from exercise is also abnormal in patients with PAD.  Because the 
recovery of [PCr] is almost entirely dependent upon the oxidative resynthesis of ATP, 
slowed recovery dynamics of [PCr] and calculated free [ADP] are indicative of abnormal 
mitochondrial respiration (Hands et al. 1986).  In PAD, the time course of [PCr] recovery 
following claudication-producing exercise is slowed compared with healthy muscle 
(Hands et al. 1986, Kemp et al. 1993, Kemp et al. 1995, Kemp et al. 2001) and is related 
to the slowed dynamics of muscle re-oxygenation (and thus presumably blood flow) due 
to the arterial occlusions (Kemp et al. 2001).  However, even when exercise is not 
associated with a decrease in muscle pH or the development of claudication pain, [PCr] 
recovery remains altered (Pipinos et al. 2000) suggesting an intrinsic impairment in 
mitochondrial function that may be independent of the muscle blood flow limitation 
(Pipinos et al. 2000, Kemp 2005).  This latter view is supported by the findings that [PCr] 
recovery following exercise remains abnormal after revascularization despite an acute 
improvement in limb hemodynamics (Zatina et al. 1986).  These data suggest the 
impairment in blood flow may explain a portion of the mitochondrial dysfunction 
observed in recovery from ischemia-producing exercise.  However, the altered dynamics 
of [PCr] and free [ADP] following exercise onset and during recovery from non-ischemic 
exercise as well as after post-revascularization are most consistent with an impairment in 
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mitochondrial function in PAD skeletal muscle even when a limitation in limb blood flow 
and oxygen delivery may not be manifest. These changes ultimately have important 
influences on the expression and dynamics of skeletal muscle O2 in the rest-to-exercise 
transition.   
1.8    Pulmonary O2 kinetics  
In the transition from rest to exercise, the rate of increase in muscle oxygen 
consumption ( O2 kinetics) is not instantaneous, but rather follows an exponential course 
determined by the dynamics of increasing oxidative metabolism (e.g. O2 utilization) and 
possibly the delivery of oxygen.  Further, the increase in muscle O2 is coupled to that of 
pulmonary O2 through predictable interactions of blood volume, gas stores, and 
circulatory transit delays such that dynamic increases in pulmonary O2 may reflect 
those occurring at the level of the exercising muscle (Barstow et al. 1990, Grassi et al. 
1996, Rossiter et al. 1999).  Thus, measurement of pulmonary O2 in the transition from 
rest to exercise provides a useful, non-invasive method for evaluation of the integration 
of cardiovascular, pulmonary, and muscle systems in health and disease.   
Classically, pulmonary O2 kinetics are characterized by three temporal phases 
described using modeling techniques with distinct exponential components: 
O2(t)= O2(b) + A1(1 - e-(t-TD1)/τ1)   phase I        
         + A2[1- e -(t-TD2)/τ2]   phase II 
         + A3[1- e -(t-TD3)/τ3]   slow component               (5)    
The model provides estimates of the baseline O2 ( O2(b)), amplitudes of the 
increase in O2 for the individual exponential components (A1, A2, A3), independent 
time delays for the onset of each exponential phase (TD1, TD2, TD3), and time constants 
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of the respective exponential responses (τ1, τ2, τ3).  With little delay following the onset 
of exercise, phase I reflects a rapid increase in pulmonary O2 above baseline resulting 
from an abrupt increase in cardiac output and pulmonary gas exchange (Casaburi et al. 
1989).  This phase is typically of short duration lasting approximately 15-20 seconds 
during cycle exercise and with a time course that roughly corresponds to a transit delay 
for blood arriving from the exercising limbs (Barstow and Mole 1987).  Thus, phase I 
represents an immediate increase in pulmonary O2 that is largely independent of 
increases in muscle O2 (Grassi et al. 1996).   Upon arrival of desaturated venous blood 
from the exercising muscles, phase II begins and pulmonary O2 increases with an 
exponential time course similar to that of muscle O2 and [PCr] depletion (Whipp and 
Mahler M. 1980, Barstow and Mole 1987, Barstow et al. 1990, Grassi et al. 1996, 
Rossiter et al. 1999).  Phase III reflects the steady state of oxygen consumption for 
exercise moderate intensity work rates defined as work rate below the individual’s lactate 
threshold.   However, for work rates above the individual’s lactate threshold, phase III 
may demonstrate further increases secondary to a slowly developing additional oxygen 
consumption above that predicted from the O2/WR relationship from moderate intensity 
work rates (Whipp and Mahler M. 1980).  The phase III increase in oxygen consumption 
(e.g. the O2 slow component) is derived predominantly from the exercising legs (Poole 
et al. 1991) possibly reflecting an increase in the recruitment of ‘lower efficiency’ type II 
muscle fibers with sustained heavy intensity exercise or a difference in the relative 
composition of type II to type I fibers in the skeletal muscle.  The precise mechanisms of 
which remain to be more fully elucidated.   
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As noted above, pulmonary O2 kinetics during phase II are closely matched with 
the dynamic increase in muscle O2.  The evidence for this relationship comes primarily 
from the work of several groups.  Using modeling simulations, Barstow and colleagues 
(1987 & 1990) suggested that muscle O2 dynamics could be predictably described in 
the expression of phase II pulmonary O2 kinetics (Barstow and Mole 1987, Barstow et 
al. 1990).  More directly, Grassi and colleagues (1996) measured muscle O2 kinetics 
invasively using catheterization techniques and found similar time constants with the 
phase II pulmonary O2 responses during exercise in human subjects (Grassi et al. 1996).  
Rossiter et al. (1999) made simultaneous measurements of [PCr] depletion and 
pulmonary O2 kinetics that allowed the description of a close temporal time course 
between muscle bioenergetics and phase II pulmonary O2 responses during moderate 
exercise (Rossiter et al. 1999).  This was consistent with previous studies where 
simultaneous measurements could not be obtained (Barstow et al. 1994, Grassi et al. 
1996, McCreary et al. 1996, Chilibeck et al. 1998).  Thus, at least in healthy subjects 
during moderate exercise transitions, these observations have led to the conclusion that 
muscle O2 kinetics are closely matched to the expression of pulmonary O2 measured 
at the level of the mouth.   
Considerable debate has been centered on the primary determinants of the O2 
kinetic response to exercise.  One view contends that O2 kinetics are determined by the 
dynamics of blood flow and oxygen delivery.  Thus, a shortfall in oxygen supply 
constrains the dynamics of oxygen uptake following the onset of exercise (Hughson 
1990).  This view is largely supported by observations where O2 kinetics were slowed 
under conditions that might impair oxygen delivery.  For example, O2 kinetics are 
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slowed by the administration of beta-blockade in healthy subjects (Petersen et al. 1983, 
Hughson 1984).  This finding was attributed to the effect of beta-blockade slowing 
cardiac output dynamics and thus bulk delivery of blood flow.   Moreover, body position 
appears to affect O2 kinetics such that O2 kinetics during leg exercise are slower in 
the supine position compared to the upright position in healthy subjects (Hughson et al. 
1991, Hughson et al. 1993, MacDonald et al. 1998).   That the slowed O2 kinetics were 
then speeded to values similar to that of upright exercise by the application of lower body 
negative pressure appears to support a blood flow limitation to the O2 kinetic response, 
at least during supine exercise (Hughson et al. 1993).  Similar support has come from an 
apparent slowing of O2 kinetics during forearm exercise with the arm elevated above 
the heart compared to the arm in a dependent position (Hughson et al. 1996).  These data 
have been interpreted to suggest that perfusion pressure to the exercising muscles may 
play an important role in the determination of O2 kinetics, a factor that may become 
reduced in both the supine and elevated arm positions.  Another factor in altering oxygen 
delivery is through the lowering of arterial oxygen content by breathing hypoxic gas 
mixtures.  This has been shown to slow the O2 kinetic response (Springer et al. 1991, 
Hughson and Kowalchuk 1995, Engelen et al. 1996) consistent with a reduction in 
oxygen diffusion due to a lowering of the capillary-mitochondrial PO2 gradient (Koike et 
al. 1990).  Thus, there is evidence that O2 kinetics may be slowed under conditions of 
significant blood flow or oxygen delivery compromise.    
An opposing view has suggested that muscle O2 kinetics are determined by the 
intramuscular metabolic processes that affect muscle O2 utilization (Whipp and Mahler 
M. 1980).  This concept, termed ‘metabolic inertia’ (Grassi et al. 1996), is supported by a 
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series of experiments comparing the dynamics of blood flow and oxygen consumption.   
For example, the kinetics of cardiac output are normally faster than pulmonary O2 (De 
et al. 1991, Yoshida and Whipp 1994).   Non-invasive studies of limb blood flow 
dynamics using ultrasonic Doppler technology and pulmonary O2 have demonstrated 
faster limb blood flow dynamics than pulmonary O2 kinetics during the transition from 
rest to moderate exercise (Hughson et al. 1996, MacDonald et al. 1998).   Invasive 
studies confirm faster increases in directly measured leg blood flow than leg oxygen 
uptake during moderate and intense exercise (Grassi et al. 1996, Bangsbo et al. 2000).  
These studies also suggested that following the onset of contractions, muscle oxygen 
delivery may transiently exceed muscle oxygen uptake resulting in a decrease (Grassi et 
al. 1996) or delay (Bangsbo et al. 2000, Behnke et al. 2001) in oxygen extraction 
following exercise onset.  Moreover, as described above, the dynamics of a potential 
controller of muscle mitochondrial respiration ([PCr] kinetics) closely match the phase II 
pulmonary O2 kinetic response (Rossiter et al. 1999).   While these data are suggestive 
of an intrinsic metabolic limitation, more compelling evidence of an intrinsic muscle 
metabolic limitation to O2 kinetics would come from experiments that tested whether 
O2 kinetics could become faster under conditions of increased blood flow and oxygen 
delivery.  For example, in patients who underwent heart transplantation, Grassi et al. 
(1997) found no difference in pulmonary O2 kinetics during exercise transitions after a 
“priming” bout of prior exercise (Grassi et al. 1997).  The significance of this experiment 
was that an elevated cardiac output (resulting from the first bout of exercise) prior to and 
during the exercise transient of the second bout did not cause an appreciable speeding of 
pulmonary O2 kinetics.  Further, using animal preparations of isolated canine muscle, 
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Grassi et al. (1998a) were able to increase blood flow to exercise levels prior to beginning 
exercise contractions (Grassi et al. 1998a).  In this experiment, faster oxygen delivery 
caused no discernable speeding of muscle O2 kinetics compared to the non-adapted 
blood flow condition (Grassi et al. 1998a) similar to the results found in heart transplant 
patients.  In a subsequent experiment, neither hyperoxia nor hyperoxia + pharmacological 
right-shifting of the oxygen-hemoglobin dissociation relationship (to favor oxygen 
unloading from hemoglobin, e.g. Bohr effect) speeded the muscle O2 kinetic response 
(Grassi et al. 1998b).  In contrast to studies demonstrating slowed O2 kinetics when 
exercise blood flow and oxygen delivery is significantly reduced, these experiments 
suggested that O2 kinetics are normally determined by an intrinsic limitation within the 
exercising skeletal muscle.  Thus, it is generally accepted that in healthy individuals 
during the transition from rest to moderate exercise, the acceleration of muscle oxygen 
uptake following the onset of exercise is set by factors within the exercising muscle that 
affect the rate of increase in muscle oxygen utilization ( e.g. metabolic inertia).  However, 
the precise location of this inertia remains to be elucidated.   
Several lines of investigation have attempted to identify the location of metabolic 
inertia during the exercise transition.   Nitric oxide, the product of nitric oxide synthase 
and L-arginine, is involved in an incredibly wide array of physiological reactions that 
include the endothelial regulation of arterial vasodilation and skeletal muscle 
mitochondrial respiration (Stamler and Meissner 2001).  Nitric oxide synthase is also 
expressed in skeletal muscles, and its product, nitric oxide, reversibly binds with 
cytochrome –c oxidase inhibiting a key enzyme of the electron transport system (Stamler 
and Meissner 2001).  Thus, its endogenous activity on mitochondrial respiration has been 
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suggested as a potential contributor to the metabolic inertia following the onset of 
exercise (Kindig et al. 2001).  Kindig et al. (2001) were the first to demonstrate that 
inhibition of nitric oxide synthase with nitro-L-arginine methyl esther (L-NAME) 
speeded pulmonary O2 kinetics during heavy and moderate exercise transitions in the 
horse (Kindig et al. 2001, Kindig et al. 2002).  Their results suggested that inhibition of 
nitric oxide synthase resulted in reduced availibility of nitric oxide and thus may have 
removed the inhibitory effects of nitric oxide on cytochrome-c oxidase.  Consistent with 
this notion, subsequent investigations in exercising humans using nitric oxide synthase 
inhibitors demonstrated faster pulmonary phase II O2 kinetics during moderate (Jones et 
al. 2003) and heavy exercise transitions (Jones et al. 2004b).  Thus, a portion of the 
intrinsic metabolic inertia following the onset of moderate and intense exercise in healthy 
subjects may be related to the inhibitory effects of nitric oxide on cytochrome-c oxidase 
and mitochondrial respiration.   
Another possible location of metabolic inertia is in the activity of the pyruvate 
dehydrogenase complex and provision of its metabolic substrate, acetyl-Coenzyme A, for 
oxidation in the citric acid cycle.  The control of pyruvate dehydrogenase is complex 
relating to its inhibition by accumulation of its products and to phosphorylation by 
complex associated components.  Timmons et al. (1998) have proposed that the basal 
activation state of pyruvate dehydrogenase, and thus availability of muscle acetyl-
Coenzyme A, may be related to the delay (e.g. metabolic inertia) of mitochondrial 
oxidative metabolism following the onset of exercise (Timmons et al. 1998a).  Their 
postulate rests upon the notion that there is an inherent delay in the activation of pyruvate 
dehydrogenase and acetyl-Coenzyme A provision following exercise onset.  This results 
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in an initial limitation in providing adequate acetyl-Coenzyme A groups to the citric acid 
cycle for oxidation causing an acetyl group ‘deficit’ or shortfall following exercise onset.  
Thus, a transient lag of acetyl-Coenzyme A production may limit the oxidation of acetyl 
groups affecting the generation of high energy equivalents (NADH) and oxidation by the 
electron transport chain.  A method to test this hypothesis is through the administration of 
dichloroacetate, an agent that blocks the kinase that inhibits pyruvate dehydrogenase 
activity (e.g resulting in a greater proportion of the active fraction of pyruvate 
dehydrogenase).  As a result, dichloroacetate administration increases acetyl group 
formation and availability for oxidation by the citric acid cycle thereby reducing substrate 
level phosphorylation (e.g. oxygen independent routes of ATP synthesis: [PCr] depletion 
and glycolysis resulting in the formation of lactate) following the onset of exercise.  
Muscle biopsy studies suggested that activation of the pyruvate dehydrogenase complex 
by dichloroacetate prior to exercise elevated resting acetylcarnitine concentration (a 
marker of acetyl-Coenzyme A accumulation) and decreased the magnitude of [PCr] fall 
and muscle [lactate] increase during exercise compared to the control condition 
(Timmons et al. 1998a).  This was particularly evident during muscle contractions in 
animal models of partial ischemia (Timmons et al. 1996, Timmons et al. 1997, Roberts et 
al. 2002) and a model of human peripheral ischemia using lower body positive pressure 
(Timmons et al. 1998b).  Indeed, during ischemic exercise in canine muscle, a transient 
decrease followed by an increase in acetylcarnitine levels was observed during the first 
minute of exercise contractions in the control condition and that was not apparent during 
ischemic exercise contractions with dichloroacetate (Roberts et al. 2002).  These 
observations were consistent with the hypothesis that an acetyl group deficit and thus the 
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kinetics of pyruvate dehydrogenase activation may have regulatory effects on the 
oxidative production of ATP in the transition from rest to exercise.  However, a series of 
investigations comparing the effects of pyruvate dehydrogenase activation on muscle 
O2 kinetics during exercise yielded contrasting results.  Bangsbo et al. (2002) found no 
difference in muscle O2 or [PCr] dynamics with dichloroacetate administration during 
supra-maximal exercise transitions in humans despite increased pyruvate dehydrogenase 
activity at rest and throughout exercise (Bangsbo et al. 2002).  Grassi et al. (2002) found 
no speeding of muscle O2 kinetics in exercising canine muscle contracting at 60-70% of 
peak O2 with dichloroacetate despite an elevation in muscle acetyl group concentration 
(Grassi et al. 200a).  Similar findings of unaltered pulmonary phase II O2 kinetics with 
dichloroacetate administration have been observed during moderate (Koppo et al. 2004) 
and heavy exercise in human subjects (Rossiter et al. 2003, Jones et al. 2004a).  Using 
simultaneous 31P-NMR and pulmonary O2, Rossiter et al. (2003) observed no change in 
pulmonary phase II O2 kinetics or [PCr] depletion kinetics with dichloroacetate 
administration compared to the control condition (Rossiter et al. 2003).   Despite this, 
dichloroacetate administration significantly reduced end-exercise [lactate] and the 
magnitude of [PCr] depletion versus the control condition (Rossiter et al. 2003).  
Although consistent with the energetic effects of reducing substrate level 
phosphorylation, pre-exercise activation of pyruvate dehydrogenase with dichloroacetate 
did not result in a speeding of the phase II O2 kinetic response, and by inference, of 
muscle O2 kinetics.  Thus, these results suggest that in healthy subjects the acetyl group 
deficit does not likely represent a functional intramuscular limitation to O2 kinetics 
following the onset of exercise.  However, whether the mechanism of acetyl group deficit 
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plays a role in determining muscle O2 kinetics following the onset of ischemic exercise 
remains to be more fully characterized.    
As discussed above in healthy subjects, O2 kinetics appear to be set by the 
metabolic characteristics controlling oxidative metabolism within the exercising muscle.  
However, as described in the previous section, O2 kinetics may become slowed under 
conditions where blood flow and oxygen delivery are significantly compromised.  Thus, 
under certain circumstances, pulmonary O2 kinetics may be dominated by the dynamics 
of O2 delivery rather than local intramuscular mechanisms when blood flow adjustments 
(i.e. the time constant for O2 delivery) or oxygen diffusion are impaired.   This has 
particular relevance in the study of O2 kinetics in human cardiovascular diseases.   
One common factor to all cardiovascular diseases is the abnormal circulatory 
hemodynamics associated with the diseased condition.  Indeed, understanding the 
influences of circulatory modulation on the expression of muscle O2 kinetics at the 
level of the mouth is critical in evaluating the potential determinants of O2 kinetics in 
cardiovascular diseases.  Barstow et al. modeled the circulatory modulation of O2 
kinetics in healthy subjects using computer simulations that allowed the parameters of 
blood flow and O2 to be manipulated independently (Barstow et al. 1990).  Based upon 
these simulations, the authors made the following conclusions regarding the interaction 
between blood flow dynamics and O2 kinetics: 1.) O2 delivery is only limiting to 
muscle O2 kinetics when the time course of blood flow (i.e. O2 delivery) increase is 
substantially longer than that for muscle O2 and 2.)  Under normal circulatory (cardiac 
and muscle blood flow) and muscle O2 dynamics, pulmonary phase II O2 kinetics 
predominantly reflect muscle O2 kinetics.  Moreover, pulmonary phase II O2 kinetics 
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are largely invariant across moderate work intensities and slowing circulatory dynamics 
(assuming normal muscle O2 utilization) predictably lengthens the pulmonary phase 1 
duration, decreases the phase 1 amplitude, and speeds pulmonary phase 2 O2 kinetic 
time constant. Thus, these experimental data provide a substantial foundation for 
examining pulmonary O2 kinetic responses and indirectly, the possible contributors to 
slowed O2 kinetics and exercise intolerance in cardiovascular diseases.   
Conceptually, slowed pulmonary O2 kinetics in cardiovascular diseases are the 
expected result of a disruption of the cardiovascular system where modulation of the 
circulatory dynamics and oxygen delivery may delay the O2 kinetic response to 
exercise.  Indeed, patients with cardiovascular diseases have characteristically slowed 
pulmonary O2 kinetics following the onset of exercise.  For example, in cyanotic 
congenital heart disease, a falling arterial O2 content following exercise onset secondary 
to a cardiac shunt (R to L) impairs the dynamic increase in O2 delivery (via the fall in 
arterial oxygen content) resulting in profoundly slowed pulmonary O2 kinetic responses 
(Sietsema et al. 1986).  Constraining dynamic increases in cardiac output during exercise 
transitions slows pulmonary O2 kinetics as observed in coronary heart disease (Koike et 
al. 1994, Koike et al. 1995).    Moreover, abnormalities in the skeletal muscle may 
potentially serve as a secondary mechanism that could impair O2 kinetics following the 
onset of exercise (e.g. chronic heart failure) (Sietsema et al. 1994, Hepple et al. 1999).   
Thus, deciphering the mechanisms of impaired O2 kinetics in cardiovascular diseases 
requires consideration of whether the response is due to a primary reduction in oxygen 
delivery or a reduction in exercising skeletal muscle oxygen utilization, or both.     
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Previous studies have described slowed pulmonary O2 kinetics in patients with 
intermittent claudication secondary to peripheral arterial disease (Auchincloss et al. 1980, 
Haouzi et al. 1997, Barker et al. 2003, Barker et al. 2004).  Auchincloss et al. (1976) 
noted a lower oxygen uptake one-minute following the onset of walking exercise in 
patients with peripheral arterial disease using the Douglas bag technique (Auchincloss et 
al. 1976, Auchincloss et al. 1980).  Haouzi et al. (1997), using breath–by-breath 
pulmonary O2, found a significantly prolonged half-time of the total increase in 
pulmonary O2 following the onset of treadmill exercise among a group of severe PAD 
patients (Haouzi et al. 1997).  These early studies attributed the slowed pulmonary O2 
responses in peripheral arterial disease to the primary limitation in lower limb blood flow.  
In contrast, more recent observations have postulated that peripheral factors relating to 
abnormal skeletal muscle metabolism may also play a significant role in the impairment 
of peripheral arterial disease O2 kinetics.   For example, we previously described 
slowed phase II pulmonary O2 kinetic responses in patients with intermittent 
claudication compared to controls and that was not correlated with the degree of 
hemodynamic severity (e.g. ABI) (Bauer et al. 1999).  We interpreted these data to 
suggest that the altered skeletal muscle metabolism in patients with intermittent 
claudication may play a significant role in the peripheral arterial disease O2 kinetic 
impairment, although the potential limb blood flow limitation could not be excluded.  In 
order to evaluate a potential metabolic limitation in the O2 kinetic response in 
peripheral arterial disease, Barker et al. (2003) examined pyruvate dehydrogenase activity 
and acetylcarnitine concentration from resting muscle along with pulmonary O2 
kinetics in patients with PAD (Barker et al. 2003).   They found that in the patients, the 
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phase II O2 kinetic time constants were inversely correlated with maximal walking time 
and peak O2.  They also observed that pyruvate dehydrogenase activity was ~32% 
lower and resting acetylcarnitine concentration was ~13% higher in the resting skeletal 
muscle of patients with intermittent claudication compared to controls; although these 
changes did not reach statistical significance.  Interestingly, resting pyruvate 
dehydrogenase activity in patients with intermittent claudication tended to be inversely 
correlated with the phase II time constant.  The authors interpreted these data to indicate 
that the impaired O2 kinetics contributed to the exercise intolerance of patients with 
intermittent claudication and suggested that the impairment in pulmonary O2 kinetics 
with peripheral arterial disease may be linked, in part, to changes in pyruvate 
dehydrogenase activity and alterations in carbohydrate metabolism (Barker et al. 2003).  
Thus, research has demonstrated that pulmonary O2 kinetics are slowed in patients with 
PAD.  However, it remains unresolved whether the slowed O2 kinetics in patients are 
related to limitations in limb blood flow due to the peripheral arterial stenoses and/or to 
abnormalities of skeletal muscle metabolism.  Moreover, there remain potential systemic 
abnormalities secondary to atherosclerosis that could also explain the impaired 
pulmonary O2 kinetics in peripheral arterial disease.  To clarify these issues, further 
research is needed to localize the observed O2 kinetic defect to exercise of the affected 
lower limbs and evaluate parameters of oxygen delivery and oxygen utilization at the 
level of the affected exercising skeletal muscle.     
1.9   Muscle deoxygenation kinetics 
Continuous wavelength near-infrared spectroscopy (cwNIRS) provides a non-
invasive method of evaluating tissue oxygenation in vivo.  Near-infrared spectroscopy 
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utilizes light sources generating near-infrared wavelengths typically in the range of 650-
950nm and is based on the principle that the amount of each wavelength reflected back to 
a detector is dependent upon the absorption by biological chromophores and effects of 
light scattering in tissue (e.g. skin, fat, muscle, bone) (Chance 1989).  In biological 
tissues, only the heme groups of hemoglobin and myoglobin and the copper moiety of 
cytochrome– c oxidase are known to influence NIR absorption as a function of oxygen 
tension (Boushel and Piantadosi 2000).  Thus, cwNIRS can follow changes in the heme 
absorption characteristics with alterations in oxygen tension, as may occur during 
muscular exercise or ischemia.   
Most continuous wave NIRS devices use between two and six near-infrared 
wavelengths to assess changes in tissue concentrations of oxygenated and deoxygenated 
heme chromophores (e.g. hemoglobin and myoglobin) using the modified Beer-Lambert 
law (Cooper et al. 1996).  The maximal penetration of light reflected to the detectors is 
approximately 50% of the distance between the light source and photo detector, and the 
NIRS signal is suggested to be dominated by hemoglobin within the microvasculature of 
the region of NIRS interrogation (Seiyama et al. 1988, Mancini et al. 1994).  However, it 
should be noted that the optical spectra of heme groups for hemoglobin and myoglobin 
cannot be easily differentiated due to their spectral similarities.  Thus, myoglobin may 
influence NIRS signals, and its contribution to the NIRS signal remains an important and 
controversial issue.  For example, Seiyama et al. (1988) showed in an isolated rat 
hindlimb using fluorocarbon perfusion (e.g. hemoglobin-free tissue perfusion) that the 
contribution of myoglobin and cytochrome aa3 to the overall NIRS signal in skeletal 
muscle totaled less than 10% (Seiyama et al. 1988).  However, the influence of 
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myoglobin saturation on NIRS could be more important in muscle characterized by 
higher myoglobin contents, such as cardiac tissue, and may contribute as much as 46% to 
the NIRS signals (Nighswander-Rempel et al. 2005).  The relevance of myoglobin 
saturation and its contribution to the NIRS signals during exercise has more recently been 
disputed.  Tran et al. (1999) suggested that NIRS signals primarily reflect changes in 
myoglobin rather than hemoglobin saturation due to similarities between the desaturation 
kinetics of NIRS and 1H NMR-derived myoglobin during plantar flexion exercise (Tran 
et al. 1999).  Indeed, myoglobin has been shown to become desaturated at moderate work 
rates (~50% maximum) (Mole et al. 1999, Richardson et al. 1999b) but may not show 
further decreases with increments in exercise intensity up to maximal exercise 
(Richardson et al. 2001).  It should be noted that similar data by the same group of Tran 
et al. (1999) also describe the fall in NIRS signals to follow similar kinetics to that of 
hemoglobin desaturation (Jue et al. 1999).  Unfortunately, the time course analysis by 
Tran et al. (1999) is confounded by an inability to detect low levels of deoxyhemoglobin 
signals using 1H NMR and a slow data acquisition rate that precludes more complete  
kinetic analysis (Tran et al. 1999).  In this context, at present it can only be assumed that 
NIRS provides a composite view of tissue oxygenation, inclusive of myoglobin and 
hemoglobin oxygen saturation.   
Another limitation of cwNIRS is that the quantification of absolute heme 
concentrations requires the direct knowledge of tissue scattering coefficients and light 
path lengths. Unfortunately, these parameters can only be assessed through the use of 
more sophisticated methods. Thus, cwNIRS is generally limited to the description of 
relative directional changes in oxygenated and deoxygenated heme concentrations.   
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The application of second derivative spectroscopy to multi-wavelength cwNIRS 
data has extended the utility of the NIRS to quantitatively determine hemoglobin (and 
more recently myoglobin) oxygen saturation in muscle (Cooper et al. 1996, Schenkman 
et al. 1997, Marcinek et al. 2004, Myers et al. 2005).  The second derivative as a function 
of wavelength (Cooper et al. 1996, Schenkman et al. 1997, Harrison et al. 1998) or the 
ratio of two 2nd derivative optical attenuation signals (Myers et al. 2005) can be 
empirically scaled to a calibration relationship for pure hemoglobin (or myoglobin) 
saturation.  Thus, a non-invasive, quantitative measure of hemoglobin oxygen saturation 
in tissues (StO2) can be evaluated without the explicit determination of tissue scattering, 
differential path lengths, or calculation of absolute hemoglobin concentration.  This is a 
distinct advantage over traditional cwNIRS, and NIRS-derived StO2 has been shown to 
be experimentally robust to tissue scattering, motion artifact, and changes in total 
hemoglobin concentration (Myers et al. 2005).   Moreover, StO2 is significantly 
correlated with weighted venous hemoglobin oxygen saturation among isolated muscle 
preparations in animal models and in humans (D.E. Myers, personal 
communication)(Myers et al. 2005).   
Muscle oxygenation is defined by intracellular myoglobin oxygen saturation and 
microvascular oxygen contents and reflects the dynamic balance between local oxygen 
delivery and oxygen utilization (Behnke et al. 2001, Grassi et al. 2003, DeLorey et al. 
2003).  Recent work using traditional cwNIRS has characterized the kinetics of muscle 
deoxygenation (measured as relative [deoxyhemoglobin] changes) following the onset of 
exercise in healthy subjects (Chuang et al. 2002, Grassi et al. 2003, DeLorey et al. 2003).  
These studies unanimously showed that muscle oxygenation decreases after a short time 
 41
delay and with faster kinetics than for muscle O2 as assessed by phase II pulmonary 
O2 kinetics (Chuang et al. 2002, Grassi et al. 2003, DeLorey et al. 2003).  Importantly, 
these findings are consistent with observations of microvascular PO2 kinetics in animal 
models that indicated the presence of an initial delay prior to deoxygenation (Behnke et 
al. 2001). This observation may reflect an early matching or surplus of oxygen delivery 
relative to oxygen utilization following exercise onset.  Moreover, because of the 
characteristics that define muscle oxygenation (e.g. hemoglobin and myoglobin 
concentrations and oxygen saturation), it has been suggested that the muscle 
deoxygenation following exercise onset may reflect the dynamics of oxygen extraction 
(Grassi et al. 2003).  Indeed, the kinetics of muscle deoxygenation appear quite similar to 
that of directly measured venous effluent from exercising skeletal muscle (Grassi et al. 
1996).  Importantly, these data provide a basis for the evaluation of altered muscle 
deoxygenation kinetics in human diseases where initial changes in oxygen delivery or 
oxygen utilization following the onset of exercise may be impaired.     
Previous studies with cwNIRS in peripheral arterial disease have described a 
greater decrease in muscle oxygenation during claudication-producing exercise in the 
affected legs of patients compared with healthy limbs exercising at the same absolute 
work rate (McCully et al. 1994, Kooijman et al. 1997, Egun et al. 2002, Comerota et al. 
2003).  These findings are consistent with invasive measures of lower intramuscular PO2, 
and blood gases of the venous effluent in PAD patients compared with controls during 
equivalent exercise (Nissen et al. 1974, Holm and Bylund-Fellenius 1981, Bylund-
Fellenius et al. 1981, Maass and Alexander 1983).  Thus, during claudication-producing 
(e.g. ischemic) exercise there is an increase in oxygen extraction as would be predicted 
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for an equivalent oxygen demand (e.g. consumption) from the Fick principle.   Moreover, 
muscle re-oxygenation is slowed following ischemic exercise in PAD consistent with the 
blood flow limitation that occurs during claudication-producing exercise and the 
prolonged recovery of oxygen consumption and blood flow when exercise ceases 
(McCully et al. 1994, Kooijman et al. 1997, Kemp et al. 2001, Egun et al. 2002, 
Komiyama et al. 2002, Comerota et al. 2003).   Indeed, the kinetics of muscle 
oxygenation recovery following claudication-producing exercise is correlated with 
hemodynamic disease severity (McCully et al. 1994, McCully et al. 1997, Kooijman et al. 
1997, Comerota et al. 2003).  However, the recovery from exercise may represent a 
different pathophysiological event than the onset of exercise.  For example, at the end of 
claudication-producing exercise, patients with PAD experience skeletal muscle ischemia 
and claudication pain.  This contrasts with the situation at rest in patients with PAD, 
where limb blood flow and hemoglobin oxygen saturation are normal (Maass and 
Alexander 1983, Kooijman et al. 1997).  During the early moments of exercise, limb 
blood flow responses may initially match the external work demand in PAD (Pernow et 
al. 1975, Bernink et al. 1982).  Studies have not specifically addressed the muscle 
deoxygenation responses at exercise onset, but if initial blood flow is not limiting, then 
the early muscle deoxygenation responses may be driven by alterations in tissue oxygen 
diffusion or mitochondrial oxygen utilization.  Thus, if patients with PAD have a normal 
or elevated capacity for O2 diffusion and skeletal muscle oxygen utilization (e.g. 
increased muscle capillarization and oxidative enzyme capacities), then a limitation in O2 
delivery would be associated with normal or faster muscle deoxygenation kinetics 
compared with control subjects following the onset of exercise.  In contrast, if oxygen 
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utilization is impaired secondary to a diffusive or oxidative metabolic limitation, there 
could be an associated slowing of the muscle deoxygenation kinetics in PAD during the 
transition to exercise.  Only one study has examined muscle deoxygenation responses 
following the onset of exercise in patients with PAD.  Kemp et al. (2001) in a study of 
31P-NMR and cwNIRS showed the rate constant (e.g. total muscle 
deoxygenation/exercise duration) of muscle oxygenation during 50% and 75% MVC calf 
ergometer exercise was greater in patients with peripheral arterial disease compared with 
control subjects, however the time course (e.g. half-time) of muscle deoxygenation 
appeared prolonged (G.J. Kemp personal communication 12/2004) (Kemp et al. 2001).  
The greater rate constant suggested a significant oxygen delivery shortfall relative to 
oxygen demand (e.g. the greater oxygen utilization exceeds oxygen delivery, the greater 
rate of muscle deoxygenation). This is consistent with a primary blood flow limitation 
and resulting muscle ischemia in these patients.  However, the prolonged half-time 
following exercise onset in PAD patients suggests that the dynamics of the balance 
between oxygen utilization and oxygen delivery was continually altered throughout 
ischemia-producing exercise.  However, whether the slowed muscle deoxygenation 
kinetics in PAD reflects an impaired oxygen delivery or an intrinsic abnormality of 
oxidative metabolism, or both cannot be presently resolved.  Further investigations are 
needed that specifically evaluate the muscle deoxygenation kinetics across the rest-
exercise transition using systemic and local muscle exercises across a range of exercise 
intensities and levels of blood flow limitation in PAD.  Abnormalities in PAD muscle 
deoxygenation kinetics at work rates associated with and without a blood flow 
impairment would provide valuable insight into the pathophysiology and potential 
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contributors to the abnormal O2 kinetics and exercise intolerance of patients with 
peripheral arterial disease.  This concept has not been previously examined in PAD.   
1.10 Summary 
Patients with peripheral arterial disease (PAD) have atherosclerotic arterial 
occlusions in the lower extremities that can constrain the blood flow response to exercise.  
However, reduced limb arterial pressures and impaired exercise blood flow responses 
may not entirely explain the exercise limitation in PAD patients.  PAD is also associated 
with a spectrum of histological and metabolic changes in affected skeletal muscle that 
may suggest both adaptation and metabolic dysfunction.  For example, many oxidative 
enzyme activities are increased in patients with intermittent claudication whereas the 
function or control of oxidative ATP production in PAD-affected skeletal muscle may be 
impaired.  Slowed pulmonary oxygen uptake kinetics in patients with peripheral arterial 
disease suggest that oxygen delivery and/or muscle oxygen utilization may be impaired.  
Observations using 31P NMR have shown that the time course of phosphocreatine 
depletion (and inferred kinetics of muscle oxidative metabolism) following exercise onset 
in PAD may be slowed.  Indeed, the large vessel blood flow limitation and intrinsic 
metabolic alterations of the affected skeletal muscle could likely contribute to the 
exercise impairment in peripheral arterial disease.  The respective roles of these 
pathophysiological mechanisms have not been elucidated and a significant question 
remains regarding the relative contribution of impaired limb blood flow versus the 
metabolic abnormalities in the exercise impairment in PAD.  Key steps to further 
understanding the pathophysiology of exercise limitation in PAD require localizing the 
oxygen uptake kinetic abnormality during exercise of the affected lower limbs in PAD. 
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This would include obtaining dynamic measurements of muscle deoxygenation directly at 
the level of the exercising skeletal muscles and assessing the acute effects of increased 
blood flow capacity on oxygen uptake kinetics following revascularization.  A greater 
understanding of the PAD-associated processes that disrupt the normal dynamic 
responses of oxygen uptake in the transition from rest to exercise would provide further 
insight into the mechanisms of exercise intolerance and functional disability in patients 
with peripheral arterial disease.   
 
References 
 
Vascular Surgery: A Comprehensive Review. (1998).  5th Edition ed., edited by W. S. 
Moore. Philadelphia: W.B. Saunders Company. 
Alpert, J. S., O. A. Larsen, and N. A. Lassen. (1969). Exercise and intermittent 
claudication.  Blood flow in the calf muscle during walking studied by the xenon-
133 clearance method. Circulation. 39, 353-359. 
Andersen, P. and B. Saltin. (1985). Maximal perfusion of skeletal muscle in man. 
J.Physiol (Lond). 366, 233-249. 
Anderson, T. J., M. D. Gerhard, I. T. Meredith, F. Charbonneau, D. Delagrange, M. A. 
Creager, A. P. Selwyn, and P. Ganz. (1995). Systemic nature of endothelial 
dysfunction in atherosclerosis. Am J Cardiol. 75, 71B-74B. 
Arfvidsson, B., J. Karlsson, A. G. Dahllof, K. Lundholm, and M. Sullivan. (1993). The 
impact of intermittent claudication on quality of life evaluated by the Sickness 
Impact Profile technique. Eur.J.Clin.Invest. 23, 741-745. 
Askew, C. D., S. Green, X. Y. Hou, and P. J. Walker. (2002). Physiological and 
symptomatic responses to cycling and walking in intermittent claudication. 
Clin.Physiol Funct.Imaging. 22, 348-355. 
Auchincloss, J. H., K. Ashutosh, S. Rana, D. Peppi, L. W. Johnson, and R. Gilbert. 
(1976). Effect of cardiac, pulmonary, and vascular disease on one-minute oxygen 
uptake. Chest. 70, 486-493. 
Auchincloss, J. H. Jr, J. W. Meade, R. Gilbert, and B. E. Chamberlain. (1980). One 
minute oxygen uptake in peripheral ischemic vascular disease. Ann.Surg. 191, 
203-206. 
 46
Bangsbo, J., M. J. Gibala, P. Krustrup, J. Gonzalez-Alonso, and B. Saltin. (2002). 
Enhanced pyruvate dehydrogenase activity does not affect muscle O2 uptake at 
onset of intense exercise in humans. Am.J.Physiol Regul.Integr.Comp Physiol. 
282, R273-R280. 
Bangsbo, J., P. Krustrup, J. Gonzalez-Alonso, R. Boushel, and B. Saltin. (2000). Muscle 
oxygen kinetics at onset of intense dynamic exercise in humans. Am.J.Physiol 
Regul.Integr.Comp Physiol. 279, R899-R906. 
Barker, G. A., S. Green, A. A. Green, and P. J. Walker. (2003). Walking performance, 
oxygen uptake kinetics and resting muscle pyruvate dehydrogenase complex 
activity in peripheral arterial disease. Clin.Sci.(Lond). 
Barker, G. A., S. Green, and P. J. Walker. (2004). Effect of carbohydrate 
supplementation on walking performance in peripheral arterial disease: a 
preliminary physiologic study. J.Vasc.Surg. 40, 932-938. 
Barstow, T. J., S. Buchthal, S. Zanconato, and D. M. Cooper. (1994). Muscle energetics 
and pulmonary oxygen uptake kinetics during moderate exercise. Journal of 
Applied Physiology. 77, 1742-1749. 
Barstow, T. J., N. Lamarra, and B. J. Whipp. (1990). Modulation of muscle and 
pulmonary O2 uptakes by circulatory dynamics during exercise. J.Appl.Physiol. 
68, 979-989. 
Barstow, T. J. and P. A. Mole. (1987). Simulation of pulmonary O2 uptake during 
exercise transients in humans. J.Appl.Physiol. 63, 2253-2261. 
Bauer, T. A., J. G. Regensteiner, E. P. Brass, and W. R. Hiatt. (1999). Oxygen uptake 
kinetics during exercise are slowed in patients with peripheral arterial disease. 
J.Appl.Physiol. 87, 809-816. 
Behnke, B. J., T. J. Barstow, C. A. Kindig, P. McDonough, T. I. Musch, and D. C. Poole. 
(2002). Dynamics of oxygen uptake following exercise onset in rat skeletal 
muscle. Respir.Physiol Neurobiol. 133, 229-239. 
Behnke, B. J., C. A. Kindig, T. I. Musch, S. Koga, and D. C. Poole. (2001). Dynamics of 
microvascular oxygen pressure across the rest-exercise transition in rat skeletal 
muscle. Respir.Physiol. 126, 53-63. 
Belch, J. J., I. R. Mackay, A. Hill, P. Jennings, and P. McCollum. (1995). Oxidative 
stress is present in atherosclerotic peripheral arterial disease and further increased 
by diabetes mellitus. Int.Angiol. 14, 385-388. 
Bernink, P. J., J. Lubbers, G. J. Barendsen, and Berg J. van den. (1982). Blood flow in 
the calf during and after exercise: measurements with Doppler ultrasound and 
venous occlusion plethysmography in healthy subjects and in patients with arterial 
occlusive disease. Angiology. 33, 146-160. 
 47
Bhat, H. K., W. R. Hiatt, C. L. Hoppel, and E. P. Brass. (1999). Skeletal Muscle 
Mitochondrial DNA Injury in Patients With Unilateral Peripheral Arterial 
Disease. Circulation. 99, 807-812. 
Bollinger, A., J. Eckert, B. Ruttimann, and F. Becker. (2000). The "galloping" history of 
intermittent claudication. VASA. 29, 295-299. 
Boushel, R. and C. A. Piantadosi. (2000). Near-infrared spectroscopy for monitoring 
muscle oxygenation. Acta Physiol Scand. 168, 615-622. 
Brass, E. P. and W. R. Hiatt. (2000). Acquired skeletal muscle metabolic myopathy in 
atherosclerotic peripheral arterial disease. Vasc.Med. 5, 55-59. 
Brass, E. P., W. R. Hiatt, A. W. Gardner, and C. L. Hoppel. (2001). Decreased NADH 
dehydrogenase and ubiquinol-cytochrome c oxidoreductase in peripheral arterial 
disease. Am.J.Physiol. 280, H603-H609. 
Brendle, D. C., L. J. Joseph, M. C. Corretti, A. W. Gardner, and L. I. Katzel. (2001). 
Effects of exercise rehabilitation on endothelial reactivity in older patients with 
peripheral arterial disease. Am.J.Cardiol. 87, 324-329. 
Bylund, A. C., J. Hammarsten, J. Holm, and T. Schersten. (1976). Enzyme activities in 
skeletal muscles from patients with peripheral arterial insufficiency. 
Eur.J.Clin.Invest. 6, 425-429. 
Bylund-Fellenius, A. C., J. P. Idstrom, and S. Holm. (1984a). Muscle respiration during 
exercise. Am.Rev.Respir.Dis. 129, S10-S12. 
Bylund-Fellenius, A. C., P. M. Walker, A. Elander, S. Holm, J. Holm, and T. Schersten. 
(1981). Energy metabolism in relation to oxygen partial pressure in human 
skeletal muscle during exercise. Biochem.J. 200, 247-255. 
Bylund-Fellenius, A. C., P. M. Walker, A. Elander, and T. Schersten. (1984b). Peripheral 
vascular disease. Am.Rev.Respir.Dis. 129, S65-S67. 
Casaburi, R., J. Daly, J. E. Hansen, and R. M. Effros. (1989). Abrupt changes in mixed 
venous blood gas composition after the onset of exercise. J.Appl.Physiol. 67, 
1106-1112. 
Chance, B. (1989). Time resolved spectroscopic (TRS) and continuous wave 
spectroscopic (CWS) studies of photon migration in human arms and limbs. 
Adv.Exp.Med.Biol. 248, 21-31. 
Charcot, J. m. (1858). Obstruction arterielle et claudication intermittente dans le cheval et 
dans l'homme. Mem Soc Biol. 1, 225-238. 
 48
Chilibeck, P. D., D. H. Paterson, C. R. McCreary, G. D. Marsh, D. A. Cunningham, and 
R. T. Thompson. (1998). The effects of age on kinetics of oxygen uptake and 
phosphocreatine in humans during exercise. Exp.Physiol. 83, 107-117. 
Chuang, M. L., H. Ting, T. Otsuka, X. G. Sun, F. Y. Chiu, J. E. Hansen, and K. 
Wasserman. (2002). Muscle deoxygenation as related to work rate. 
Med.Sci.Sports Exerc. 34, 1614-1623. 
Clyne, C. A. C., H. Mears, R. O. Weller, and T. F. O'Donnell. (1985). Calf muscle 
adaptation to peripheral vascular disease. Cardiovasc.Res. 19, 507-512. 
Clyne, C. A. C., R. O. Weller, W. G. Bradley, D. I. Silber, T. F. O'Donnell, and A. D. 
Callow. (1982). Ultrastructural and capillary adaptation of gastrocnemius muscle 
to occlusive peripheral vascular disease. Surgery. 92, 434-440. 
Comerota, A. J., R. C. Throm, P. Kelly, and M. Jaff. (2003). Tissue (muscle) oxygen 
saturation (StO2): a new measure of symptomatic lower-extremity arterial disease. 
J.Vasc.Surg. 38, 724-729. 
Cooper, C. E., C. E. Elwell, J. H. Meek, S. J. Matcher, J. S. Wyatt, M. Cope, and D. T. 
Delpy. (1996). The noninvasive measurement of absolute cerebral 
deoxyhemoglobin concentration and mean optical path length in the neonatal 
brain by second derivative near infrared spectroscopy. Pediatr.Res. 39, 32-38. 
Criqui, M. H., A. Fronek, E. Barrett-Connor, M. R. Klauber, S. Gabriel, and D. 
Goodman. (1985). The prevalence of peripheral arterial disease in a defined 
population. Circulation. 71, 510-515. 
Dahllof, A., J. Holm, T. Schersten, and R. Sivertsson. (1976). Peripheral arterial 
insufficiency.  Effect of physical training on walking tolerance, calf blood flow, 
and blood flow resistance. Scand.J.Rehab.Med. 8, 19-26. 
De, Cort SC, J. A. Innes, T. J. Barstow, and A. Guz. (1991). Cardiac output, oxygen 
consumption and arteriovenous oxygen difference following a sudden rise in 
exercise level in humans. J.Physiol.(Lond.). 441:501-12, 501-512. 
DeLorey, D. S., J. M. Kowalchuk, and D. H. Paterson. (2003). Relationship between 
pulmonary O2 uptake kinetics and muscle deoxygenation during moderate-
intensity exercise. J.Appl.Physiol. 95, 113-120. 
DiMauro, S. (2004). Mitochondrial diseases. Biochim.Biophys.Acta. 1658, 80-88. 
Duborjal, H., R. Beugnot, B. M. De Camaret, and J. P. Issartel. (2002). Large functional 
range of steady-state levels of nuclear and mitochondrial transcripts coding for the 
subunits of the human mitochondrial OXPHOS system. Genome Res. 12, 1901-
1909. 
 49
Egun, A., V. Farooq, F. Torella, R. Cowley, M. S. Thorniley, and C. N. McCollum. 
(2002). The severity of muscle ischemia during intermittent claudication. 
J.Vasc.Surg. 36, 89-93. 
Ekroth, R., A. Dahllof, B. Gundevall, J. Holm, and T. Schersten. (1978). Physical 
training of patients with intermittent claudication: Indications, methods, and 
results. Surgery. 84, 640-643. 
Elander, A., M. Sjostrom, F. Lundgren, T. Schersten, and A. C. Bylund-Fellenius. (1985). 
Biochemical and morphometric properties of mitochondrial populations in human 
muscle fibres. Clin.Sci. 69, 153-164. 
Eldridge, J. E. and K. F. Hossack. (1987). Patterns of oxygen consumption during 
exercise testing in peripheral vascular disease. Cardiology. 74, 236-240. 
Engelen, M., J. Porszasz, M. Riley, K. Wasserman, K. Maehara, and T. J. Barstow. 
(1996). Effects of hypoxic hypoxia on O2 uptake and heart rate kinetics during 
heavy exercise. J.Appl.Physiol. 81, 2500-2508. 
Folse, R. (1965). Alterations in femoral blood flow and resistance during rhythmic 
exercise and sustained muscular contractions in patients with arteriosclerosis. 
Surg.Gynecol.Obstet. 121, 767-776. 
Gardner, A. W., J. S. Skinner, B. W. Cantwell, and L. K. Smith. (1992). Prediction of 
claudication pain from clinical measurements obtained at rest. Med.Sci.Sports 
Exerc. 24, 163-170. 
Gerdle, B., B. Hedberg, K. A. Angquist, and A. R. Fugl-Meyer. (1986). Isokinetic 
strength and endurance in peripheral arterial insufficiency with intermittent 
claudication. Scand.J.Rehab.Med. 18, 9-15. 
Grassi, B., L. B. Gladden, M. Samaja, C. M. Stary, and M. C. Hogan. (1998a). Faster 
adjustment of O2 delivery does not affect VO2 on-kinetics in isolated in situ 
canine muscle. J.Appl.Physiol. 85, 1394-1403. 
Grassi, B., L. B. Gladden, C. M. Stary, P. D. Wagner, and M. C. Hogan. (1998b). 
Peripheral O2 diffusion does not affect VO2on-kinetics in isolated insitu canine 
muscle. J.Appl.Physiol. 85, 1404-1412. 
Grassi, B., M. C. Hogan, P. L. Greenhaff, J. J. Hamann, K. M. Kelley, W. G. 
Aschenbach, D. Constantin-Teodosiu, and L. B. Gladden. (2002). Oxygen uptake 
on-kinetics in dog gastrocnemius in situ following activation of pyruvate 
dehydrogenase by dichloroacetate. J.Physiol. 538, 195-207. 
Grassi, B., C. Marconi, M. Meyer, M. Rieu, and P. Cerretelli. (1997). Gas exchange and 
cardiovascular kinetics with different exercise protocols in heart transplant 
recipients. J.Appl.Physiol. 82, 1952-1962. 
 50
Grassi, B., S. Pogliaghi, S. Rampichini, V. Quaresima, M. Ferrari, C. Marconi, and P. 
Cerretelli. (2003). Muscle oxygenation and pulmonary gas exchange kinetics 
during cycling exercise on-transitions in humans. J.Appl.Physiol. 95, 149-158. 
Grassi, B., D. C. Poole, R. S. Richardson, D. R. Knight, B. K. Erickson, and P. D. 
Wagner. (1996). Muscle O2 uptake kinetics in humans: implications for metabolic 
control. J.Appl.Physiol. 80, 988-998. 
Green, S. (2002). Haemodynamic limitations and exercise performance in peripheral 
arterial disease. Clin.Physiol Funct.Imaging. 22, 81-91. 
Hammarsten, J., A. C. Bylund-Fellenius, J. Holm, T. Schersten, and M. Krotkiewski. 
(1980). Capillary supply and muscle fibre types in patients with intermittent 
claudication: Relationships between morphology and metabolism. 
Eur.J.Clin.Invest. 10, 301-305. 
Hands, L. J., P. J. Bore, G. Galloway, P. J. Morris, and G. K. Radda. (1986). Muscle 
metabolism in patients with peripheral vascular disease investigated by 31P 
nuclear magnetic resonance spectroscopy. Clin.Sci. 71, 283-290. 
Hands, L. J., M. H. Sharif, G. S. Payne, P. J. Morris, and G. K. Radda. (1990). Muscle 
ischaemia in peripheral vascular disease studied by 31P-magnetic resonance 
spectroscopy. Eur.J.Vasc.Surg. 4, 637-642. 
Haouzi, P., J. J. Hirsch, F. Marchal, and A. Huszczuk. (1997). Ventilatory and gas 
exchange response during walking in severe peripheral vascular disease. 
Respir.Physiol. 107, 181-190. 
Harrison, D. K., C. Voss, H. S. Vollmar, A. G. Koutsiaris, and D. J. Newton. (1998). 
Response of muscle oxygen saturation to exercise, measured with near infrared 
spectrophotometry in patients with peripheral vascular disease. 
Adv.Exp.Med.Biol. 454, 45-52. 
Haseler, L. J., C. A. Kindig, R. S. Richardson, and M. C. Hogan. (2004). The role of 
oxygen in determining phosphocreatine onset kinetics in exercising humans. 
J.Physiol. 558, 985-992. 
Haseler, L. J., R. S. Richardson, J. S. Videen, and M. C. Hogan. (1998). Phosphocreatine 
hydrolysis during submaximal exercise: the effect of FIO2. J.Appl.Physiol. 85, 
1457-1463. 
Henriksson, J., E. Nygaard, J. Andersson, and B. Eklof. (1980). Enzyme activities, fibre 
types and capillarization in calf muscles of patients with intermittent claudication. 
Scand.J.Clin.Lab.Invest. 40, 361-369. 
Hepple, R. T., P. P. Liu, M. J. Plyley, and J. M. Goodman. (1999). Oxygen uptake 
kinetics during exercise in chronic heart failure: influence of peripheral vascular 
reserve. Clin.Sci.(Lond). 97, 569-577. 
 51
Hertzer, N. R., E. G. Beven, J. R. Young, P. J. O'Hara, W. F. Ruschhaupt, R. A. Graor, 
V. G. Dewolfe, and L. C. Maljovec. (1984). Coronary artery disease in peripheral 
vascular patients. A classification of 1000 coronary angiograms and results of 
surgical management. Ann.Surg. 199, 223-233. 
Hiatt, W. R., D. Nawaz, and E. P. Brass. (1987). Carnitine metabolism during exercise in 
patients with peripheral vascular disease. J.Appl.Physiol. 62, 2383-2387. 
Hiatt, W. R., D. Nawaz, J. G. Regensteiner, and K. F. Hossack. (1988). The evaluation of 
exercise performance in patients with peripheral vascular disease. 
J.Cardiopulmonary Rehabil. 12, 525-532. 
Hiatt, W. R., J. G. Regensteiner, E. E. Wolfel, M. R. Carry, and E. P. Brass. (1996). 
Effect of exercise training on skeletal muscle histology and metabolism in 
peripheral arterial disease. J.Appl.Physiol. 81, 780-788. 
Hiatt, W. R., E. E. Wolfel, R. H. Meier, and J. G. Regensteiner. (1994). Superiority of 
treadmill walking exercise vs. strength training for patients with peripheral 
arterial disease  Implications for the mechanism of the training response. 
Circulation. 90, 1866-1874. 
Hiatt, W. R., E. E. Wolfel, J. G. Regensteiner, and E. P. Brass. (1992). Skeletal muscle 
carnitine metabolism in patients with unilateral peripheral arterial disease. 
J.Appl.Physiol. 73, 346-353. 
Hickman, P., D. K. Harrison, A. Hill, M. McLaren, H. Tamei, P. T. McCollum, and J. J. 
Belch. (1994). Exercise in patients with intermittent claudication results in the 
generation of oxygen derived free radicals and endothelial damage. 
Adv.Exp.Med.Biol. 361, 565-570. 
Hillestad, L. K. (1963a). The Peripheral Blood Flow In Intermittent Claudication  IV. The 
Significance Of The Claudication Distance. Acta Med Scand. 173, 467-478.   
Hillestad, L. K. (1963b). The Peripheral Blood Flow in Intermittent Claudication  V. 
Plethsmorgraphic Studies. The Signigicance of The Caif Blood Flow at Rest and 
in Response to Timed Arrest of The Circulation. Acta Med.Scand. 174, 23-41. 
Hlavova, A., J. Linhart, I. Prerovsky, V. Ganz, and A. Fronek. (1966). Leg oxygen 
consumption at rest and during exercise in normal subjects and in patients with 
femoral artery occlusion. Clin.Sci. 30, 377-387. 
Hlavova, J., J. Linhart, I. Prerovsky, V. Ganz, and A. Fronek. (1965). Leg blood flow at 
rest, during and after exercise in normal subjects and in patients with femoral 
artery occlusion. Clin.Sci. 29, 555-564. 
Hogan, M. C., S. Nioka, W. F. Brechue, and B. Chance. (1992). A 31P-NMR study of 
tissue respiration in working dog muscle during reduced O2 delivery conditions. 
J.Appl.Physiol. 73, 1662-1670. 
 52
Holloszy, J. O. and E. F. Coyle. (1984). Adaptations of skeletal muscle to endurance 
exercise and their metabolic consequences. J.Appl.Physiol. 56, 831-838. 
Holm, S. and A. C. Bylund-Fellenius. (1981). Continuous monitoring of oxygen tension 
in human gastrocnemius muscle during exercise. Clin.Physiol. 1, 541-552. 
Hou, X. Y., S. Green, C. D. Askew, G. Barker, A. Green, and P. J. Walker. (2002). 
Skeletal muscle mitochondrial ATP production rate and walking performance in 
peripheral arterial disease. Clin.Physiol Funct.Imaging. 22, 226-232. 
Hughson, R. L. (1984). Alterations in the oxygen deficit-oxygen debt relationships with 
beta-adrenergic receptor blockade in man. J.Physiol. 349, 375-387. 
Hughson, R. L. (1990). Exploring cardiorespiratory control mechanisms through gas 
exchange dynamics. Med.Sci.Sports Exerc. 22, 72-79. 
Hughson, R. L., J. E. Cochrane, and G. C. Butler. (1993). Faster O2 uptake kinetics at 
onset of supine exercise with than without lower body negative pressure. 
J.Appl.Physiol. 75, 1962-1967. 
Hughson, R. L. and J. M. Kowalchuk. (1995). Kinetics of oxygen uptake for submaximal 
exercise in hyperoxia, normoxia, and hypoxia. Can.J.Appl.Physiol. 20, 198-210. 
Hughson, R. L., J. K. Shoemaker, M. E. Tschakovsky, and J. M. Kowalchuk. (1996). 
Dependence of muscle VO2 on blood flow dynamics at onset of forearm exercise. 
J.Appl.Physiol. 81, 1619-1626. 
Hughson, R. L., H. C. Xing, C. Borkhoff, and G. C. Butler. (1991). Kinetics of 
ventilation and gas exchange during supine and upright cycle exercise. 
Eur.J.Appl.Physiol Occup.Physiol. 63, 300-307. 
Jansson, E., J. Johansson, C. Sylven, and L. Kaijser. (1988). Calf muscle adaptation in 
intermittent claudication. Side-differences in muscle metabolic characteristics in 
patients with unilateral arterial disease. Clin.Physiol. 8, 17-29. 
Jones, A. M., K. Koppo, D. P. Wilkerson, S. Wilmshurst, and I. T. Campbell. (2004a). 
Dichloroacetate does not speed phase-II pulmonary VO2 kinetics following the 
onset of heavy intensity cycle exercise. Pflugers Arch. 447, 867-874. 
Jones, A. M., D. P. Wilkerson, K. Koppo, S. Wilmshurst, and I. T. Campbell. (2003). 
Inhibition of nitric oxide synthase by L-NAME speeds phase II pulmonary .VO2 
kinetics in the transition to moderate-intensity exercise in man. J.Physiol. 552, 
265-272. 
Jones, A. M., D. P. Wilkerson, S. Wilmshurst, and I. T. Campbell. (2004b). Influence of 
L-NAME on pulmonary O2 uptake kinetics during heavy-intensity cycle exercise. 
J.Appl.Physiol. 96, 1033-1038. 
 53
Jue, T., T. K. Tran, P. Mole, Y. Chung, N. Sailasuta, R. Hurd, U. Kreutzer, and S. Kuno. 
(1999). Myoglobin and O2 consumption in exercising human gastrocnemius 
muscle. Adv.Exp.Med.Biol. 471, 289-294. 
Karmazyn, M. (1991). Ischemic and reperfusion injury in the heart:  cellular mechanisms 
and pharmacologic interventions. Can.J.Physiol Pharmacol. 69, 719-730. 
Kemp, G. J. (2005). Mitochondrial dysfunction in chronic ischemia and peripheral 
arterial disease. Mitochondrion. 4, 629-640. 
Kemp, G. J., L. J. Hands, G. Ramaswami, D. J. Taylor, A. Nicolaides, A. Amato, and G. 
K. Radda. (1995). Calf muscle mitochondrial and glycogenolytic ATP synthesis 
in patients with claudication due to peripheral vascular disease analysed using 31P 
magnetic resonance spectroscopy. Clin.Sci.(Colch.). 89, 581-590. 
Kemp, G. J., N. Roberts, W. E. Bimson, A. Bakran, and S. P. Frostick. (2002). Muscle 
oxygenation and ATP turnover when blood flow is impaired by vascular disease. 
Mol.Biol.Rep. 29, 187-191. 
Kemp, G. J., N. Roberts, W. E. Bimson, A. Bakran, P. L. Harris, G. L. Gilling-Smith, J. 
Brennan, A. Rankin, and S. P. Frostick. (2001). Mitochondrial function and 
oxygen supply in normal and in chronically ischemic muscle: a combined 31P 
magnetic resonance spectroscopy and near infrared spectroscopy study in vivo. 
J.Vasc.Surg. 34, 1103-1110. 
Kemp, G. J., D. J. Taylor, C. H. Thompson, L. J. Hands, B. Rajagopalan, P. Styles, and 
G. K. Radda. (1993). Quantitative analysis by 31P magnetic resonance 
spectroscopy of abnormal mitochondrial oxidation in skeletal muscle during 
recovery from exercise. NMR Biomed. 6, 302-310. 
Kindig, C. A., P. McDonough, H. H. Erickson, and D. C. Poole. (2001). Effect of L-
NAME on oxygen uptake kinetics during heavy-intensity exercise in the horse. 
J.Appl.Physiol. 91, 891-896. 
Kindig, C. A., P. McDonough, H. H. Erickson, and D. C. Poole. (2002). Nitric oxide 
synthase inhibition speeds oxygen uptake kinetics in horses during moderate 
domain running. Respir.Physiol Neurobiol. 132, 169-178. 
Koike, A., M. Hiroe, H. Adachi, T. Yajima, Y. Yamauchi, A. Nogami, H. Ito, Y. 
Miyahara, M. Korenaga, and F. Marumo. (1994). Oxygen uptake kinetics are 
determined by cardiac function at onset of exercise rather than peak exercise in 
patients with prior myocardial infarction. Circulation. 90, 2324-2332. 
Koike, A., K. Wasserman, D. K. McKenzie, S. Zanconato, and D. Weiler-Ravell. (1990). 
Evidence that diffusion limitation determines oxygen uptake kinetics during 
exercise in humans. J.Clin.Invest. 86, 1698-1706. 
 54
Koike, A., T. Yajima, H. Adachi, N. Shimizu, H. Kano, K. Sugimoto, A. Niwa, F. 
Marumo, and M. Hiroe. (1995). Evaluation of exercise capacity using 
submaximal exercise at a constant work rate in patients with cardiovascular 
disease. Circulation. 91, 1719-1724. 
Komiyama, T., A. Onozuka, T. Miyata, and H. Shigematsu. (2002). Oxygen saturation 
measurement of calf muscle during exercise in intermittent claudication. 
Eur.J.Vasc.Endovasc.Surg. 23, 388-392. 
Kooijman, H. M., M. T. Hopman, W. N. Colier, J. A. van der Vliet, and B. Oeseburg. 
(1997). Near infrared spectroscopy for noninvasive assessment of claudication. 
J.Surg.Res. 72, 1-7. 
Koppo, K., D. P. Wilkerson, J. Bouckaert, S. Wilmshurst, I. T. Campbell, and A. M. 
Jones. (2004). Influence of DCA on pulmonary (.-)VO2 kinetics during moderate-
intensity cycle exercise. Med.Sci.Sports Exerc. 36, 1159-1164. 
Leng, G. C., A. J. Lee, F. G. Fowkes, M. Whiteman, J. Dunbar, E. Housley, and C. V. 
Ruckley. (1996). Incidence, natural history and cardiovascular events in 
symptomatic and asymptomatic peripheral arterial disease in the general 
population. Int.J.Epidemiol. 25, 1172-1181. 
Liao, J. K., M. A. Bettmann, T. Sandor, J. I. Tucker, S. M. Coleman, and M. A. Creager. 
(1991). Differential impairment of vasodilator responsiveness of peripheral 
resistance and conduit vessels in humans with atherosclerosis. Circ.Res. 68, 1027-
1034. 
Lieberman, E. H., M. D. Gerhard, A. Uehata, A. P. Selwyn, P. Ganz, A. C. Yeung, and 
M. A. Creager. (1996). Flow-induced vasodilation of the human brachial artery is 
impaired in patients <40 years of age with coronary artery disease. Am J Cardiol. 
78, 1210-1214. 
Lundgren, F., A. G. Dahllof, T. Schersten, and A. C. Bylund-Fellenius. (1989). Muscle 
enzyme adaptation in patients with peripheral arterial insufficiency: Spontaneous 
adaptation, effect of different treatments and consequences on walking 
performance. Clin.Sci. 77, 485-493. 
Maass, U. and K. Alexander. (1983). Effect of treadmill exercise on blood gases and 
acid-base balance in patients with intermittent claudication. Z.Kardiol. 72, 537-
542. 
Maass, U. and K. Alexander. (2001). Lactate and Pyruvate Changes During Treadmill 
Exercise In Patients With Intermittent Claudication. Kardiologie. 71, 39-43. 
MacDonald, M. J., J. K. Shoemaker, M. E. Tschakovsky, and R. L. Hughson. (1998). 
Alveolar oxygen uptake and femoral artery blood flow dynamics in upright and 
supine leg exercise in humans. J.Appl.Physiol. 85, 1622-1628. 
 55
Makitie, J. (1977). Skeletal muscle capillaries in intermittent claudication. 
Arch.Pathol.Lab Med. 101, 500-503. 
Makitie, J. and H. Teravainen. (1977). Histochemical changes in striated muscle in 
patients with intermittent claudication. Arch.Pathol.Lab Med. 101, 658-663. 
Mancini, D. M., L. Bolinger, H. Li, K. Kendrick, B. Chance, and J. R. Wilson. (1994). 
Validation of near-infrared spectroscopy in humans. J.Appl.Physiol. 77, 2740-
2747. 
Marcinek, D. J., K. A. Schenkman, W. A. Ciesielski, and K. E. Conley. (2004). 
Mitochondrial coupling in vivo in mouse skeletal muscle. Am.J.Physiol Cell 
Physiol. 286, C457-C463. 
McCreary, C. R., P. D. Chilibeck, G. D. Marsh, D. H. Paterson, D. A. Cunningham, and 
R. T. Thompson. (1996). Kinetics of pulmonary oxygen uptake and muscle 
phosphates during moderate-intensity calf exercise. J.Appl.Physiol. 81, 1331-
1338. 
McCully, K. K., C. Halber, and J. D. Posner. (1994). Exercise-induced changes in oxygen 
saturation in the calf muscles of elderly subjects with peripheral vascular disease. 
J.Gerontol. 49, B128-B134. 
McCully, K. K., L. Landsberg, M. Suarez, M. Hofmann, and J. D. Posner. (1997). 
Identification of peripheral vascular disease in elderly subjects using optical 
spectroscopy. J.Gerontol.A Biol.Sci.Med.Sci. 52, B159-B165. 
McGuigan, M. R., R. Bronks, R. U. Newton, M. J. Sharman, J. C. Graham, D. V. Cody, 
and W. J. Kraemer. (2001). Muscle fiber characteristics in patients with peripheral 
arterial disease. Med.Sci.Sports Exerc. 33, 2016-2021. 
Mole, P. A., Y. Chung, T. K. Tran, N. Sailasuta, R. Hurd, and T. Jue. (1999). Myoglobin 
desaturation with exercise intensity in human gastrocnemius muscle. 
Am.J.Physiol. 277, R173-R180. 
Murabito, J. M., J. C. Evans, K. Nieto, M. G. Larson, D. Levy, and P. W. Wilson. (2002). 
Prevalence and clinical correlates of peripheral arterial disease in the Framingham 
Offspring Study. Am.Heart J. 143, 961-965. 
Myers, D. E., C. E. Cooper, G. E. Beilman, J. D. Mowlem, L. D. Andersen, R. P. Seifert, 
and J. P. Ortner. (2005). A wide gap second derivative NIR spectroscopic method 
for measuring tissue hemoglobin oxygen saturation. In Oxygen Transport to 
Tissue. Proceedings of the 32nd annual meeting of the International Society on 
Oxygen Transport to Tissue. ed. Edited by D. F. Bruley M. Ferrari and D. K. 
Harrison G.Cicco. Vol. XXVII.  New York, NY: Kluwer Academic/Plenum 
Publishers. 
 56
Ness, J. and W. S. Aronow. (1999). Prevalence of coexistence of coronary artery disease, 
ischemic stroke, and peripheral arterial disease in older persons, mean age 80 
years, in an academic hospital-based geriatrics practice. J.Am.Geriatr.Soc. 47, 
1255-1256. 
Nighswander-Rempel, S. P., V. V. Kupriyanov, and R. A. Shaw. (2005). Relative 
contributions of hemoglobin and myoglobin to near-infrared spectroscopic images 
of cardiac tissue. Appl.Spectrosc. 59, 190-193. 
Nissen, P., K. Alexander, A. Wittenborg, K. Tagder, H. Hundeshagen, and H. Fabel. 
(1974). [Oxygen extraction and blood flow under ergometric load in occlusive 
arterial disease]. VASA. 3, 257-262. 
Ohara, Y., T. E. Peterson, and D. G. Harrison. (1993). Hypercholesterolemia increases 
endothelial superoxide anion production. J.Clin.Invest. 91, 2546-2551. 
Pastoris, O., L. Panella, P. Foppa, M. Catapano, R. Moia, L. Memelli, M. Bejor, and M. 
Dossena. (1996). Instrumental and metabolic evaluation of patients affected by 
peripheral arterial occlusive disease (PAOD) following surgical revascularization 
surgery. G.Ital.Med.Lav. 18, 41-49. 
Pentecost, B. L. (2003). The Effect of Exercise on The External Iliac Vein Blood Flow 
and Local Oxygen Consumption in Normal Subjects, and in Those With 
Occlusive Artierial Disease. Clinical Science 27(1964), 437-445.   
Pernow, B., B. Saltin, J. Wahren, R. Cronestrand, and S. Ekestroom. (1975). Leg blood 
flow and muscle metabolism in occlusive arterial disease of the leg before and 
after reconstructive surgery. Clin.Sci.Mol.Med. 49, 265-275. 
Pernow, B. and S. Zetterquist. (1968). Metabolic evaluation of the leg blood flow in 
claudicating patients with arterial obstructions at different levels. 
Scand.J.Clin.Lab.Invest. 21, 277-287. 
Petersen, E. S., B. J. Whipp, J. A. Davis, D. J. Huntsman, H. V. Brown, and K. 
Wasserman. (1983). Effects of beta-adrenergic blockade on ventilation and gas 
exchange during exercise in humans. J.Appl.Physiol. 54, 1306-1313. 
Pipinos, I. I., A. D. Shepard, P. V. Anagnostopoulos, A. Katsamouris, and M. D. Boska. 
(2000). Phosphorus 31 nuclear magnetic resonance spectroscopy suggests a 
mitochondrial defect in claudicating skeletal muscle. J.Vasc.Surg. 31, 944-952. 
Poole, D. C., W. Schaffartzik, D. R. Knight, T. Derion, B. Kennedy, H. J. Guy, R. 
Prediletto, and P. D. Wagner. (1991). Contribution of excising legs to the slow 
component of oxygen uptake kinetics in humans. J.Appl.Physiol. 71, 1245-1260. 
Regensteiner, J. G., J. F. Steiner, R. J. Panzer, and W. R. Hiatt. (1990). Evaluation of 
walking impairment by questionnaire in patients with peripheral arterial disease. 
J.Vasc.Med.Biol. 2, 142-152. 
 57
Regensteiner, J. G., E. E. Wolfel, E. P. Brass, M. R. Carry, S. P. Ringel, M. E. Hargarten, 
E. R. Stamm, and W. R. Hiatt. (1993). Chronic changes in skeletal muscle 
histology and function in peripheral arterial disease. Circulation. 87, 413-421. 
Richardson, R. S., B. Grassi, T. P. Gavin, L. J. Haseler, K. Tagore, J. Roca, and P. D. 
Wagner. (1999a). Evidence of O2 supply-dependent VO2 max in the exercise-
trained human quadriceps. J.Appl.Physiol. 86, 1048-1053. 
Richardson, R. S., D. R. Knight, D. C. Poole, S. S. Kurdak, M. C. Hogan, B. Grassi, and 
P. D. Wagner. (1995). Determinants of maximal exercise VO2 during single leg 
knee-extensor exercise in humans. Am.J.Physiol. 268, H1453-H1461. 
Richardson, R. S., J. S. Leigh, P. D. Wagner, and E. A. Noyszewski. (1999b). Cellular 
PO2 as a determinant of maximal mitochondrial O2 consumption in trained human 
skeletal muscle. J.Appl.Physiol. 87, 325-331. 
Richardson, R. S., S. C. Newcomer, and E. A. Noyszewski. (2001). Skeletal muscle 
intracellular PO2 assessed by myoglobin desaturation: response to graded 
exercise. J.Appl.Physiol. 91, 2679-2685. 
Richardson, R. S., K. Tagore, L. J. Haseler, M. Jordan, and P. D. Wagner. (1998). 
Increased VO2 max with right-shifted Hb-O2 dissociation curve at a constant O2 
delivery in dog muscle in situ. J.Appl.Physiol. 84, 995-1002. 
Roberts, P. A., S. J. Loxham, S. M. Poucher, D. Constantin-Teodosiu, and P. L. 
Greenhaff. (2002). The acetyl group deficit at the onset of contraction in 
ischaemic canine skeletal muscle. J.Physiol. 544, 591-602. 
Ross, R. (1997). Cellular and molecular studies of atherosclerosis. Atherosclerosis. 131, 
S3-S4. 
Rossiter, H. B., S. A. Ward, V. L. Doyle, F. A. Howe, J. R. Griffiths, and B. J. Whipp. 
(1999). Inferences from pulmonary O2 uptake with respect to intramuscular 
[phosphocreatine] kinetics during moderate exercise in humans. J.Physiol. 518 ( 
Pt 3), 921-932. 
Rossiter, H. B., S. A. Ward, F. A. Howe, D. M. Wood, J. M. Kowalchuk, J. R. Griffiths, 
and B. J. Whipp. (2003). Effects of dichloroacetate on VO2 and intramuscular 31P 
metabolite kinetics during high-intensity exercise in humans. J.Appl.Physiol. 95, 
1105-1115. 
Rouslin, W. (1983). Mitochondrial complexes I, II, III, IV, and V in myocardial ischemia 
and autolysis. Am.J.Physiol. 244, H743-H748. 
Rouslin, W. and S. Ranganathan. (1983). Impaired function of mitochondrial electron 
transfer complex I in canine myocardial ischemia: loss of flavin mononucleotide. 
J Mol.Cell Cardiol. 15, 537-542. 
 58
Schenkman, K. A., D. R. Marble, D. H. Burns, and E. O. Feigl. (1997). Myoglobin 
oxygen dissociation by multiwavelength spectroscopy. J.Appl.Physiol. 82, 86-92. 
Schersten, T., A. C. Bylund-Fellenius, A. Elander, J. Holm, J. P. Idstrom, and P. M. 
Walker. (2001). Metabolic Adaptation In Peripheral Arterial Insufficiency. 
Induced Skeletal Muscle Ischemia in Man.Symp.101-116. 
Schweiger, H. (1991). Investigations on the biochemical characteristics of chronically 
underperfused muscle. Angiology. 42, 239-250. 
Seiyama, A., O. Hazeki, and M. Tamura. (1988). Noninvasive quantitative analysis of 
blood oxygenation in rat skeletal muscle. J.Biochem.(Tokyo). 103, 419-424. 
Sietsema, K. E., I. Ben-Dov, Y. Y. Zhang, C. Sullivan, and K. Wasserman. (1994). 
Dynamics of oxygen uptake for submaximal exercise and recovery in patients 
with chronic heart failure. Chest. 105, 1693-1700. 
Sietsema, K. E., D. M. Cooper, J. K. Perloff, M. H. Rosove, J. S. Child, M. M. Canobbio, 
B. J. Whipp, and K. Wasserman. (1986). Dynamics of oxygen uptake during 
exercise in adults with cyanotic congenital heart disease. Circulation. 73, 1137-
1144. 
Sjostrom, M., K. A. Angquist, and O. Rais. (1980). Intermittent claudication and muscle 
fiber fine structure: Correlation between clinical and morphological data. 
Ultrastruct.Pathol. 1, 309-326. 
Smerdu, V., I. Karsch-Mizrachi, M. Campione, L. Leinwand, and S. Schiaffino. (1994). 
Type IIx myosin heavy chain transcripts are expressed in type IIb fibers of human 
skeletal muscle. Am.J.Physiol. 267, C1723-C1728. 
Sorlie, D. and K. Myhre. (1978). Lower leg blood flow in intermittent claudication. 
Scand.J.Clin Lab Invest. 38, 171-179. 
Springer, C., T. J. Barstow, K. Wasserman, and D. M. Cooper. (1991). Oxygen uptake 
and heart rate responses during hypoxic exercise in children and adults. 
Med.Sci.Sports Exerc. 23, 71-79. 
Stamler, J. S. and G. Meissner. (2001). Physiology of nitric oxide in skeletal muscle. 
Physiol Rev. 81, 209-237. 
Steinacker, J. M., A. Opitz-Gress, S. Baur, W. Lormes, K. Bolkart, L. Sunder-Plassmann, 
F. Liewald, M. Lehmann, and Y. Liu. (2000). Expression of myosin heavy chain 
isoforms in skeletal muscle of patients with peripheral arterial occlusive disease. 
J.Vasc.Surg. 31, 443-449. 
Stoffers, H. E., A. D. Kester, V. Kaiser, P. E. Rinkens, P. J. Kitslaar, and J. A. 
Knottnerus. (1996). The diagnostic value of the measurement of the ankle-
 59
brachial systolic pressure index in primary health care. J.Clin.Epidemiol. 49, 
1401-1405. 
Strandell, T. and R. A. Wain. (2003). Circulation In The Calf At Rest, After Arterial 
Occlusion And After Exercise In Normal Subjects And In Patients /with 
Intermittent Claudication. Acta Med Scand. 173, 99-105.   
Sugar, O. (1994). Jean-Francois Bouley (Bouley jeune). Pioneer investigator in 
intermittent claudication. Spine. 19, 346-349. 
Sumner, D. S. and D. E. Strandness, Jr. (1969). The relationship between calf blood flow 
and ankle blood pressure in patients with intermittent claudication. Surgery. 65, 
763-771. 
Sumner, D. S. and D. E. Strandness, Jr. (1970). The effect of exercise on resistance to 
blood flow in limbs with an occluded superficial femoral artery. Vasc.Surg. 4, 
229-237. 
Teravainen, H. and J. Makitie. (1977). Striated muscle ultrastructure in intermittent 
claudication. Arch.Pathol.Lab Med. 101, 230-235. 
Tesfamariam, B. and R. A. Cohen. (1992). Free radicals mediate endothelial cell 
dysfunction caused by elevated glucose. Am.J.Physiol. 263, H321-H326. 
Timmons, J. A., T. Gustafsson, C. J. Sundberg, E. Jansson, and P. L. Greenhaff. (1998a). 
Muscle acetyl group availability is a major determinant of oxygen deficit in 
humans during submaximal exercise. Am.J.Physiol. 274, E377-E380. 
Timmons, J. A., T. Gustafsson, C. J. Sundberg, E. Jansson, E. Hultman, L. Kaijser, J. 
Chwalbinska-Moneta, D. Constantin-Teodosiu, I. A. MacDonald, and P. L. 
Greenhaff. (1998b). Substrate availability limits human skeletal muscle oxidative 
ATP regeneration at the onset of ischemic exercise. J.Clin.Invest. 101, 79-85. 
Timmons, J. A., S. M. Poucher, D. Constantin-Teodosiu, I. A. MacDonald, and P. L. 
Greenhaff. (1997). Metabolic responses from rest to steady state determine 
contractile function in ischemic skeletal muscle. Am.J.Physiol. 273, E233-E238. 
Timmons, J. A., S. M. Poucher, D. Constantin-Teodosiu, V. Worrall, I. A. MacDonald, 
and P. L. Greenhaff. (1996). Metabolic responses of canine gracilis muscle during 
contraction with partial ischemia. Am.J.Physiol. 270, E400-E406. 
Tran, T. K., N. Sailasuta, U. Kreutzer, R. Hurd, Y. Chung, P. Mole, S. Kuno, and T. Jue. 
(1999). Comparative analysis of NMR and NIRS measurements of intracellular 
PO2 in human skeletal muscle. Am.J.Physiol. 276, R1682-R1690. 
Tsao, P. S., R. Buitrago, H. Chang, U. D. I. Chen, and G. M. Reaven. (1995). Effects of 
diabetes on monocyte-endothelial interactions and endothelial superoxide 
 60
 61
production in fructose-induced insulin-resistant and hypertensive rats. Circulation. 
92, A2666. 
Turrens, J. F., M. Beconi, J. Barilla, U. B. Chavez, and J. M. McCord. (1991). 
Mitochondrial generation of oxygen radicals during reoxygenation of ischemic 
tissues. Free Radic.Res.Commun. 12-13 Pt 2, 681-689. 
Voet, D. and J. G. Voet. (1995). Biochemistry. 2nd Edition ed. New York: John Wiley & 
Sons, Inc. 
Wagner, P. D. (1996). Determinants of maximal oxygen transport and utilization. 
Annu.Rev.Physiol. 58, 21-50. 
Wahren, J., R. Cronestrand, and A. Juhlin-Dannfelt. (1973). Leg blood flow during 
exercise in patients with occlusion of the iliac artery: pre- and postoperative 
studies. Scand.J.Clin.Lab Invest. 32, 257-263. 
Wang, H., W. R. Hiatt, T. J. Barstow, and E. P. Brass. (1999). Relationships between 
muscle mitochondrial DNA content, mitochondrial enzyme activity and oxidative 
capacity in man: alterations with disease. Eur.J.Appl.Physiol. 80, 22-27. 
Weitz, J. I., J. Byrne, G. P. Clagett, M. E. Farkouh, J. M. Porter, D. L. Sackett, D. E. Jr 
Strandness, and L. M. Taylor. (1996). Diagnosis and treatment of chronic arterial 
insufficiency of the lower extremities: a critical review. Circulation. 94, 3026-
3049. 
Whipp, B. J. and Mahler M. (1980). Dynamics of Pulmonary Gas Exchange during 
Exercise. In Pulmonary Gas Exchange. Edited by J. B. West. Vol. II. 33-95. New 
York: Academic Press, Inc. 
Wibom, R., E. Hultman, M. Johansson, K. Matherei, D. Constantin-Teodosiu, and P. G. 
Schantz. (1992). Adaptation of mitochondrial ATP production in human skeletal 
muscle to endurance training and detraining. J.Appl.Physiol. 73, 2004-2010. 
Yoshida, T. and B. J. Whipp. (1994). Dynamic asymmetries of cardiac output transients 
in response to muscular exercise in man. J.Physiol.(Lond.). 480, 355-359. 
Zatina, M. A., H. D. Berkowitz, G. M. Gross, J. M. Maris, and B. Chance. (1986). 31P 
nuclear magnetic resonance spectroscopy: Noninvasive biochemical analysis of 
the ischemic extremity. J.Vasc.Surg. 3, 411-420. 
Zetterquist, S. (1970). The effect of active training on the nutritive blood flow in 
exercising ischemic legs. Scand.J.Clin.Lab.Invest. 25, 101-111. 
 
 
 
 Chapter 2 
 
Pulmonary O2 Dynamics during Treadmill and Arm Exercise  
In Peripheral Arterial Disease 1 
Abstract 
 Slowed pulmonary oxygen uptake kinetics ( O2 kinetics) in peripheral arterial 
disease (PAD) have been attributed to impaired limb blood flow and/or peripheral muscle 
metabolic abnormalities.  While PAD results from atherosclerotic occlusive disease in the 
arteries to the lower extremities, systemic abnormalities affecting whole body oxygen 
delivery or vascular function in PAD could also partially explain the exercise 
impairment.  To date, the effects of these systemic abnormalities have not been evaluated.  
In order to test the hypothesis that the slowed pulmonary O2 kinetics in PAD reflects 
local and not systemic abnormalities, O2 kinetics were evaluated following the onset of 
constant load exercise of the upper and lower limbs in PAD patients and healthy controls.  
Ten PAD patients and 10 control subjects (CON) without significant cardiopulmonary 
dysfunction performed multiple transitions from rest to moderate intensity arm ergometry 
and treadmill exercise to assess their O2 kinetic responses.  Reactive hyperemic (RH) 
blood flow was assessed in the arms and legs as a measure of endothelial function.  As 
compared with controls, PAD O2 kinetic phase 2 time constants were prolonged during 
treadmill exercise (PAD 34.3+9.2 sec. vs. CON 19.6+3.5 sec., p<0.01) but not arm 
exercise (PAD 38.5+7.5 sec. vs. CON 32.5+9.0 sec. p>0.05).  RH blood flow was 
significantly reduced in the legs (PAD 20.7+8.3 vs. CON 46.1+17.1 ml/100ml/min, 
p<0.01) and arms of PAD subjects (PAD 34.0+8.6 vs. CON 50.8+12.2 ml/100ml/min, 
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 p<0.01) compared with controls, but RH limb flow was not correlated with arm or 
treadmill O2 kinetic responses in either group.  In summary, slowed pulmonary O2 
kinetics in PAD patients occur only with exercise of the lower limbs affected by the 
arterial occlusive disease process, and are not slowed with exercise of the unaffected 
upper extremities as compared with controls.  Further, the slowed pulmonary O2 kinetics 
of the lower extremity could not be explained by any abnormalities in resting cardiac or 
pulmonary function, and were not related to the magnitude of reduction in limb vascular 
reactivity. 
Introduction 
Patients with peripheral arterial disease (PAD) have atherosclerotic arterial 
occlusions that predominantly affect the lower limbs (Laroche et al. 1976, Welling et al. 
1981).  The principal symptom of PAD is claudication pain in the muscles of the lower 
extremity that results in a profound reduction in exercise tolerance and community-based 
walking ability (Hiatt et al. 1988, Hiatt et al. 1994).   
Following the onset of walking exercise in PAD, pulmonary oxygen uptake 
kinetics ( O2 kinetics) are slowed indicating an impaired rate of oxygen uptake to meet 
the increased muscle metabolic demand of exercise (Auchincloss et al. 1980, Haouzi et 
al. 1997, Bauer et al. 1999, Barker et al. 2003).  Previous observations of slowed O2 
kinetics in PAD have attributed the impaired kinetic response to the arterial occlusions of 
the lower extremity limiting O2 delivery (Auchincloss et al. 1980) and/or to abnormalities 
of peripheral skeletal muscle metabolism (Bauer et al. 1999, Barker et al. 2003).  
However, it remains unresolved whether the observed pulmonary O2 kinetic responses 
in PAD result from systemic rather than local abnormalities secondary to atherosclerosis 
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 that could influence O2 delivery.  For example, abnormalities in cardiac or pulmonary 
function could slow pulmonary O2 kinetics by altering systemic O2 delivery via a 
central cardiopulmonary impairment as observed in patients with atherosclerotic coronary 
artery disease (Koike et al. 1995) or obstructive pulmonary disease (Somfay et al. 2002).  
Further, O2 delivery in PAD could be influenced not only by the large artery occlusions, 
but also by reductions in systemic vascular reactivity that are observed in atherosclerotic 
diseases (Harris et al. 1995).  Thus, given the complex pathophysiology of PAD, 
distinguishing between these potential systemic and regional influences on pulmonary 
O2 kinetics would further clarify and localize potential causes of the exercise 
impairment in PAD.    
The present investigation tested the hypothesis that the abnormal pulmonary O2 
kinetics in PAD reflect local and not systemic abnormalities.  To differentiate the impact 
of systemic sequelae from atherosclerotic disease as a factor in the abnormal O2 
kinetics, pulmonary O2 kinetics were measured during leg (affected by the arterial 
occlusive disease process) and arm (no gross evidence of arterial disease) exercise in 
PAD patients compared with healthy controls.  Reactive hyperemic responses in the arms 
and legs were assessed to quantify the anticipated systemic dysfunction, and the 
relationships between the hyperemic response and O2 kinetics were defined.  Formal 
evaluations were conducted to ensure that no participants in the studies had significant 
cardiac or pulmonary dysfunction, thus partially excluding the influence of any central O2 
delivery impairment on the PAD O2 kinetic responses.   
Materials and Methods 
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 Subjects.  Ten patients with PAD and 10 healthy control subjects of similar ages were 
recruited for this investigation.  The University of Colorado Multiple Institutional Review 
Board approved the study, and informed consent was obtained from all subjects prior to 
study participation.   
All subjects underwent screening pulmonary function tests, resting echocardiography, 
and peak exercise testing with electrocardiograph (ECG) monitoring in order to exclude 
cardiopulmonary disease that could affect systemic O2 delivery.  Subjects were excluded 
from study if they exhibited: 1) a history of coronary artery disease, previous myocardial 
infarction or coronary revascularization, angina, stroke, congestive heart failure, or 
diabetes mellitus 2), hematology or chemistry laboratory values outside of normal limits, 
3) evidence of impaired pulmonary function (FEV1/FVC < 0.70 or > 1.20), 4) 
echocardiographic findings of impaired cardiac performance (resting EF < 50%, diastolic 
dysfunction, or any left ventricular wall motion abnormalities) or 5) evidence of ischemic 
ECG changes during graded maximal exercise testing.   
Healthy, non-smoking, control subjects were studied who had no chronic medical 
diseases by medical history, and a normal physical examination.  Healthy subjects had an 
ankle-brachial index (ABI) > 1.00 in both legs at rest, no history of PAD or other 
cardiovascular disease, and had no ischemic ECG changes at rest or with graded, 
maximal exercise testing.  All subjects were sedentary as defined by not participating in a 
regular exercise program (< 1 episode of exercise/week) and having similar scores on the 
Low Level Physical Activity Recall (LOPAR) questionnaire with PAD patients (Table 
1)(Regensteiner et al. 1996).  Two healthy control subjects were treated with statin drugs, 
but the remaining healthy subjects were taking no medications. 
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 Peripheral arterial disease was confirmed in patients by a resting ABI < 0.90, that 
fell at least 0.10 following peak exercise.  All PAD patients exhibited symptoms of 
claudication during walking, defined as localized discomfort or cramping in the muscles 
of the affected legs that occurred only with exercise and that was completely relieved 
following ten minutes of rest.  The absence of upper extremity occlusive arterial disease 
was confirmed by equal arm blood pressures and pulse examinations, and the absence of 
ischemic arm symptoms during arm ergometer testing.  Patients with ischemic rest pain 
or ischemic ulceration in either leg were excluded from study.  Patients with PAD 
included eight subjects with bilateral occlusive disease and two subjects with unilateral 
disease (defined as a reduced ABI and claudication symptoms in one leg, but no 
symptoms and an ABI greater than 0.90 at rest that did not decrease with exercise in the 
other leg).  All patients with PAD were taking aspirin, seven were treated with statin 
drugs, four were treated with calcium channel blocking agents, two with diuretics, and 
one with an angiotensin-converting enzyme inhibitor.  Since beta -adrenergic blocking 
drugs may alter the O2 kinetic response to exercise (Petersen et al. 1983), subjects 
taking these medications were excluded from study.   
Protocol Design.  Each study participant visited the Vascular Research Laboratory at the 
University of Colorado-Health Sciences Center on seven occasions for evaluation.  
Subjects were instructed to avoid the consumption of alcohol, caffeine, and smoking 
(only 2 PAD patients and no control subjects were current smokers) within the 12 hours 
prior to each visit and to avoid food consumption within 4 hours before each visit.  All 
exercise testing visits took place at the same time of day for each subject.  The first visit 
was used to obtain initial screening measurements and for subject familiarization with the 
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 exercise testing equipment.  At the second visit, all subjects underwent a resting 
echocardiogram.  The subsequent five visits consisted of peak treadmill and arm 
ergometry testing, arm and leg limb blood flow measurements, and constant work rate 
exercise tests for the analysis of the oxygen uptake kinetics. 
Graded Exercise Testing.  Subjects performed a single graded treadmill test and an 
incremental arm ergometry test on separate days for the determination of peak arm and 
peak treadmill exercise performance (peak O2).  Patients with PAD performed their 
graded treadmill test using the Gardner Protocol (speed constant at 2 mph, 2% increase in 
grade every 2 minutes) to maximal claudication pain that prevented any further walking 
(Gardner et al. 1992).  Healthy subjects performed a standard Bruce protocol to maximal 
effort (Bruce et al. 1973).  All treadmill tests were performed on a Quinton 4000 
treadmill (Quinton Instruments, Seattle, WA).  For determination of upper extremity peak 
O2, subjects performed an incremental arm ergometry test (ramping function of 7-10 
watts/minute) on an electrically braked cycle ergometer modified for this purpose (Lode 
Excalibur, The Netherlands).  For all graded exercise tests, heart rate (HR) was measured 
continuously using 12-lead ECG recordings.   
Constant Work Rate (CWR) Exercise Testing.  On two separate days, subjects performed 
exercise transitions from rest to a constant work rate (CWR) of treadmill walking (2.0 
mph, 4% grade) as previously described (Bauer et al. 1999).  This particular work rate 
was selected because all subjects (including PAD) could sustain six-minutes of constant 
work rate exercise without stopping, and because the work rate was sufficient to elicit a 
measurable increase in oxygen consumption suitable for determination of the O2 kinetic 
responses.  Each exercise transition consisted of a resting baseline period to obtain gas 
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 exchange data, followed by six-minutes of CWR walking exercise.  On a different day, 
subjects performed three six-minute CWR arm exercise transitions at a moderate 
workload equal to approximately 90% of the individual subject’s arm-specific lactate 
threshold (LT) by gas exchange criteria (i.e. 10% below the individual LT).  Each arm 
transition was separated by 10 minutes of rest.  Respiratory gas exchange measurements 
and heart rate data were recorded throughout the resting baseline, exercise, and recovery 
of each CWR bout.   
Reactive Hyperemia (RH) Blood Flow Measurements.  Limb blood flow was measured in 
the supine position using venous occlusion strain gauge plethysmography (D.E. 
Hokanson Inc. Issaquah, WA) at rest and during reactive hyperemia (RH) immediately 
after release of cuff occlusion as previously described (Hellige et al. 1979).  The limb to 
be assessed was supported just above the level of the heart and a mercury-in-silastic 
strain gauge was placed around the widest part of the forearm or calf.  A cuff distal to the 
strain gauge on the wrist or ankle was inflated to 50 mmHg above systolic pressure to 
eliminate hand or foot circulation from the measurement.  A pneumatic cuff was placed 
on the arm or thigh and inflated to 30mmHg to achieve venous occlusion.  The cuff 
occlusion was maintained for several (4-6) cardiac cycles to obtain resting blood flow 
measurements.  Blood flow was expressed as ml of flow/100ml of tissue/minute.  Resting 
blood flow was calculated as the average of 6 separate measurements in each limb.  Peak 
RH blood flow was determined following limb ischemia induced by a proximal cuff that 
was inflated 50 mmHg above systolic blood pressure for 5 minutes.  Post-occlusion RH 
blood flow measurements were made every few seconds and the highest value achieved 
was taken as the peak value.  Resting blood flow, peak RH blood flow and the change in 
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 blood flow from rest to peak RH (∆ blood flow, peak RH -resting blood flow) are 
presented as the sum of the individual values from both arms or both legs. 
Ankle Brachial Index.  The ABI was calculated in all subjects at rest and in PAD patients 
within one-minute following graded treadmill exercise as previously described (Bauer et 
al. 1999).  The ratio of ankle-to-brachial systolic pressure was determined by taking the 
highest arm pressure divided into the higher of the two vessels in each ankle.  
Spirometry.  Lung volumes and flow rates were measured using the flow meter and 
pulmonary function software of a metabolic system (Medical Graphics Corporation, 
BreezEx, St. Paul, MN).  Tidal volumes, Forced Vital Capacity (FVC), and Forced 
Expiratory Volume measured at 1.0 second (FEV1) were assessed.   
Echocardiography.  A cardiologist blinded to study group assessed resting cardiac 
function using echocardiography (Sonos 5500, Philips Medical Systems, Andover, MA).  
Measurements of left ventricular size and wall thickness were determined in standard 
fashion as recommended by the American Society of Echocardiography (Schiller et al. 
2003).  Specifically, systolic function was assessed by visual inspection, fractional 
shortening, and measurement of left ventricular ejection fraction by the method of disks 
(Schiller et al. 2003).  Diastolic function was assessed using left ventricular inflow 
Doppler and tissue Doppler measurements as previously described (Rakowski et al. 
1996).  Any regional wall motion abnormalities were noted and considered a 
disqualifying index of cardiac dysfunction.   
Measurement of Pulmonary Gas Exchange.  For all exercise tests, oxygen consumption  
( O2), carbon dioxide production ( CO2), minute ventilation ( E), and other respiratory 
variables were measured and recorded breath-by-breath using a metabolic measurement 
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 system (MedGraphics CPX/D, Medical Graphics Corp., St. Paul, MN, USA).  The 
system O2 and CO2 analyzers were calibrated prior to each test using gases of known 
concentrations.  Inspired and expired volumes were also calibrated using a syringe of 
known volume (3.0 L).  All breath-by-breath data collected were stored to computer disk 
for analysis.  During graded exercise, the highest O2 averaged over 20-seconds was 
defined as peak O2.  The respiratory exchange ratio (RER) was calculated as the ratio of 
CO2/ O2.  Estimated lactate threshold (LT) was determined from graded exercise gas 
exchange data for each individual’s arm and leg exercise using the V-slope method (point 
of nonlinear increase of CO2 in relation to O2) (Beaver et al. 1986).  Individual lactate 
thresholds could be determined for all subjects (PAD and control) during graded arm 
exercise.  However, no PAD patients demonstrated a measurable V-slope point of 
inflection during graded treadmill exercise and thus, a LT by gas exchange could not be 
determined.    
Data Analysis.  Breath-by-breath gas exchange data for each exercise transition were 
processed using a software program developed by our laboratory as previously described 
(Bauer et al. 1999).  Breath-by-breath data for each exercise transition were time 
interpolated to 1-second intervals.  The first constant work rate treadmill exercise 
transitions from each day of testing were time-aligned and averaged to provide a single 
O2 kinetic response for each subject (e.g. average of 2 CWR transitions).  In a similar 
fashion, the breath-by-breath data from 3 transitions of CWR arm exercise were 
processed to achieve a single kinetic response for arm ergometry exercise.   
The pulmonary O2 kinetic responses at the onset of CWR exercise were evaluated using 
2- and 3- component exponential mathematical models (e.g. 1and 2).   
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 O2(t)= O2(b) + A1(1 - e-(t-TD1)/τ1)   phase 1 
     + A2[1- e -(t-TD2)/τ2]   phase 2  (1) 
 
O2(t)= O2(b) + A1(1 - e-(t-TD1)/τ1)   phase 1   
     + A2[1- e -(t-TD2)/τ2]   phase 2 
     + A3[1- e -(t-TD3)/τ3]   phase 3  (2) 
The models provided estimates of the baseline O2, amplitude of the individual 
exponential components (A1, A2, A3), independent time delays for the onset of each 
exponential phase (TD1, TD2, TD3), and time constants of the individual exponential 
components (τ1, τ2, τ3) using nonlinear regression (Sigmaplot 2001, SPSS, Inc., Chicago, 
IL) as previously described (Bauer et al. 1999).  For each subject, the best-fit model 
(decision to include 2 versus 3 components) was determined across all exercise data 
points by an  F-test and confirmed by examination of the residuals between 20 and 180 
seconds (i.e. phase 2 of the response).  The latter criterion was included to ensure that 
data points within the likely period of phase 2 of the response were appropriately 
represented.  All CWR arm exercise transitions were performed at an exercise intensity of 
90% of arm LT (moderate exercise), and the pulmonary O2 kinetics were best fit using a 
two component exponential model.  The physiologically relevant amplitude of O2 for 
each phase of the transition was computed from the individual kinetic parameter 
estimates:  
A1′ = A1(1-e-(TD2/τ1)),                    (3)  
 
A2′ = A1′ + A2,          (4) 
 
A3′ = A3(1-e(-(ED-TD3)/τ3)),        (5) 
    
Atot = A2′ + A3′         (6). 
   
Heart Rate Kinetics.  The heart rate half-time (HR50) was calculated as the time for HR to 
achieve 50% of the change in HR from rest to end-CWR exercise.   
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 Statistical Analysis.  Unpaired student t-tests were used for comparisons between groups 
for all variables.  Planned comparisons within groups for arm and leg variables were 
made using paired t-tests.  The planned comparisons were PAD versus control for arm 
and leg responses and within PAD or control groups for arm versus leg responses with 
the primary endpoint of O2 kinetics.  The Pearson’s R product was used to evaluate 
significant correlations.  Statistical significance for all comparisons was declared at p < 
0.05.   
Results 
Subject Characterization.  Subject characteristics are presented in Table 1.  PAD and 
control subjects were of similar age, weight and BMI.  Two PAD subjects were current 
smokers and the PAD group had a significantly greater smoking history than controls as 
assessed by pack years (p < 0.05).  No differences were observed between PAD and 
controls for measures of pulmonary function (FEV1/FVC), resting cardiac function 
(Ejection Fraction >56% in all subjects), or in habitual physical activity (Low Level 
Physical Activity Recall, LOPAR).  Further, no subject demonstrated evidence of cardiac 
diastolic dysfunction or regional wall motion abnormalities.  As expected, resting ABI 
values were lower in the PAD group than controls (2 unilateral and 8 bilateral subjects 
are combined in PAD group mean).  Furthermore, following graded treadmill exercise, 
the ABI significantly decreased in both legs of bilateral subjects in the PAD group and in 
the affected leg of the two unilateral PAD subjects (p < 0.05).    
Peak Performance.  The peak lower and upper extremity exercise responses are presented 
in Table 2.  As previously described in the PAD patient population, claudication-limited 
peak O2 during graded treadmill exercise was reduced approximately 50% in PAD 
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 subjects compared with age-matched healthy controls (p < 0.01) (Hiatt et al. 1988).  This 
was associated with a reduced peak RER and peak HR in PAD patients as compared with 
controls during graded treadmill exercise (p < 0.01).  In the control subjects, the O2 at 
the lactate threshold was 19.3+ 2.7 ml/kg/min.  However, no PAD patient demonstrated a 
measurable V-slope point of inflection during graded treadmill exercise, and therefore a 
LT by gas exchange could not be determined.  During peak arm exercise, peak O2 was 
similar between groups, and no PAD subject was limited by ischemic arm symptoms (i.e. 
arm muscle cramping or localized arm symptoms) during upper extremity exercise.  
There were also no differences with graded arm exercise in peak RER or peak HR 
between PAD and control groups.  With arm exercise, PAD patients did demonstrate a 
LT by gas exchange criteria which occurred at a similar O2 compared with control 
subjects.  The only difference in arm exercise responses was that control subjects attained 
a greater power output at peak exercise than PAD subjects (p<0.05).   
Constant work rate exercise.  All PAD subjects experienced claudication pain during the 
CWR treadmill exercise with a mean onset at 142 seconds (Table 3).  No PAD patient 
stopped exercise prior to completing 6-minutes of CWR exercise.  Heart rate kinetics 
during lower extremity exercise, assessed by HR50, was prolonged in PAD (p < 0.01), but 
the PAD group had a greater change in HR from onset to the end of 6-minutes of CWR 
treadmill exercise (∆HR) compared with control subjects.  End-exercise oxygen 
consumption was similar between PAD and control groups during treadmill CWR 
walking exercise.  However, the relative intensity of CWR treadmill exercise as a 
percentage of peak exercise O2 was greater in the PAD group (83+17%) compared with 
controls (43+9%) (p < 0.01).  Consistent with a high relative exercise intensity in PAD, 
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 the respiratory exchange ratio was significantly greater in PAD subjects compared with 
controls at end treadmill CWR exercise (0.93 + 0.05 in PAD vs. 0.87 + 0.03 in controls, p 
< 0.05).  In contrast, there were no differences in exercise characteristics during CWR 
arm exercise at an individual relative intensity of 90% of mode-specific lactate threshold 
in both PAD and control groups.  Specifically, HR kinetics were similar between PAD 
and control groups during arm exercise. 
O2 uptake kinetics.  Kinetic data from all control subjects and three of ten PAD subjects’ 
treadmill CWR tests were best fit using a 2-component model, while seven PAD patients 
required 3-component modeling due to the presence of a slow, phase 3 component.  
Consistent with previous reports (Haouzi et al. 1997, Bauer et al. 1999), the pulmonary 
O2 time constant for phase 2 (τ2) during treadmill CWR exercise was 75% longer in 
PAD patients than controls (Table 4, p < 0.01).  In contrast, during CWR arm ergometry, 
the phase 2 O2 time constant was similar in PAD patients and controls (Figure 1).  
Individual subject data are presented in Figure 2.   
The amplitude parameter (A1′) of O2 during phase 1 was significantly lower in 
PAD subjects than in controls during both treadmill (p < 0.05) and arm CWR exercise (p 
< 0.05).  The O2 amplitude of phase 2 (A2′) was also reduced in PAD during treadmill 
CWR exercise (p < 0.01) but not arm exercise.  However, the total amplitude of O2 
(Atot) during treadmill and arm CWR exercise was similar between groups.  In the seven 
PAD subjects whose O2 kinetics were best fit with a 3-component model, the 
magnitude of the slow component (phase 3) accounting for approximately 20% of the 
total increase in end-exercise O2.   
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 Limb Hemodynamics.  Resting blood flow measurements of the upper and lower limbs 
were not different between groups (Table 5).  Peak RH ∆ blood flow was reduced over 
50% in the legs of PAD patients compared with control subjects (p < 0.01).  In PAD, the 
upper extremity ∆ blood flow was reduced 33% compared with control subjects (p < 
0.01) despite equal brachial systolic pressures across the upper extremities in PAD 
patients.  Whereas there were no differences in RH blood flow responses between the 
arms and legs of control subjects, patients with PAD had reduced RH blood flow 
responses in the legs compared with the arms (p < 0.05).   
Relationships between exercise and hemodynamic parameters.  There were no significant 
relationships between RH blood flow responses and the phase 2 (τ2) time constants for 
arm or treadmill CWR exercise within either group.  Whereas there were slowed heart 
rate kinetics (HR50) during CWR treadmill exercise in PAD patients, this was not 
correlated with the prolonged phase 2 time constants (τ2).  Consistent with previous 
reports, no relationships between the ABI and exercise performance parameters were 
observed.  However, a significant relationship was observed between the lower extremity 
∆ RH blood flow and treadmill peak O2 in patients with PAD (y= 0.22x + 10.98, R = 
0.70, p < 0.03).  This relationship was not observed in the control group. 
Discussion 
Consistent with our hypothesis, as compared with healthy subjects, PAD patients 
with no cardiac or pulmonary dysfunction demonstrated a specific defect (slowed time 
constant) in pulmonary O2 kinetics during leg but not arm exercise.   A systemic 
abnormality in vascular reactivity (reduced RH blood flow responses) was demonstrated 
in both the arms and legs of PAD patients compared with control subjects.  However, the 
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 RH blood flow abnormality in PAD was not correlated with the O2 kinetic responses of 
either the upper or lower extremity.  These data suggest that the slowed PAD pulmonary 
O2 kinetic responses appear localized to the lower extremities directly affected by the 
arterial occlusive disease process, and cannot be explained by a systemic defect in 
endothelial function (RH blood flow) nor by any systemic impairment in cardiac or 
pulmonary function.  Thus, the altered O2 kinetic responses to leg exercise are likely 
related to the peripheral impairment in O2 delivery or oxygen utilization in the PAD-
affected lower limbs. 
Previous studies have described prolonged pulmonary O2 kinetics in PAD 
patients during CWR treadmill walking (Auchincloss et al. 1980, Haouzi et al. 1997, 
Bauer et al. 1999, Barker et al. 2003).  Auchincloss et al. attributed a lower one-minute 
O2 in PAD to the limitation of lower limb blood flow (Auchincloss et al. 1980) while 
more recently we and others have suggested that peripheral muscle metabolic 
abnormalities may play a significant role in the O2 kinetic impairment (Bauer et al. 
1999, Barker et al. 2003).  However, these studies did not evaluate the potential 
confounders of impairments in systemic O2 delivery from cardiac or pulmonary disease, 
or the potential contributions of altered vascular function (reduced vascular reactivity), 
that occur in patients with atherosclerotic disease.  The present study demonstrates that 
the abnormal pulmonary O2 kinetics in PAD is specific to exercise of the lower limbs 
affected by the arterial occlusive disease process.   Oxygen uptake kinetics of the 
exercising muscles reflect the inter-related influences of local muscle oxygen delivery, 
oxygen diffusion and mitochondrial oxygen consumption.  As described by Barstow et 
al., impairment of O2 delivery may influence the expression of pulmonary O2 kinetics 
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 (Barstow et al. 1990).  However, in these modeling experiments (where muscle oxygen 
uptake was assumed to be normal), a reduction in O2 delivery was associated with a 
paradoxical speeding of the primary exponential phase of pulmonary O2 kinetics (phase 
2) as O2 extraction increases across the ‘exercising’ muscle (Barstow et al. 1990). Thus, 
our findings of slowed phase 2 time constants in PAD as compared with controls during 
treadmill exercise may not be consistent with a simple reduction in the rate of oxygen 
delivery but could also indicate a localized defect in oxygen diffusion or mitochondrial 
oxygen uptake that was not observed during arm exercise.  Indeed, using magnetic 
resonance spectroscopy, Kemp and colleagues have previously suggested a significant 
impairment in muscle oxidative metabolism during calf-muscle exercise that could alter 
the kinetics of mitochondrial respiration in PAD (Kemp et al. 1995, Kemp et al. 2001).  
Taking into account these considerations, our findings confirm that the defect of slowed 
pulmonary O2 kinetics during treadmill walking reflects the disease-associated 
abnormalities specific to the lower extremities in PAD. 
Heart rate dynamics (HR50) were slowed during treadmill walking exercise in 
patients with PAD.  Moreover, although resting heart rates were similar between groups, 
PAD patients had a greater absolute increase in HR during fixed-rate treadmill walking 
than did control subjects.  In contrast, the HR responses (HR50 and ∆HR) during arm 
exercise were not different between groups.  In consideration that the HR50 was not 
correlated with pulmonary O2 kinetics during arm or leg exercise, it is unlikely that any 
alterations in the heart rate component of cardiac output affected the slowed O2 kinetics 
during leg exercise.  Rather, the slowed HR50 during PAD leg exercise may have been 
related to their greater ∆HR, or other factors.   
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 Limb blood flow during reactive hyperemia increased above baseline in the arms 
and legs of PAD patients following supra-systolic cuff occlusion.  Thus, all PAD patients 
demonstrated a functional limb blood flow reserve.  However, the RH blood flow 
responses were reduced 33% in the arms and by 50% in the legs of PAD patients 
compared with control subjects.  Impaired vascular reactivity, measured as flow-mediated 
vasodilation or reactive hyperemic blood flow, has been demonstrated in the lower 
(occluded) and upper (non-occluded) arterial circulations in PAD patients indicating a 
systemic defect in endothelial vasodilator function (Yataco et al. 1999, Brendle et al. 
2001, Brevetti et al. 2003).  Presumably, the reduction in arm reactive hyperemia 
response in PAD patients was not the result of arterial occlusive disease as systolic 
pressures were equal between the arms in the PAD patients.  Moreover, no patient 
experienced muscle cramping or other evidence of muscle ischemia during arm exercise.  
Thus, we conclude that the reduction in the arm reactive hyperemic responses in the 
present PAD patients most likely reflected a systemic non-occlusive limitation in limb 
vascular reactivity related to their endothelial dysfunction. 
The reductions in reactive hyperemic blood flow were not correlated with arm or 
leg pulmonary O2 kinetics in either group.  In the upper extremity of PAD patients, the 
lack of a direct correlation between RH blood flow and pulmonary O2 kinetics suggests 
that these changes in vascular function alone were insufficient to compromise (i.e. slow) 
the arm O2 kinetic response.  Thus, in the present study we conclude that the PAD-
associated systemic reduction in vascular reactivity alone does not significantly impair 
the pulmonary O2 kinetic responses in these highly selected PAD patients.   
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 Despite the inferences above, we cannot exclude the possibility that the arterial 
occlusions in PAD combined with the impaired vascular reactivity contributed to the 
slowed lower extremity O2 kinetics.  Dorigo and Bartoli previously described that 
reactive hyperemia responses in PAD are quantitatively less than the blood flow response 
immediately following exercise (Bartoli et al. 1979).  Thus, our measure of reactive 
hyperemia likely does not elicit the same level of hyperemia achieved during exercise 
and could partially explain the lack of correlation with O2 kinetic and peak arm 
responses.  However, the PAD lower extremity reactive hyperemia responses did 
correlate with claudication-limited peak exercise performance.  This result emphasizes 
the significance of limb atherosclerosis and impaired arterial flow in contributing to the 
limitation of peak exercise function in PAD (Green 2002).  Moreover, the reactive 
hyperemic blood flow response may not only reflect the severity of the arterial 
obstruction, but also may be a surrogate for the magnitude of oxidative perturbation and 
altered regulatory processes that occur distal to the arterial obstruction in PAD.  This 
could include metabolic dysfunction of the affected skeletal muscle mitochondria, which 
may relate to a portion of the mechanism of exercise limitation and claudication 
symptoms in PAD (Walker 1991).  Thus, the correlation between reactive hyperemic 
measures and peak exercise performance in PAD may also suggest that the PAD exercise 
impairment is more than simply a flow limited phenomenon.  This could explain why 
reactive hyperemia, but not resting blood flow or resting ABI measurements are 
correlated with peak exercise function.  Clearly, the mechanism of exercise limitation in 
PAD is multifactorial, with contributions from both the blood flow limitation and the 
distal responses to the ischemic condition.  
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 Study limitations. 
Treadmill walking was employed in the current study to assess lower extremity 
pulmonary O2 kinetics because walking is the mode of exercise that predominantly 
produces the symptoms of claudication pain and exercise intolerance in PAD.  Whereas 
the arm CWR transitions were of low exercise intensity (below the individual’s lactate 
threshold) for all subjects, the treadmill CWR exercise represented a higher relative 
percent of peak exercise performance in PAD (83% of claudication -limited peak O2) 
than in control subjects (43% of peak O2) at the same absolute treadmill work rate.  
This resulted in a heterogeneous exercise response during treadmill CWR exercise in 
PAD patients such that seven patients demonstrated an apparent O2 slow component, 
consistent in healthy subjects with exercise in the heavy domain (i.e. > LT).  Although 
there is evidence that heavy exercise may alter the phase 2 time constants from that 
observed during moderate exercise due to a potential O2 delivery limitation in healthy 
subjects (Gerbino et al. 1996, Macdonald et al. 1997), others have described invariant or 
faster phase 2 time constants using similar modeling methods during heavy or severe 
exercise (Hughson et al. 2000, Ozyener et al. 2001, Scheuermann et al. 2003).  From the 
present data, we cannot directly evaluate the influence of exercise intensity on the 
pulmonary O2 kinetic responses in PAD.  However, consistent with previous 
observations (Haouzi et al. 1997, Bauer et al. 1999), the phase 2 time constants during 
treadmill CWR exercise were slowed in PAD as compared with controls irrespective of 
modeling procedure.  Moreover, the phase 2 time constants were similar in PAD patients 
that demonstrated a O2 slow component (n=7) to those without a phase 3 O2 increase 
(n=3) (subject means of 35.9 s. vs. 36.9 s, respectively).   
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 A second limitation of the study is that we did not conduct imaging studies of the 
upper extremity circulation to exclude potential upper extremity occlusive disease.  
However, previous studies have suggested that significant arterial occlusive involvement 
occurs approximately 20 times less frequently in the arms than the legs in the PAD 
patient population (Laroche et al. 1976, Welling et al. 1981).  Thus, our findings of 
preserved peak arm exercise capacity along with the absence of any symptoms of muscle 
ischemia during arm exercise, suggest that the arm exercise comparison with controls 
may provide a valid basis for evaluating potential systemic influences on pulmonary O2 
kinetics in PAD.   
In conclusion, the present results show that in PAD patients without apparent 
cardiopulmonary disease, pulmonary O2 kinetics are slowed during exercise of the 
affected lower extremities but not during exercise of the unaffected upper extremities 
compared with controls.  That the leg pulmonary O2 kinetic responses were slowed in 
these highly selected PAD patients supports the presence of a significant peripheral O2 
impairment that is localized to the PAD lower extremity and not related to their abnormal 
vascular reactivity.  Local abnormalities distal to the lower extremity arterial occlusions 
in patients with PAD offer putative explanations for their slowed pulmonary oxygen 
uptake kinetics.   
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 Table 1: Subject Characteristics 
 Control  
Range 
PAD  
Range 
N 10  10  
Age (years) 63.1 + 5.5 [53-70] 57.5 +12.4 [40-76] 
Weight (kg) 82.1 + 12.5 [70-100] 80.3 + 16.0 [69-114] 
BMI (kg/m2) 26.55 + 4.06 [22-31.7] 26.53 + 3.75 [20-35.2] 
Pack-years 4.6 + 9.6 [0-15] 41.1 + 20.2** [20-86] 
Current Smokers 0  2  
FEV1/FVC (%) 79 + 4 [73-84] 78 + 7 [70-92] 
Ejection Fraction (%) 67 + 6 [57-75] 63 + 7 [56-71] 
LOPAR (MET hrs/wk) 264 + 42 [213-279] 254 + 26 [212-289] 
ABI     
Best leg resting 1.20 + 0.09 1.09-1.23 0.89 + 0.18 ** 0.56-1.09 
- post-exercise -  0.54 + 0.33 §  
Worse leg resting 1.17 + 0.10 1.09-1.25 0.66 + 0.12 ** 0.51-0.93 
- post-exercise -  0.32 + 0.16 §  
Values are mean+ SD [Range]. PAD, peripheral arterial disease.  LOPAR, Low Level Physical 
Activity Recall.  ABI, Ankle-Brachial Index. ABI data include 2 unilateral subjects in PAD 
group.  ** p < 0.01 for PAD vs. Control; § p < 0.01 for difference in ABI from resting to post-
exercise.   
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 Table 2: Peak Exercise Characteristics 
 
 Control Range PAD Range 
Treadmill     
O2 (ml.kg-1.min-1) 30.1 + 4.8 † [22.7 - 35.6] 15.6 + 2.6 ** [12.4 – 20.2] 
       RER 1.14 + 0.09  1.00 + 0.07 **  
       HR (beats.min-1) 164 + 12  113 + 18 **  
      O2 at LT  
        (ml.kg-1.min-1) 
19.3 + 2.7  -  
       ICT (seconds) -  113 + 63  
       ACT (seconds) -  471 + 201  
Arm Ergometry     
      O2 (ml.kg-1.min-1) 18.2 + 3.4 [13.3 – 23.9] 15.1 + 4.1 [10.0 – 21.4] 
       RER 
1.21 + 0.09  1.23 + 0.09  
       HR (bpm) 
144 + 17  129 + 16  
      O2 at LT  
       (ml.kg-1.min-1) 
10.7+ 2.1  9.7+ 3.2  
       Peak Workload (w) 97 + 22  73 + 23 *  
Values are mean + SD [Range]. LT, lactate threshol; ICT, Time to onset of claudication 
symptoms; ACT, Claudication limited total walking time.  * p < 0.05, ** p < 0.0l for PAD vs. 
Control; † p < 0.05 for arm vs. leg. 
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Table 3: Constant Work Rate (CWR) Exercise Characteristics  
 
Control PAD 
Treadmill    
     ICT (seconds) - 142 + 72 
     HR50 time (seconds) 19 + 12 72 + 41 ** 
     ∆ HR (bpm) 12 + 9 20 + 6 * 
     End Exercise O2 (ml.min-1) 1042 + 228  1108 + 197  
     End Exercise O2 (% of peak) 
43 + 7 83 + 14 ** 
     End Exercise RER 
0.87+ 0.03 0.93 + 0.05 ** 
Arm Ergometry   
     Workload (watts) 32 + 8 26 + 10 
     HR50 time (seconds) 31 + 17 49 + 26 
     ∆ HR (bpm) 19 + 7 21 + 7 
     End Exercise O2 (ml.min-1) 830 + 106  777 + 147  
     End Exercise RER 
0.98  + 0.03  0.98  + 0.06 
Values are mean + SD.   All subjects exercised for 6-minutes.  CWR treadmill 
exercise was performed at 2.0 mph, 4% grade.  CWR arm ergometry was 
performed at 90% of lactate threshold. All PAD subjects experienced claudication 
symptoms during CWR treadmill testing. ICT, Time to onset of claudication 
symptoms during CWR treadmill walking.  HR50 time is time to achieve 50% of 
the heart rate response (∆HR). ∆HR, 6-minute heart rate minus resting baseline. * p 
< 0.05, ** p < 0.01 for PAD vs. Control. 
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 Table 4: O2 Kinetic Parameters for Constant Work Rate Exercise 
  
 Treadmill Arm Ergometry 
 Control PAD Control PAD 
Resting O2 (ml/min) 342 + 72 348 + 68 305 + 59 282 + 50 
Phase 1     
     n 10 10 10 10 
     τ1 (s) 1.0 + 1.0 1.3 + 1.0 0.8 + 0.9 0.9 + 1.4 
     TD1 (s) 1.1 + 2.2 2.9 + 3.5 0.5 + 1.2 1.7 + 2.5 
     A1' (ml/min) 380 + 117 258 + 89 * 198 + 33 159 + 47 * 
Phase 2     
     n 10 10 10 10 
     τ2 (sec) 19.6 + 3.5 † 34.3 + 9.2 ** 32.5 + 9.0 38.5 + 7.5 
     TD2 (s) 28.9 + 9.2 34.9 + 6.9 31.5 + 8.3 32.7 + 6.7 
     A2' (ml/min) 746 + 185 599 + 176 ** 511 + 68 498 + 126 
Phase 3    
  
     n  7 
  
     τ3 (s) - 329.9 + 715  - - 
     TD3 (s) - 156.4 + 42.1  - - 
     A3' (ml/min) - 117 + 89  - - 
     Atot (ml/min) 746 + 185 694 + 151 511 + 68 498 + 126 
Values are mean + SD.  Refer to Figure 1 for definitions.    τ  Exponential time constant. TD, time 
delay. A', Amplitude of O2 response.  Phase 3 data are presented from 7 PAD patients that 
demonstrated a slow component of O2. * p < 0.05, ** p <0.01 for PAD vs. Control,; † p < 0.05 
for arm vs. leg. 
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 Table 5: Limb Blood Flow  
 
 
Control PAD 
Leg blood flow  (ml/100cc tissue/min)   
     Resting  7.01 + 1.57 5.86 + 0.98 
     Peak 58.17 + 11.73 26.60 + 8.37 ** 
     ∆ blood flow  46.12 + 17.08 20.73 + 8.31 **,† 
   
Arm blood flow (ml/100cc tissue/min)   
     Resting  9.24 + 3.04 9.17 + 1.73 
     Peak 60.01 + 12.57 43.17 + 9.33 ** 
     ∆ blood flow 50.79 + 12.23 34.01 + 8.57 ** 
Values are mean + SD.    Measurements were made at rest and during reactive hypermia. Rest, 
Peak and ∆ blood flow are presented as sum of right and left limbs.  ∆ blood flow, (peak – resting 
flow).   Data include 2 unilateral subjects in the PAD group mean.  ** p < 0.0l for PAD vs. 
Control; † p < 0.05 for arm vs. leg. 
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Figure 1.  Comparison of pulmonary O2 kinetic responses from a representative PAD 
patient and control subject during the transition from rest to treadmill (upper panels) and 
arm ergometry (lower panels) constant work rate (CWR) exercise.  Treadmill exercise 
was performed at 2.0 mph, 4% grade, and arm ergometry was performed at 90% of 
individual LT.  Exercise was initiated at time 0.  Note presence of O2 slow component 
and modeling of third component during PAD CWR treadmill exercise. 
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Figure 2. Group means (+ SD) and individual data of pulmonary phase 2 O2 time 
constants during the transition from rest to constant work rate exercise. **, p < .01 PAD 
vs. Control; †, p < 0.05 Arm vs. leg. 
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 Chapter 3 
Impaired Muscle Oxygen Use at the Onset of Exercise  
in Peripheral Arterial Disease 2 
Abstract 
 In patients with peripheral arterial disease (PAD), abnormal muscle metabolism 
and impaired oxygen delivery distal to the arterial occlusions may contribute to the 
exercise limitation observed in this population.  Muscle tissue hemoglobin saturation 
(StO2), measured using near-infrared spectroscopy, reflects the relative contributions of 
oxygen delivery and oxygen utilization.  Thus, differences in the kinetics of StO2 in 
response to exercise may yield important insight into the potential mechanisms associated 
with the PAD exercise impairment.  The purposes of this study were to (1) characterize 
the muscle oxygenation responses in patients with PAD and healthy controls at the onset 
of exercise and (2) compare the kinetics of StO2 desaturation.  We hypothesized that at 
the onset of exercise, the kinetics of StO2 desaturation would be slowed in PAD compared 
with control responses.  Six patients with PAD and 6 healthy controls from a university 
center were evaluated in a prospective cross sectional analysis evaluating the desaturation 
kinetics of StO2 at the onset of walking exercise.  On separate visits, subjects performed 
graded treadmill exercise and three constant work rate (CWR) treadmill tests equivalent 
to ~60% (Low), ~80% (Medium), and 100% (Peak) of their peak exercise work rate.  
Gastrocnemious muscle StO2 response profiles (Inspectra tissue spectrometer) were 
measured at rest and across the rest to exercise transition.  Muscle StO2 responses were 
characterized by an exponential mathematical model.  The endpoint value was taken as 
the time constant of StO2 desaturation following the onset of exercise (e.g equivalent to 
                                                 
2 Journal of Vascular Surgery 40:488-493, 2004. 
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 the time to reach approximately 63% of the StO2 decrease).  The PAD patients and 
controls subjects were of similar age and activity level.  The qualitative patterns of StO2 
responses at the onset of exercise were also similar between PAD and controls at all work 
rates.  However, the kinetic time constants of StO2 desaturation were prolonged in PAD 
versus controls (averaged time constant across all work rates, 21.9±9.4 seconds versus 
4.9±2.2 seconds respectively, p<.01).  The slowed muscle StO2 kinetics in PAD are 
consistent with an impairment in muscle O2 utilization at the onset of walking exercise.  
Impaired muscle metabolism may contribute to the altered physiologic responses to 
exercise and the exercise impairment in patients with PAD.   
Introduction: 
 Patients with peripheral arterial disease (PAD) and claudication have a 50% 
reduction in peak exercise performance that limits daily walking activities and functional 
capacity (Hiatt et al. 1988).  In PAD, atherosclerotic arterial occlusions limit blood flow 
and oxygen delivery to the working muscles of the leg during exercise.  However, 
patients with PAD also have increased oxidative stress and a spectrum of muscle 
metabolic abnormalities which may have functional implications (Hiatt et al. 1992, 
Hickman et al. 1994, Brass et al. 2001).    
Near-infrared spectroscopy (NIRS) has utility in monitoring local muscle 
hemoglobin oxygen saturation (StO2) at rest and during exercise and recovery from 
exercise (Grassi et al. 2003).  Because muscle StO2 reflects the relative contributions of 
oxygen delivery and oxygen utilization, differences in the dynamic StO2 response across 
transitions from rest to exercise may provide insight into the pathophysiology of the 
exercise limitation in PAD.  For example, in many PAD patients, resting blood flow and 
the initial increment in blood flow with low levels of exercise is not limited (Sorlie et al. 
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 1978).  Thus, in the absence of a defect in tissue oxygen utilization, the dynamic StO2 
responses immediately following the onset of exercise should be similar between PAD 
and controls.  However at higher work rates, patients with PAD cannot deliver sufficient 
blood flow and oxygen to meet muscle metabolic demand.  Under these conditions, 
muscle metabolism would require a very rapid desaturation response as oxygen 
extraction increased in the absence of an adequate increase in oxygen delivery.  In 
contrast, if PAD was associated with an impaired ability of muscle to utilize oxygen, the 
rate of hemoglobin desaturation at the onset of exercise would be slowed.  Thus, 
quantitative differences in StO2 kinetics at the onset of exercise would identify whether a 
defect in metabolic oxygen utilization contributes to the exercise pathophysiology of 
PAD.   
Methods: 
Subjects:  Six men with PAD and six healthy men of similar age and body mass index 
were included in this study, which was approved by the Colorado Multiple Institutional 
Review Board, and all subjects gave informed consent.  Patients with PAD were defined 
by resting ankle-brachial index (ABI) < 0.90 determined as the ratio of highest ankle 
systolic blood pressure (in each leg) to the highest brachial systolic pressure.  The index 
leg was defined by the lowest ABI value in PAD subjects, and the dominant leg in 
controls.  All PAD patients experienced the symptoms of claudication (pain or cramping 
in the muscles of the affected legs) that was the only limiting symptom during graded 
treadmill exercise.  Subjects with diabetes or patients who were taking β-adrenergic 
antagonists were excluded as exercise responses are known to be altered by these factors 
(Petersen et al. 1983, Regensteiner et al. 1995).  PAD patients on other medications were 
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 not excluded, and the six studied PAD patients included five taking a statin, and all six 
were taking aspirin and antihypertensive drugs. 
Exercise Protocols:  Subjects performed a graded treadmill exercise test (Astrand 
Protocol or Gardner Protocol) to maximally tolerated workloads for the identification of 
peak exercise capacity (Q-stress, Quinton Instruments, Seattle, WA) (Astrand et al. 1977, 
Gardner et al. 1992).  On subsequent days, subjects performed six-minute constant work 
rate (CWR) treadmill tests at workloads equal to approximately 60% (Low), 80% 
(Medium), and 100% (Peak) of their peak exercise work rate.  Thus, the CWR exercise 
tests were individualized to induce a similar exercise intensity (relative to peak exercise 
capacity) and thus a measurable StO2 desaturation response.  Systemic pulmonary gas 
exchange measurements of oxygen consumption (VO2), carbon dioxide production and 
minute ventilation (Medical Graphics, CPX/D, St. Paul, MN) were measured to quantify 
the relative exercise work rate of each CWR bout as previously described.(Bauer et al. 
1999)  Arterial hemoglobin saturation was monitored and recorded using pulse oximetry 
during all exercise tests (Ohmed Corp., Louisville, CO).   
Skeletal muscle hemoglobin saturation:  Non-invasive muscle tissue oxygen saturation 
(StO2) was measured using a continuous-wave, near-infrared spectrometer (InSpectraTM 
Model 325, Hutchinson Technology, Inc, Hutchinson, MN).  The NIRS signal is derived 
from the hemoglobin in the microvasculature (precapillary, capillary, and postcapillary) 
of the tissue sampled, although contribution from intracellular myoglobin cannot be 
definitively excluded.  Thus, NIRS can be considered to reflect local tissue oxygenation.  
The InSpectra Tissue Spectrometer was modified for rapid sample measurement and data 
acquisition (6 Hz).  Prior to each study, the InSpectra device was calibrated using a single 
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 light scattering standard and validated against standard references equivalent to 38% and 
90% hemoglobin saturation.  Tissue (muscle) oxygen saturation (StO2) was determined 
utilizing the second derivative of the absorbance as a function of wavelength at near 
infra-red wavelengths associated with changes in oxy- and deoxy-hemoglobin/myoglobin 
concentrations.  The ratio of this second derivative at 720nm and 760nm has been 
empirically scaled to hemoglobin saturation, and is used by the instrument to calculate 
the reported StO2 values (Hutchinson Technology, Inc., User and Service Manual, 2004).  
The optical data were acquired using a 25mm NIRS probe that was attached to the skin 
over the lateral gastrocnemious muscle of the index limb by an adhesive patch.   
Analysis of StO2 kinetics.  The 6 Hz StO2 data for each individual CWR test were time-
bin averaged to yield 1 Hz data files.  Using a statistical graphing program (Sigmaplot, 
2002), a two component mathematical curve-fitting model was employed to describe the 
StO2 kinetic response using non-linear regression techniques.    
StO2(t) = StO2(b) + A1(1 - e-t-TD1/τ1)      (1) 
       + A2[1- e -(-t-TD2)/τ2]     (2) 
In each curve fit (see Figure 1, panel B for graphical representation), StO2(b) was the 
resting baseline value.  Following the onset of exercise, there was an initial time delay 
(TD1) followed by a primary desaturation in StO2 (below baseline) that was described 
with an exponential time constant (τ1) representing the time to reach ~63% of the 
desaturation response.  The difference between the resting StO2 and the nadir of the 
primary StO2 desaturation was calculated as A1.  Where a subsequent StO2 increase was 
observed, a second exponential function (equation 2) was employed such that the overall 
model would allow a best fit of the primary StO2 desaturation response.  Data for A2, 
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 TD2, and τ2, are not presented but contributed to the model which yielded the reported 
values for A1, TD1, and τ1. 
Results: 
Patients with PAD were of similar age (66±7 years) as compared with controls 
(65±7 years) but had a lower ABI in the index leg (0.62±0.13 versus 1.24±0.08 in 
controls, P<0.01) and reduced peak exercise oxygen uptake (16.4±4.2 ml/kg/min) as 
compared with controls (26.0±4.2 ml/kg/min, P<0.01).  No subject demonstrated arterial 
hemoglobin desaturation during any of the exercise testing.   
The qualitative patterns of the initial StO2 response were similar between groups 
during Low, Medium, and Peak CWR exercise (Figure 1).  At the Low CWR, three 
healthy subjects and one PAD patient demonstrated an StO2 profile with no desaturation 
below baseline levels (Figure 1. Panel A and Panel D).  One control subject did not 
desaturate below baseline levels during Medium CWR exercise.  The remaining control 
and PAD subjects exhibited a desaturation response at all work rates.  Following the 
onset of exercise (for example, Figure 1, Panel B), there was an initial increase in StO2 
(characterized by TD1) which was followed by a rapid decrease in StO2 to a plateau 
below baseline (StO2 nadir).  In control subjects, the nadir of StO2 desaturation typically 
occurred within 40 seconds, followed by a slow phase of increase in StO2.  In contrast, 
the initial StO2 desaturation was slower in patients with PAD, reaching a nadir at 
approximately 100 seconds into exercise (Figure 1. Panels E and F).  The nadir of STO2 
was similar at the same relative work rates between PAD and control subjects, with the 
total decrease in STO2 proportionate to increases in exercise intensity.  However as 
previously reported, the magnitude of STO2 desaturation at similar absolute work rates 
 97
 was greater in PAD as compared with control subjects (Comerota et al. 2003).  
Specifically, the StO2 desaturation with Peak CWR exercise in PAD patients was greater 
than observed during Low CWR exercise in controls (Table I) despite similar absolute 
work rates performed (1330±105 ml/min vs. 1354±219 ml/min PAD and Controls, 
respectively).    
Control subjects had a short time delay and rapid StO2 time constant (τ1) that was 
consistent between subjects and independent of work intensity (Table I).  In contrast, 
PAD patients had a longer time delay and slowed StO2 desaturation kinetics that 
displayed considerable heterogeneity between PAD subjects.  Nonetheless, within the 
PAD cohort as a whole, or when analyzed on an individual subject basis, there was no 
relationship between τ1 and workload.  The StO2 time constant (τ1) was statistically 
different between PAD and controls at Low and Medium CWR (P<0.05) and tended to 
separate at Peak CWR (P=0.14).  As the time constant did not vary as a function of 
increasing workload in individual subjects, the time constants for all CWR tests 
performed by an individual were averaged to yield the best estimate for this parameter for 
each subject.  Analyzed in this manner, the time constant average was 4.9±2.2 seconds 
for controls and 21.9±9.4 seconds for PAD subjects (n=6 per group, P<0.01).   
Discussion:  
This study demonstrated that while muscle StO2 responses at the onset of 
treadmill exercise were qualitatively similar between PAD and control subjects, the 
kinetics of StO2 desaturation were markedly slowed in PAD patients.  In both groups, a 
low relative work rate could be identified in selected subjects that was not associated with 
StO2 desaturation below resting values.  Thus, workloads could be identified in which 
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 PAD patients appeared to have increases in blood flow which matched oxygen demand, 
resulting in no StO2 desaturation.  At higher relative work rates, all subjects had StO2 
responses that were characterized by an initial increase in StO2 saturation, followed by a 
primary decrease in StO2, the magnitude of which increased with increasing relative 
exercise intensity.  In contrast, the StO2 kinetic responses (time constants) in both groups 
appeared independent of the relative work rate and remained slowed even at similar 
absolute work rates, suggesting that the observed differences in StO2 kinetic responses 
could not be explained solely on the basis of a difference in absolute work performed.  
Thus, whether the groups were compared at the same absolute or relative work rates, the 
time constants were clearly different, supporting the conclusion that the differences in 
StO2 kinetics observed reflected the PAD population and not the absolute workloads 
evaluated. 
Previous investigations have described a greater drop in muscle oxygenation 
during incremental exercise and slowed StO2 dynamics in the recovery from exercise in 
PAD, attributing these differences from healthy subjects to the impaired hemodynamics 
of the PAD condition (McCully et al. 1994, Comerota et al. 2003). The current study 
confirms the greater decrement in StO2 observed in PAD subjects at similar absolute 
work rates.  However, the analysis of metabolic processes during recovery from exercise 
are complicated by the clear differences in blood flow between PAD and control subjects 
provoked by higher workloads, and the accumulation of lactate and other metabolic 
intermediates that can modulate cellular metabolism associated with the exercise bout.  In 
contrast, the present study of the events associated with the onset of exercise begin with 
the near normal blood flow status of the resting muscle in the two groups.  Thus, our 
approach provided a unique perspective on the interaction between the metabolic and 
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 hemodynamic factors at the onset of exercise that may contribute to the exercise 
limitation in PAD. 
Patients with intermittent claudication have relatively normal resting lower limb 
blood flow, and blood flow can increase with exercise (Sorlie et al. 1978).  However as 
exercise continues, arterial occlusions restrict the exercise hyperemia, and oxygen 
delivery reaches a plateau (Sorlie et al. 1978).  When increases in metabolic demand 
exceed increases in oxygen delivery, muscle oxygen extraction increases as reflected by a 
decrease in StO2.  Thus in PAD, a limitation in oxygen delivery at the onset of exercise 
would be expected to accelerate the rate of StO2 desaturation within the muscle, provided 
that oxygen diffusion and mitochondrial function were normal.  This response was not 
observed in this cohort of PAD patients (Figure 1, Table 1) despite reports of increased 
muscle capillary density, and thus potentially enhanced microvascular oxygen diffusion 
in this patient population (Hammarsten et al. 1980).  In contrast, the slowed rate of StO2 
desaturation following the onset of treadmill exercise in PAD may be explained by the 
abnormalities of muscle oxidative metabolism previously described in this patient group.  
For example, patients with PAD have alterations in the regulation of oxidative ATP 
generation, abnormalities of electron transport chain enzyme activities, and an 
accumulation of short chain acylcarnitines in affected skeletal muscle that are inversely 
correlated with exercise performance (Hiatt et al. 1992, Brass et al. 2001, Kemp et al. 
2001).  The inherent delay to increase muscle oxidative metabolism in the face of 
increasing ATP requirements has been termed ‘metabolic inertia’ and has been 
hypothesized to be an important physiologic characteristic of the exercise response 
(Grassi et al. 1998, Greenhaff et al. 2004).  These observations support the concept that 
patients with PAD develop a mitochondrial myopathy.  Moreover, these findings support 
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 previous reports of slowed pulmonary oxygen uptake kinetics in PAD (Bauer et al. 1999, 
Barker et al. 2004) and extend these observations to suggest that metabolic abnormalities 
specific to the affected skeletal muscle in PAD may contribute, in part, to the observed 
exercise limitation of this patient population.   
Factors other than the balance between oxygen delivery and oxygen utilization 
may influence the integrated StO2 measurement at the onset of exercise.  Although the 
StO2 signal is empirically scaled to hemoglobin saturation, the contribution of myoglobin 
cannot be definitively excluded and its proportion to the overall NIRS signal remains a 
topic of controversy.  Without entering into this debate, the NIRS measurements can be 
considered to reflect local tissue oxygenation inclusive of hemoglobin and myoglobin.  
Thus, we consider our measurements to reflect a general view of muscle tissue oxygen 
saturation and cannot address interactions between microvascular and intracellular 
oxygen stores.  The StO2 measurement may also be influenced by the re-distribution of 
oxy- and deoxy-hemoglobin within the sample window representing a mixture of 
capillary and venuolar blood with different saturations (McCully et al. 2000).  For 
example, at the onset of exercise, activation of the muscle pump was associated with a 
rapid decrease in the total absorbance of hemoglobin (tHb) (data not shown) and thus 
may, in part, explain the transient increase in muscle StO2 observed immediately 
following exercise onset.   
In patients with PAD, StO2 desaturation kinetics were slowed at the onset of 
treadmill exercise, consistent with impaired muscle O2 utilization.  These findings 
provide further evidence of the interplay between the metabolic and hemodynamic 
factors that may contribute to the exercise impairment in patients with PAD.  Muscle 
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 metabolic function may be an important therapeutic target in PAD (Brass 1996, 
Greenhaff et al. 2004). 
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 Table 1. Constant work rate StO2 characteristics 
 
Control  PAD  
Low n=3  n=5  
Work intensity (%peak O2) 58±15 [43-73] 68±17 [48-90] 
StO2(b) 50±10 [38-57] 53±10 [42-60] 
τ1 (s) 4.0±0.9 [2.9-4.6] 24.0±2.9 H [19.9-28.1] 
TD1 (s) 13.9±3.1 [11.0-17.2] 27.6±9.4* [14.9-37.0] 
A1 (%) -18±5 [13-23] -22±3 [14-26] 
Med n=5  n=6  
Work intensity (%peak O2) 86±5 [78-93] 77±13 [56-93] 
StO2(b) 63±9 [52-70] 54±6 [46-59] 
τ1 (s) 5.2±2.8 [1.8-9.5] 20.0±12* [9.3-42.4] 
TD1 (s) 8.7±3.4 [3.7-11.8] 21.6±10.7* [10.5-39.7] 
A1 (%) -38±10 [20-48] -32±14 [17-56] 
Peak n=6  n=6  
(100% peak O2)     
StO2(b) 66±14 [50-89] 55±10 [37-64] 
τ1 (s) 5.7±3.1 [2.4-11.0] 19.2±18.6 I [6.7-53.5] 
TD1 (s) 8.3±4.0 [5.3-15.5] 13.2±11.2 [0.0-29.9] 
A1 (%) -41±9 [29-57] -44±17 [20-65] 
Values are mean±SD, [Range].   Three control subjects and one PAD subject had no 
desaturation during Low constant work rate exercise, and thus no kinetic parameters were 
calculated. StO2(b), resting muscle oxygenation (%).  τ1, StO2 time constant. TD1, time 
delay. A1, amplitude of StO2 response.  * p<0.05, H p<0.01, I p=0.14 for PAD vs. 
Control. 
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Figure 1.  Muscle oxygen saturation responses (StO2) from a representative PAD and 
control subject during Low (A, D), Medium (B,E) and Peak (C,F) constant work rate 
(CWR) exercise.  Exercise was initiated at time 0 (vertical dashed line).  During Low 
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 CWR exercise, there was no decrease in StO2.  With the higher work rates, there was an 
initial increase, followed by a rapid decrease in StO2.  StO2(b)=baseline, TD1=time delay 
(seconds) during the period of increase in StO2, A1=difference between the baseline and 
nadir of initial StO2 desaturation, τ1=time constant of StO2 desaturation.   
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 Chapter 4 
Muscle StO2 Kinetics are Work Rate Dependent in Peripheral  
Arterial Disease3 
Abstract  
In peripheral arterial disease (PAD), the relative influences of oxygen delivery 
limitation versus abnormal muscle metabolism on the impaired PAD exercise responses 
remain unresolved.  Using near infrared spectroscopy, we tested the hypothesis that the 
kinetics of muscle hemoglobin desaturation (StO2) are slowed following the onset of 
dynamic calf plantar flexion exercise across a range of work rates and end-exercise blood 
flow responses.  Eight subjects with PAD and eight healthy subjects performed five 
constant work rate tests (1, 5, 10, 30, 50% of MVC).  Muscle StO2 was assessed 
continuously during exercise, and limb blood flow was measured at rest and immediately 
post-exercise using venous plethysmography.  Absolute work rates across the range of 
exercise transitions were similar between groups.  In PAD, the StO2 time constants were 
slower than controls during 5% MVC (13.5±1.7 vs. 6.9±1.2) and 10% MVC work rates 
(14.5 ±2.7s vs. 6.8 ±1.1s).  However the StO2 time constants became faster in PAD 
subjects during 30% and 50% MVC work rates and did not differ from control subjects.  
Post-exercise calf blood flows were similar between groups for 1%, 5%, and 10% MVC 
exercise, but were significantly lower in PAD subjects compared with controls for 30% 
and 50% MVC exercises.  An inverse correlation was found between the 10% MVC StO2 
time constant (τ1) and peak oxygen uptake during graded treadmill exercise in PAD 
subjects (R=-0.88, p< 0.01).  In summary, muscle StO2 kinetics demonstrate a work rate 
dependence following the onset of calf exercise in PAD compared with healthy older 
                                                 
3 Submitted for publication 
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 subjects.  Whereas muscle StO2 kinetics are slowed during lower intensity exercise in 
PAD, the muscle StO2 responses were faster during higher intensity exercise where blood 
flow limitation was manifest.  These data suggest that the abnormal dynamic relationship 
between muscle oxygen utilization and oxygen delivery observed at low work rates in 
PAD may be modifiable with higher work intensity. 
Introduction 
The onset of exercise is associated with an immediate demand for energy which is 
initially met by pre-formed high-energy phosphates (creatine phosphate and ATP).  
However, sustained exercise requires the production of ATP via oxidative 
phosphorylation.  The increase in oxidative phosphorylation (and hence oxygen 
consumption) does not meet the ATP demand instantaneously, but is accelerated as 
metabolic intermediates (including free ADP, creatine, and inorganic phosphate) 
accumulate during the earliest phase of the rest-to-exercise transition (Whipp and Mahler 
M. 1980, Barstow et al. 1994, Rossiter et al. 1999).  The time course of accelerating 
aerobic ATP production and oxygen consumption following the onset of exercise has 
been associated with a ‘metabolic inertia’ that is determined, at least in part, by the 
inherent activation, sensitivity, and capacitance of the muscle mitochondria (Whipp and 
Mahler M. 1980, Meyer 1988, Grassi et al. 1996).  However, once initiated, maintaining 
optimal rates of oxidative phosphorylation with continued exercise will be dependent on 
adequate oxygen delivery via enhanced exercise blood flow.   
In patients with peripheral arterial disease (PAD), blood flow limitations during 
exercise due to lower extremity atherosclerotic arterial stenoses and occlusions are of 
primary pathophysiologic importance.  However, there are also alterations in skeletal 
muscle mitochondrial function secondary to chronic, repetitive ischemic insults that 
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 appear to be of functional significance (Hiatt et al. 1992, Brass et al. 2001).  Thus, the 
mitochondrial dysfunction of PAD skeletal muscle may promote a greater degree of 
metabolic inertia during exercise transitions.  As metabolic inertia has been hypothesized 
to be a major determinant of the muscle oxygen utilization kinetics following the onset of 
moderate exercise in healthy subjects (Whipp and Mahler M. 1980, Grassi et al. 1996), an 
alteration in the magnitude of metabolic inertia in PAD would provide insight into the 
functional consequences of the described metabolic abnormalities in PAD-affected 
muscle (Hiatt et al. 1992, Kemp et al. 1993, Brass et al. 2001)   
One approach to address this question is through the dynamic assessment of 
hemoglobin desaturation in skeletal muscle during the transition from rest to exercise 
using Near Infrared Spectroscopy (NIRS) (Shoemaker et al. 1997, Grassi et al. 2003, 
DeLorey et al. 2003).  As hemoglobin saturation in perfused muscle (StO2 ) is dependent 
upon the balance between local oxygen delivery and oxygen utilization, it has been 
suggested that NIRS-derived StO2 may reflect muscle oxygen extraction as described by 
the Fick principle (Grassi et al. 2003).  Thus, the kinetics of StO2 following the onset of 
muscle contractions may provide a unique perspective into the kinetics of muscle oxygen 
utilization (and magnitude of metabolic inertia) relative to blood flow adjustments in 
health and cardiovascular diseases.  
Consistent with these concepts, previous work has shown that both pulmonary 
oxygen uptake kinetics and calf muscle hemoglobin desaturation kinetics are slowed 
following the onset of treadmill exercise in patients with PAD compared with control 
subjects (Bauer et al. 1999, Bauer et al. 2004a).  However, others have reported an 
accelerated rate of hemoglobin desaturation associated with PAD, which could suggest 
that oxygen utilization responses in the muscle are preserved (Kemp et al. 2001).  To 
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 date, the relative influences of oxygen delivery limitation versus abnormal muscle 
metabolism on the altered NIRS and impaired oxygen uptake responses in PAD remain 
unresolved (Brass et al. 2004).  
 The current study was designed to test the hypothesis that hemoglobin 
desaturation kinetics are slowed in PAD patients using a well-defined exercise protocol 
that functionally isolates the gastrocnemius muscle.  The protocol allowed StO2 kinetics 
to be assessed as a function of muscle work rate, and also allowed post-exercise blood 
flow to be quantified.  The results confirmed that hemoglobin desaturation kinetics are 
slowed in patients with PAD performing lower intensity exercise, but that the kinetics 
were unexpectedly work rate dependent.  At high work rates, StO2 kinetics were not 
different between PAD and control subjects, suggesting the possibility that the greater 
degree of metabolic inertia associated with PAD could be overcome at high intensity 
work rates.  
Methods 
Subjects.  Eight male subjects with PAD and eight healthy men without clinical 
cardiovascular disease were enrolled in this study.  All subjects provided informed 
consent, and the study was approved by the University of Colorado Multiple Institutional 
Review Board in accordance with the Declaration of Helsinki.  
For all subjects, the following exclusion criteria were followed: 1) a history of 
coronary artery disease, previous myocardial infarction or coronary revascularization, 
angina, stroke, congestive heart failure, or diabetes mellitus 2), hematology or blood 
chemistry laboratory values outside of normal limits, 3) evidence of impaired pulmonary 
function (FEV1/FVC < 0.70), or 4) evidence of ECG changes suggestive of cardiac 
ischemia during graded exercise testing.  Additionally, subjects with skin and 
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 subcutaneous thickness greater than 15mm (by ultrasonography) over the muscle region 
of interest were excluded from the study, as increased skin and non-muscle tissue 
thickness may influence NIRS signals (van Beekvelt et al. 2001).  Subjects taking β-
adrenergic antagonists were excluded as exercise responses are known to be altered by 
these medications (Petersen et al. 1983).   
Peripheral arterial disease was defined by resting ankle-brachial index (ABI) < 
0.90 defined as the ratio of the highest ankle systolic blood pressure (in each leg) to the 
highest brachial systolic pressure.  The index leg in PAD patients was individually 
defined as the leg with the lowest ABI.  All PAD subjects experienced the symptoms of 
claudication (pain or cramping in the muscles of the affected legs) that was the only 
limiting symptom during graded treadmill exercise.  Healthy, similarly-aged control 
subjects had a normal physical examination without signs of cardiovascular disease, a 
resting ABI > 1.00 in each leg at rest, and no history of PAD.  All control subjects were 
sedentary, as defined by not participating in a regular exercise program (< 1 episode of 
exercise/week).  The dominant leg was taken as the index leg for control subjects. 
Exercise Protocol:  Subjects reported to the laboratory on three different occasions.  At 
the first visit, subjects were familiarized with single leg plantar flexion exercise using a 
dynamometer (KinCom, Chattanooga, TN), and each individual’s maximal voluntary 
contraction (MVC) was assessed in the supine position (Newtons).  Following a rest 
period, subjects performed a graded treadmill exercise test (Astrand or Gardner protocol, 
control and PAD respectively) to maximal voluntary exhaustion for the determination of 
peak exercise capacity (peak oxygen uptake) as previously described (Bauer et al. 
2004b).   
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 On a subsequent visit, subjects performed three, 3-minute, single leg plantar 
flexion exercise transitions from rest to constant work rate exercise corresponding to 1%, 
5% and 30% of the individual’s maximal voluntary contraction.  On a separate visit, 
subjects performed two exercise transitions from rest to plantar flexion exercise of 10 and 
50% of MVC.  The dynamometer was adjusted for isotonic contractions of the posterior 
calf muscles from 0 to 15º of plantar flexion.  All constant work rate transitions were 
performed in the supine position with the knee of the index leg at full extension.  Each 
constant work rate transition consisted of a resting period to establish a stable baseline 
StO2 and calf blood flow, followed by 3-minutes of contractions at the pre-determined 
load force (%MVC).  Contraction frequency was maintained at 0.5 Hz with the aid of an 
audible metronome.  Immediately following the last contraction of each 3-minute 
transition, post-exercise calf blood flow was measured and continually repeated 
throughout recovery using strain gauge plethysmography.  A resting recovery period of at 
least 25 minutes separated each constant work rate bout and subsequent exercise was 
only performed when calf blood flow and StO2 had returned to pre-exercise values.   
Tissue oxygen saturation (StO2). Tissue oxygen saturation was measured using a 
continuous-wave, near-infrared, four wavelength (680, 720, 760, and 800nm) 
spectrometer (InSpectraTM Model 325, Hutchinson Technology, Inc, Hutchinson, MN) 
as described previously (Bauer et al. 2004a).  The StO2 signal is primarily derived from 
hemoglobin in the microvasculature (pre-capillary, capillary, and post-capillary) of the 
tissue sampled, although the contribution from intracellular myoglobin in the region of 
optical interrogation cannot be definitively excluded.  Thus, StO2 is considered to reflect 
local tissue oxygenation without the ability to discern microvascular vs. intracellular 
oxygen stores.   
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   The optical data were acquired with a probe positioned over the lateral 
gastrocnemius muscle of the index leg.  Anatomic localization of the StO2 probe was 
determined prior to study and was marked for identical placement for all subsequent 
visits.  The StO2 probe was designed with a fixed distance from the LED light source to 
photodetectors of 25mm.  The probe was firmly attached to the skin over the tissue region 
for optical interrogation by an adhesive patch that eliminated contamination by ambient 
light.  The spacing between the light source and photodetectors provided light attenuation 
measurements of tissue depth averaging approximately 12mm.  Because substantial 
subcutaneous tissue may influence near infrared light absorption of the skeletal muscle 
(van Beekvelt et al. 2001), muscle tissue depth was measured by 2D ultrasonography 
(VingMed, General Electric, Milwaukee, WI) using digital calipers from the surface of 
the skin to the superficial muscle fascia border.   
The StO2 measurement was calculated as percent oxygen saturation from the 
measured attenuation of four near infrared wavelengths (680, 720, 760 and 800nm) as 
previously described in detail (Myers et al. 2005).  Briefly, the second derivative 
attenuation as a function of wavelength was calculated to correct for baseline differences, 
and the ratio of second derivative attenuations at 720 and 760 nm (2D720/2D760) was 
empirically scaled with pure blood hemoglobin oxygen saturation from a tabled 
calibration relationship as previously described (Myers et al. 2005).  This method offers 
an advantage over traditional near infrared spectroscopy systems (Runman, OMRON) in 
that quantitative tissue oxygen saturation (%) can be assessed without the determination 
of tissue scattering coefficients, absolute changes in oxy- and deoxyhemoglobin 
concentrations, or differential path lengths.  Further, the method is experimentally robust 
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 to changes in tissue blood volume and has been validated with human hemoglobin 
oxygen saturation in vivo during limb ischemia and exercise (Myers et al. 2005).  Prior to 
each visit, the InSpectra device was calibrated using a single light scattering standard and 
the StO2 measurement validated by optical references equivalent to 38% and 90% 
hemoglobin saturation.  The InSpectra Tissue Spectrometer was modified for rapid 
sample measurement and data acquisition (6 Hz) to a dedicated computer.   
Calf blood flow and blood pressure measurements. Calf blood flow was measured in the 
supine position using venous occlusion strain gauge plethysmography (D.E. Hokanson 
Inc. Issaquah, WA) at rest, immediately post-exercise, and during recovery as described 
(Dorigo et al. 1980, Bauer et al. 1999).  Briefly, a mercury-in-silastic strain gauge was 
placed around the widest part of the calf and a rapid inflating pneumatic cuff was placed 
just above the knee.  Venous occlusion was achieved by pneumatic cuff inflation to 
~35mmHg and maintained for several (4-6) cardiac cycles to obtain blood flow 
measurements.  Calf blood flow is expressed as ml of flow/100ml of tissue/minute.  
Resting blood flow was calculated as the average of 5 separate measurements.  
Immediate post-exercise and recovery blood flows are presented as individual readings, 
with peak flow determined as the highest flow post-exercise.  Ankle and arm systolic 
blood pressures were determined using a Doppler ultrasonic instrument (model 841, 
Parks Medical Electronics, Beaverton, OR) as described previously (Bauer et al. 1999).   
Pulmonary gas exchange, heart rate, and arterial saturation.  Pulmonary gas exchange 
(oxygen uptake and carbon dioxide production) was measured during graded treadmill 
exercise testing using a metabolic measurement system (CPX/D, Medical Graphics 
Corporation, St. Paul, MN) as previously detailed (Bauer et al. 1999).  The highest 20 
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 second-averaged value for pulmonary oxygen uptake was taken as peak oxygen uptake.  
Heart rate data was continuously recorded from an integrated electrocardiography system 
(Q-stress, Quinton Instruments, Seattle, WA).  Arterial hemoglobin saturation was 
monitored and recorded every 30 seconds during rest, exercise, and recovery of all 
experiments (graded and constant work rate testing) by an oximeter placed on the index 
finger of the dominant hand (Ohmeda Corp., Louisville, CO).   
Data Analysis.  The 6 Hz sampled StO2 data for each constant work rate test were 
averaged into 1s time bins using a proprietary software program (NIRPro, University of 
Colorado Health Sciences Center, Denver, CO).  Using a statistical graphing program 
(Sigmaplot, 2002), an exponential mathematical model was fit from baseline to the StO2 
nadir using non-linear regression techniques as described previously (Bauer et al. 2004a).  
StO2(t) = StO2(b) + A1(1 - e-(t-TD1)/τ1)     (1) 
For each individual exercise response, StO2(b) was the resting baseline value.  Following 
the onset of exercise, there was an initial time delay (TD1) followed by the primary fall 
in StO2 that was described by the time constant (τ1).  The difference between the resting 
StO2 and the nadir of the StO2 decrease was calculated as A1.   The mean response time 
(MRT) was calculated as the sum of the StO2 time constant (τ1) and time delay (TD1). 
Statistical Analysis.  Subject characteristics were compared using Student’s t-tests.  
Repeated-measures ANOVA was employed for comparisons between and within groups 
for all variables obtained during constant work rate testing (NCSS 2000, Kaysville, UT).  
Where a significant F statistic was observed, Tukey-Kramer multiple comparison 
analyses were performed to determine the pairing of significant differences.  Linear 
regression was performed for the determination of the blood flow/power output 
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 relationships.  The Pearson’s R product was used to evaluate significant correlations.  
Statistical significance for all comparisons was declared at p < 0.05.  Data are presented 
as mean ± S.E.M. 
 
Results 
There were no differences between control and PAD subjects in age or absolute MVC 
force (Table 1).  Typical of subjects with intermittent claudication, the ABI of the index 
leg and treadmill peak pulmonary oxygen uptake in PAD subjects were reduced 
compared with controls (p < 0.01) (Hiatt et al. 1988).  All PAD subjects were taking 
medications indicated for the treatment of cardiovascular disease, and four PAD subjects 
were taking medications indicated for the treatment of hypertension.  Two control 
subjects were treated with statin medications for hyperlipidemia.  Mean skin and 
subcutaneous tissue thickness of the region of interest for PAD and control subjects were 
5.76± 0.82mm and 5.72±1.16mm respectively.  The measurement of arterial hemoglobin 
saturation revealed no changes in any subject during graded or constant work rate 
exercise testing.  
StO2  kinetics.  The dynamic StO2 responses from a representative PAD and control 
subject across all exercise work rates are presented in Figure 1.  This figure demonstrates 
that at very low work rates, both patients and controls had no change in StO2, indicating a 
balance between oxygen supply and oxygen demand leading to no net decrease in StO2.  
However at higher work rates, both PAD and control subjects had a progressive decrease 
in StO2 that reflected the greater work intensities which reached a new steady-state after 
20-40 seconds.  The kinetic profiles of StO2 dynamics were also qualitatively similar 
between PAD and control subjects.  All subjects had a time delay from the onset of 
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 exercise to the initial StO2 decrease, following which a single exponential model was fit 
to the data as presented in Figure 2.  In some subjects, a second phase of StO2 
desaturation was observed after the initial nadir that occurred approximately 80-100 
seconds following the onset of exercise, was slower and heterogeneous between subjects, 
characterized by an increase in some, or further decrease in others.  This phase was 
excluded from exponential modeling in order to describe the primary StO2 response.  
Additionally, mathematical modeling could not be performed for some subjects at 1% 
and 5% MVC work rates as StO2 did not decrease below baseline values (Table 2).     
Within control subjects, the StO2 time constant (τ1) did not vary as a function of 
increasing work rate (p>0.05, Table 2) ranging from 6.9±1.2 seconds at 5% MVC to 
7.5±1.2 seconds at 50% MVC.  However, the time delay (TD1) prior to the primary fall 
in StO2 became shorter with increasing work rates (p<0.05).  Post-hoc analyses indicated 
that the time delay at 30% and 50% MVC was significantly shorter than at 5% and 10% 
MVC constant work rate transitions.  As a consequence, the mean response time (MRT) 
decreased with constant work rate exercise of increasing percent MVC.  The magnitude 
of StO2 desaturation generally became greater with increasing work rates (p<0.05), with 
post-hoc analyses indicating the amplitude of the primary StO2 response (A1) was 
significantly greater at 30% and 50% than at 5% or 10% MVC exercise transitions.  
Within PAD subjects, the StO2 time constant (τ1) was altered as a function of increasing 
work rate (p<0.05).  Post-hoc analyses revealed significantly slower StO2 time constants 
for PAD subjects at 1% , 5% and 10% than at 30% or 50% MVC constant work rate 
exercise (p<0.05, Table 2).  As in controls, the time delay (TD1) became shorter with 
increasing constant work rates in PAD (p<0.05).  Post-hoc tests indicated that the time 
delays at 30% and 50% MVC were significantly shorter than for 1%, 5%, or 10% MVC 
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 transitions.  The MRT decreased with increasing % MVC exercise, similar to that 
observed in control subjects.  The magnitude of the primary StO2 desaturation became 
greater with increasing exercise work rates (p<0.05), with post-hoc tests revealing that 
hemoglobin desaturation (A1) was significantly greater at 10%, 30%, and 50% than for 
5% or 1% MVC exercise transitions. 
Comparing control with PAD subjects, baseline StO2 was not different for any 
work rate.  The StO2 time constants at 5% and 10% MVC exercise were significantly 
slowed in PAD subjects compared with controls (p<0.05, Table 2).  No differences 
between groups were observed for the StO2 time constants at 30% or 50% MVC exercise.  
There were no differences in time delay between groups at any work rate.  The MRT was 
longer in PAD subjects compared with controls at 5% and 10% MVC transitions 
(p<0.05), but no differences in MRT were observed between groups for 30%, and 50% 
MVC transitions.  The magnitude of the primary StO2 desaturation in PAD subjects was 
significantly greater than controls at 10% MVC exercise (p<0.05) and tended to be 
greater at 30 and 50% MVC exercises although these differences did not reach statistical 
significance.   
Calf blood flow responses.  Resting calf blood flow was not different between groups 
(p>0.05, Figure 3A).  There were no differences in post-exercise blood flow responses 
between PAD and controls at 1%, 5%, or 10% MVC exercise.  However, the post-
exercise blood flow of PAD subjects was significantly reduced compared with controls at 
30% and 50% MVC exercise (p<0.05).  The difference in blood flow between groups was 
8.6 ml/100mltissue/min at 30% and 21.8 ml/100mltissue/min at 50% MVC exercise.  The 
slope of the leg blood flow/power output relationship was not different between PAD and 
control subjects compared across 1, 5, and 10% MVC work rates (PAD 2.6± 0.55 vs. 
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 control 2.8±0.55 ml/100mltissue/min . watt-1, p>0.05, Figure 3B).  However above 4 
watts (30% and 50% MVC), the slope of the leg blood flow/power output relationship 
decreased in PAD (2.0±0.40 ml/100mltissue/min . watt-1), but this did not reach statistical 
significance (p=0.14).  This contrasts with the controls in which the blood flow-work 
relationship was relatively constant or tended to become steeper when 30% and 50% 
MVC work rates were included in the regression. 
Correlations.  There was a significant positive correlation between the post exercise 
blood flow at the 50% MVC work rate and whole body peak oxygen uptake (ml/min) in 
the PAD group (R = 0.82, p<0.05).  A significant inverse correlation was observed 
between the time constant (τ1) of StO2 during 10%MVC exercise and peak oxygen 
uptake (ml/min) in PAD subjects (R=-0.88, p<0.01).  
Discussion 
The present study demonstrated a work rate dependence of muscle hemoglobin 
desaturation responses (StO2 kinetics) during exercise in subjects with PAD that was not 
observed in healthy controls.  At lower work rates, and under conditions of normal 
increase in end-exercise calf blood flow, the PAD StO2 kinetics were slowed compared 
with control subjects.  In contrast, with higher work rate intensities where end-exercise 
blood flow did not increase to the same degree as control subjects, PAD StO2 kinetics 
became faster and similar to the control StO2 kinetic responses.  Thus, in PAD subjects, 
an exercise state characterized by a high relative exercise intensity and inability to 
increment end-exercise blood flow to the level expected for the work demand was 
associated with speeded StO2 kinetics.    
Previous studies have demonstrated that pulmonary oxygen uptake kinetics are 
slowed in PAD patients following the onset of exercise (Bauer et al. 1999, Barker et al. 
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 2004, Bauer et al. 2004b). Further, there is an inverse correlation between pulmonary 
oxygen uptake kinetics and peak exercise performance in PAD, suggesting that the 
determinants of oxygen uptake at the beginning of exercise in PAD may have functional 
significance (Barker et al. 2004).  The slowed pulmonary oxygen uptake kinetics in PAD 
could not be explained by the severity of the arterial disease as defined by resting ankle-
brachial index, number of limbs involved (Bauer et al. 1999), reactive hyperemic limb 
blood flow, or by systemic cardiovascular abnormalities (Bauer et al. 2004b).  These 
observations raised the possibility that slowed pulmonary oxygen uptake kinetics could 
reflect a limitation in skeletal muscle oxygen uptake independent of an oxygen delivery 
impairment due to arterial disease.  Numerous examples of abnormal skeletal muscle 
metabolism in the affected legs of patients with PAD support this concept. For example, 
aerobic metabolism is abnormal in PAD-affected skeletal muscle resulting in the 
accumulation of short chain acylcarnitines that are inversely correlated with peak 
exercise performance (Hiatt et al. 1992).  The skeletal muscle mitochondria of patients 
with PAD demonstrate numerous histological irregularities that may be associated with 
impaired function (Teravainen and Makitie 1977).  Several key complexes in the electron 
transport chain have also been shown to exhibit decreased activities relative to citrate 
synthase activity (Brass et al. 2001).  Moreover, the initial rate of oxidative ATP 
synthesis following the onset of exercise appears reduced in PAD skeletal muscle (Kemp 
et al. 2002).  Thus, changes in PAD skeletal muscle metabolism may result in a reduced 
ability to increase oxygen utilization in response to submaximal metabolic demands.  
Indeed, such changes could contribute to the magnitude of metabolic inertia of oxidative 
metabolism in PAD-affected skeletal muscle, resulting in impaired dynamics of muscle 
oxygen extraction that are particularly evident when resting blood flow and initial 
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 increments in limb blood flow during submaximal exercise are normal (Pernow et al. 
1975, Bernink et al. 1982).   
The present finding of slowed StO2 kinetics in PAD muscles during lower 
intensity work rates is consistent with the notion that the initial increase in muscle oxygen 
utilization is impaired relative to local oxygen delivery in PAD following the onset of 
exercise.  These observations in PAD muscles during lower intensity calf work rates are 
consistent with our previous findings of slowed StO2 kinetics during submaximal 
treadmill exercise (Bauer et al. 2004a).  Moreover, the similarity between end-exercise 
calf blood flows in PAD and control subjects at the same relative and absolute lower 
intensity work rates strengthens the possibility of abnormal oxygen utilization in PAD 
muscle when exercise blood flow responses may not be impaired, although the kinetics of 
muscle blood flow immediately following the onset of exercise in PAD limbs remains 
unresolved.  If true, this would imply altered QO2 to VO2 matching in PAD muscle.  
Nevertheless, as StO2 measurements provide an indirect assessment of the dynamic 
balance between oxygen delivery and oxygen utilization in muscle, the presence of a time 
delay and prolonged desaturation kinetics of StO2 in PAD support the concept of an 
intrinsic impairment to increase oxygen utilization relative to oxygen delivery following 
the onset of exercise in PAD skeletal muscle, at least during low levels of calf exercise.  
These observations are also consistent with direct measurements of intramuscular PO2 
during exercise contractions in PAD, which indicated slower kinetics in PAD-affected 
calf muscles compared with controls during exercise of similar absolute decreases in 
muscle PO2 (Holm and Bylund-Fellenius 1981).   
An interesting finding was that StO2 kinetics became faster in PAD subjects at 
higher calf exercise intensities.  The work rates at which StO2 kinetics accelerate in PAD 
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 subjects were the same at which the absolute post-exercise blood flows were less than 
those observed in control subjects.  Thus, these work rates appear to be associated with 
an oxygen utilization/oxygen delivery mismatch at the level of the skeletal muscle 
secondary to the obstructive arterial lesions associated with PAD.  This contrasts with the 
apparent work rate independence of muscle hemoglobin desaturation kinetics observed 
during submaximal treadmill exercise (Bauer et al. 2004a) or across cycling work 
intensities in healthy subjects (Grassi et al. 2003, Shibuya et al. 2004), a factor that may 
be explained by the different exercise conditions of the current investigation.  Indeed, the 
present study employed a different exercise from treadmill walking or cycling, consisting 
of isolated calf muscle contractions in the supine position.  At the highest work rates, the 
force of calf muscle contraction (%MVC) likely exceeded that experienced even during 
peak treadmill exercise (Cavagna 1975).  Accordingly, calf blood flow responses may 
have become more limited in PAD subjects given the high contractile forces, lower 
hydrostatic forces, and reduced arterial pressures distal to the arterial stenoses 
(Richardson 1981, Leyk et al. 1994).  Thus, the effects of exercise type and position on 
PAD blood flow responses may have exacerbated any oxygen utilization/oxygen delivery 
mismatch, resulting in the speeded PAD StO2 kinetics observed (Ferreira et al. 2005).  
Kemp and colleagues found similar results in PAD muscles during similarly-intense, 
claudication-producing calf exercise (Kemp et al. 2001).  In that study, the calculated rate 
constant of muscle hemoglobin desaturation was faster in PAD than control subjects 
despite a lower oxidative generation of ATP in legs of individuals with PAD (Kemp et al. 
2001).  The authors reasoned that the faster rate of muscle hemoglobin desaturation was 
reflective of local oxygen utilization that greatly outpaced oxygen delivery, consistent 
with the kinetic models of muscle venous oxygen content predicted by Ferreira et al. 
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 (Ferreira et al. 2005).  Kemp et al. suggested the apparent slowing of oxidative ATP 
resynthesis was likely due to a limitation in oxygen delivery; however no measures of 
blood flow were assessed (Kemp et al. 2001).  An interesting alternative possibility could 
relate to the altered regulation of oxidative metabolism in PAD, and potentially the 
increased magnitude of metabolic inertia in PAD muscle that may be modified under the 
conditions of high work intensity and extreme mismatch of oxygen supply to metabolic 
demand. Walsh et al., using saponin-skinned skeletal muscle fibers, have demonstrated 
that free ADP control of mitochondrial respiration may be sensitized by the decreasing 
phosphocreatine-to-creatine ratio during high intensity exercise (Walsh et al. 2001).  As 
changes in this ratio as well as accumulation of free [ADP] and inorganic phosphate may 
occur rapidly following the onset of heavy exercise in both healthy subjects and patients 
with PAD, these changes could easily affect the kinetics of oxygen utilization, 
particularly if mitochondrial sensitivity (a potential contributor to metabolic inertia) to 
these metabolites may be abnormal (e.g. PAD).  Indeed, increased changes in free [ADP], 
[CrP], [creatine], and [Pi] for a given rate of oxidative ATP synthesis are characteristic of 
exercising PAD skeletal muscle (Kemp et al. 1993).  In this context, an increase in 
mitochondrial sensitivity to potential metabolic controllers could reduce the magnitude of 
PAD metabolic inertia, allowing an early acceleration of oxidative phosphorylation and 
oxygen utilization that may exacerbate any developing oxygen utilization/oxygen 
delivery mismatch, speeding the muscle StO2 kinetics as observed.  Clearly, further study 
will be necessary to directly assess muscle oxygen uptake, intracellular energetics, and 
blood flow kinetics following the onset of exercise at low compared with high intensity 
exercise in patients with PAD in order to clarify the muscle StO2 and local oxygen uptake 
kinetic responses.   
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 Implications of altered StO2 kinetics in PAD. 
Peripheral arterial disease is associated with a profound impairment in peak 
exercise capacity as well as limitations in the ability to sustain even low levels of walking 
exercise.  The importance of the primary hemodynamic limitation of leg blood flow 
during peak exercise is supported by the observation of a positive correlation between 
end-exercise blood flow at 50% MVC and peak pulmonary oxygen uptake.  However, the 
PAD StO2 time constants during 10% MVC exercise were inversely correlated with peak 
oxygen uptake during graded treadmill testing, consistent with previous work describing 
an inverse relationship between peak oxygen uptake and the accumulation of metabolic 
intermediates in PAD skeletal muscle (Hiatt et al. 1992).  The metabolic abnormalities in 
PAD-affected skeletal muscle are likely reflected in the altered dynamic increase and 
regulation of muscle oxygen utilization throughout the range of tolerable work rates 
rather than simply reflecting a reduced maximal oxygen consumption per gram of 
muscle, a factor that is often overlooked during study of isolated mitochondria.  For 
example, in addition to specific abnormalities in electron transport chain component 
activities in PAD muscle, an increased dynamic change in intracellular metabolite 
concentrations required for a given level of oxidative phosphorylation could contribute to 
the level of metabolic inertia in PAD during low levels of exercise, predisposing the 
muscle to early fatigue and symptom development.  This could, in part, explain how 
factors related to the slowed kinetics of oxygen uptake during the early period of exercise 
may be related to the functional limitation of patients with PAD.  Thus, in addition to a 
primary hemodynamic impairment, metabolic abnormalities of the affected skeletal 
muscle may contribute to the profound exercise intolerance in patients with PAD.   
Limitations.     
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 A limitation of this study was that the kinetics of limb blood flow following the 
onset of exercise could not be measured with the plethysmographic technique.  Thus, the 
effects of the early and rapid changes in limb blood flow at the onset of exercise could 
not be directly assessed and compared with the work load dependent changes in muscle 
StO2 in the PAD patients.  In addition, the assessment of muscle StO2 by NIRS may be 
influenced by factors other than the balance between oxygen delivery and oxygen 
utilization within the muscle microvasculature.  For example, the absorption spectra of 
myoglobin and hemoglobin are nearly identical and have differing kinetics of 
desaturation (Tran et al. 1999, Marcinek et al. 2003).  However the actual quantitative 
contributions of myoglobin to the overall StO2 signal is not known, but is estimated to be 
relatively small (Seiyama et al. 1988, Mancini et al. 1994).   
The dynamic StO2 measurements may also be influenced by the redistribution of 
oxyhemoglobin and deoxyhemoglobin within the NIRS sample window (McCully and 
Hamaoka 2000, DeLorey et al. 2003).  In the present study, following the onset of 
contractions, there was a rapid decrease in the total absorbance of hemoglobin, 
representing a decrease in the total admixture of arteriolar (pre-capillary), capillary and 
venular (post-capillary) blood.  Thus, shifts in the relative distribution of oxy- and deoxy-
hemoglobin could also explain a portion of the transient increase or time delay 
immediately following the onset of contractions.  Moreover, skin thickness and muscle 
depth can alter measures of muscle oxygenation (van Beekvelt et al. 2001).  In order to 
minimize this latter effect, we excluded subjects with a skin and subcutaneous adipose 
thickness equal to or greater than 15mm.  However, because near infrared light must pass 
through these superficial layers, it is possible that the StO2 measurements also reflected a 
portion of hemoglobin oxygen saturation in the non-active (fat and skin) tissue.  Thus, 
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 while the kinetic response of StO2 desaturation primarily reflects the changes in muscle 
microvascular hemoglobin oxygen saturation due to the exercise contractions, the 
inclusion of non-active tissue could alter the magnitude of StO2 decrease (e.g. A1).   
Conclusions 
 Muscle StO2 kinetics demonstrate a work rate dependence following the onset of 
calf exercise in PAD compared with healthy older subjects.  The muscle StO2 time 
constants were prolonged in PAD as compared with controls during lower intensity work 
rates, consistent with previous observations during submaximal treadmill exercise.  
However, the accelerated muscle StO2 responses in PAD patients during higher levels of 
exercise intensity and blood flow limitation indicates an extreme oxygen 
utilization/oxygen delivery mismatch and suggests the possibility that a greater degree of 
metabolic inertia associated with PAD might be overcome at high intensity work rates.  
Studies measuring dynamic muscle oxygen consumption, muscle bioenergetics, and 
blood flow following the onset of exercise will be critical in further understanding the 
pathophysiology of impaired blood flow and muscle metabolism in the exercise 
limitation observed in PAD.  
 
 
References 
 
Barker, G. A., S. Green, A. A. Green, and P. J. Walker. (2004). Walking performance, 
oxygen uptake kinetics and resting muscle pyruvate dehydrogenase complex 
activity in peripheral arterial disease. Clin.Sci.(Lond). 106, 241-249. 
Barstow, T. J., S. Buchthal, S. Zanconato, and D. M. Cooper. (1994). Muscle energetics 
and pulmonary oxygen uptake kinetics during moderate exercise. J.Appl.Physiol. 
77, 1742-1749. 
Bauer, T. A., E. P. Brass, and W. R. Hiatt. (2004a). Impaired muscle oxygen use at onset 
of exercise in peripheral arterial disease. J.Vasc.Surg. 40, 488-493. 
 126
 Bauer, T. A., E. P. Brass, M. Nehler, T. J. Barstow, and W. R. Hiatt. (2004b). Pulmonary 
VO2 dynamics during treadmill and arm exercise in peripheral arterial disease. 
J.Appl.Physiol. 97, 627-634. 
Bauer, T. A., J. G. Regensteiner, E. P. Brass, and W. R. Hiatt. (1999). Oxygen uptake 
kinetics during exercise are slowed in patients with peripheral arterial disease. 
J.Appl.Physiol. 87, 809-816. 
Bernink, P. J., J. Lubbers, G. J. Barendsen, and Berg J. van den. (1982). Blood flow in 
the calf during and after exercise: measurements with Doppler ultrasound and 
venous occlusion plethysmography in healthy subjects and in patients with arterial 
occlusive disease. Angiology. 33, 146-160. 
Brass, E. P., W. R. Hiatt, A. W. Gardner, and C. L. Hoppel. (2001). Decreased NADH 
dehydrogenase and ubiquinol-cytochrome c oxidoreductase in peripheral arterial 
disease. Am.J.Physiol. 280, H603-H609. 
Brass, E. P., W. R. Hiatt, and Green S. (2004). Skeletal muscle metabolic changes in 
peripheral arterial disease contribute to exercise intolerance: a point-counterpoint 
discussion. Vasc.Med. 9, 293-301. 
Cavagna, G. A. (1975). Force platforms as ergometers. J.Appl.Physiol. 39, 174-179. 
DeLorey, D. S., J. M. Kowalchuk, and D. H. Paterson. (2003). Relationship between 
pulmonary O2 uptake kinetics and muscle deoxygenation during moderate-
intensity exercise. J.Appl.Physiol. 95, 113-120. 
Dorigo, B., V. Bartoli, D. Grisillo, D. Beconi, and A. Zanini. (1980). Exercise hyperemia 
for the study of peripheral circulation. Angiology. 31, 50-57. 
Ferreira, L. F., D. C. Poole, and T. J. Barstow. (2005). Muscle blood flow-O(2) uptake 
interaction and their relation to on-exercise dynamics of O(2) exchange. 
Respir.Physiol Neurobiol. 147, 91-103. 
Grassi, B., S. Pogliaghi, S. Rampichini, V. Quaresima, M. Ferrari, C. Marconi, and P. 
Cerretelli. (2003). Muscle oxygenation and pulmonary gas exchange kinetics 
during cycling exercise on-transitions in humans. J.Appl.Physiol. 95, 149-158. 
Grassi, B., D. C. Poole, R. S. Richardson, D. R. Knight, B. K. Erickson, and P. D. 
Wagner. (1996). Muscle O2 uptake kinetics in humans: implications for metabolic 
control. J.Appl.Physiol. 80, 988-998. 
Hiatt, W. R., D. Nawaz, J. G. Regensteiner, and K. F. Hossack. (1988). The evaluation of 
exercise performance in patients with peripheral vascular disease. 
J.Cardiopulmonary Rehabil. 12, 525-532. 
 127
 Hiatt, W. R., E. E. Wolfel, J. G. Regensteiner, and E. P. Brass. (1992). Skeletal muscle 
carnitine metabolism in patients with unilateral peripheral arterial disease. 
J.Appl.Physiol. 73, 346-353. 
Holm, S. and A. C. Bylund-Fellenius. (1981). Continuous monitoring of oxygen tension 
in human gastrocnemius muscle during exercise. Clin.Physiol. 1, 541-552. 
Kemp, G. J., N. Roberts, W. E. Bimson, A. Bakran, and S. P. Frostick. (2002). Muscle 
oxygenation and ATP turnover when blood flow is impaired by vascular disease. 
Mol.Biol.Rep. 29, 187-191. 
Kemp, G. J., N. Roberts, W. E. Bimson, A. Bakran, P. L. Harris, G. L. Gilling-Smith, J. 
Brennan, A. Rankin, and S. P. Frostick. (2001). Mitochondrial function and 
oxygen supply in normal and in chronically ischemic muscle: a combined 31P 
magnetic resonance spectroscopy and near infrared spectroscopy study in vivo. 
J.Vasc.Surg. 34, 1103-1110. 
Kemp, G. J., D. J. Taylor, C. H. Thompson, L. J. Hands, B. Rajagopalan, P. Styles, and 
G. K. Radda. (1993). Quantitative analysis by 31P magnetic resonance 
spectroscopy of abnormal mitochondrial oxidation in skeletal muscle during 
recovery from exercise. NMR Biomed. 6, 302-310. 
Leyk, D., D. Essfeld, K. Baum, and J. Stegemann. (1994). Early leg blood flow 
adjustment during dynamic foot plantarflexions in upright and supine body 
position. Int.J.Sports Med. 15, 447-452. 
Mancini, D. M., L. Bolinger, H. Li, K. Kendrick, B. Chance, and J. R. Wilson. (1994). 
Validation of near-infrared spectroscopy in humans. J.Appl.Physiol. 77, 2740-
2747. 
Marcinek, D. J., W. A. Ciesielski, K. E. Conley, and K. A. Schenkman. (2003). Oxygen 
regulation and limitation to cellular respiration in mouse skeletal muscle in vivo. 
Am.J.Physiol Heart Circ.Physiol. 285, H1900-H1908. 
McCully, K. K. and T. Hamaoka. (2000). Near-infrared spectroscopy: what can it tell us 
about oxygen saturation in skeletal muscle? Exerc.Sport Sci.Rev. 28, 123-127. 
Meyer, R. A. (1988). A linear model of muscle respiration explains monoexponential 
phosphocreatine changes. Am.J.Physiol. 254, C548-C553. 
Myers, D. E., C. E. Cooper, G. E. Beilman, J. D. Mowlem, L. D. Andersen, R. P. Seifert, 
and J. P. Ortner. (2005). A wide gap second derivative NIR spectroscopic method 
for measuring tissue hemoglobin oxygen saturation. In Oxygen Transport to 
Tissue. Proceedings of the 32nd annual meeting of the International Society on 
Oxygen Transport to Tissue. ed. Edited by D. F. Bruley M. Ferrari and D. K. 
Harrison G.Cicco. Vol. XXVII.  New York, NY: Kluwer Academic/Plenum 
Publishers. 
 128
 Pernow, B., B. Saltin, J. Wahren, R. Cronestrand, and S. Ekestroom. (1975). Leg blood 
flow and muscle metabolism in occlusive arterial disease of the leg before and 
after reconstructive surgery. Clin.Sci.Mol.Med. 49, 265-275. 
Petersen, E. S., B. J. Whipp, J. A. Davis, D. J. Huntsman, H. V. Brown, and K. 
Wasserman. (1983). Effects of beta-adrenergic blockade on ventilation and gas 
exchange during exercise in humans. J.Appl.Physiol. 54, 1306-1313. 
Richardson, D. (1981). Blood flow response of human calf muscles to static contractions 
at various percentages of MVC. J.Appl.Physiol. 51, 929-933. 
Rossiter, H. B., S. A. Ward, V. L. Doyle, F. A. Howe, J. R. Griffiths, and B. J. Whipp. 
(1999). Inferences from pulmonary O2 uptake with respect to intramuscular 
[phosphocreatine] kinetics during moderate exercise in humans. J.Physiol. 518 ( 
Pt 3), 921-932. 
Seiyama, A., O. Hazeki, and M. Tamura. (1988). Noninvasive quantitative analysis of 
blood oxygenation in rat skeletal muscle. J.Biochem.(Tokyo). 103, 419-424. 
Shibuya, K., J. Tanaka, and T. Ogaki. (2004). Muscle oxygenation kinetics at the onset of 
exercise do not depend on exercise intensity. Eur.J.Appl.Physiol. 91, 712-715. 
Shoemaker, J. K., J. R. Halliwill, R. L. Hughson, and M. J. Joyner. (1997). Contributions 
of acetylcholine and nitric oxide to forearm blood flow at exercise onset and 
recovery. Am.J.Physiol. 273, H2388-H2395. 
Teravainen, H. and J. Makitie. (1977). Striated muscle ultrastructure in intermittent 
claudication. Arch.Pathol.Lab Med. 101, 230-235. 
Tran, T. K., N. Sailasuta, U. Kreutzer, R. Hurd, Y. Chung, P. Mole, S. Kuno, and T. Jue. 
(1999). Comparative analysis of NMR and NIRS measurements of intracellular 
PO2 in human skeletal muscle. Am.J.Physiol. 276, R1682-R1690. 
van Beekvelt, M. C., M. S. Borghuis, B. G. van Engelen, R. A. Wevers, and W. N. 
Colier. (2001). Adipose tissue thickness affects in vivo quantitative near-IR 
spectroscopy in human skeletal muscle. Clin.Sci.(Lond). 101, 21-28. 
Walsh, B., M. Tonkonogi, K. Soderlund, E. Hultman, V. Saks, and K. Sahlin. (2001). The 
role of phosphorylcreatine and creatine in the regulation of mitochondrial 
respiration in human skeletal muscle. J.Physiol. 537, 971-978. 
Whipp, B. J. and Mahler M. (1980). Dynamics of Pulmonary Gas Exchange during 
Exercise. In Pulmonary Gas Exchange. Edited by J. B. West. Vol. II. 33-95. New 
York: Academic Press, Inc. 
 
 
 129
 Table 1: Subject Characteristics 
 
Control PAD 
Age (years) 63±2 64±3  
ABI,  Index Leg  1.25±0.02 0.68±0.05 ** 
Peak O2 (ml.kg-1.min-1) 26.2±1.2  17.3±1.40 ** 
MVC, Index Leg (N) 591±67 528±68 
   
Medications  (n) (n) 
Aspirin 0 8 
Statin 2 8 
Ca2+ blockers 0 4 
Diuretic  0 2 
Values are mean± S.E.M. ABI, Ankle-Brachial Index. Peak O2, peak oxygen uptake during 
graded treadmill exercise testing.  MVC, maximal voluntary contraction.   ** p < 0.01 for PAD 
vs. Control.  
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  Table 2: StO2 dynamics during constant work rate calf muscle exercise in peripheral 
arterial disease patients and healthy controls. 
MVC  Power output (w) StO2(b) (%) A1 (%) τ1 (s) TD1 (s) 
MRT (s) 
 1%        
Control n=0 0.8 ± 0.1 83 ± 4 No  StO2 desaturation  
PAD n=4 1.4 ± 0.3 82 ± 4 -12 ± 4 15.7 ± 4.3 22.3 ± 2.9 38.0±5.3 
5%        
Control n=6 1.7 ±0.2 81 ±5 -12± 3 6.9 ±1.2 32.1 ± 3.2 30.8±1.5 
PAD n=7 2.3 ±0.5 82 ± 3 -21 ± 4 13.5 ± 1.7* 20.3 ± 2.5 * 36.1±3.0* 
10%        
Control n=8 3.2 ±0.3 79 ±5 -18 ± 5 6.8 ±1.1 18.6 ±1.9 25.4±1.6 
PAD n=8 3.5 ±0.5 80 ± 3 -43 ± 8*, I 14.5 ± 2.7* 15.4 ± 2.6 34.8±2.7* 
30%        
Control n=8 6.9 ±0.6 78 ± 5 -45 ± 7H 7.5 ± 1.1 11.8 ± 1.5 H 19.3±1.7H 
PAD n=8 6.2 ±0.8 81 ± 3 -58 ± 7I 7.9 ± 0.7H 9.1 ± 1.3H 17.1±1.4H 
50%        
Control n=8 8.6 ±0.8 83 ± 4 -56 ± 6H 7.5 ± 1.2 10.5 ± 1.3H 10.4±1.9H 
PAD n=8 7.9 ±1.1 82 ± 4 -62 ± 7I 6.8 ± 0.8H 7.6 ± 1.3H 10.5±0.7H 
 
Table 2.  Values are mean±S.E.M.   StO2(b), muscle saturation (%) at baseline.  τ1, StO2 time 
constant. TD1, time delay. A1, Amplitude of StO2 response.  No StO2 desaturation was observed 
during 1% MVC exercise for the controls.   * p < 0.05 for PAD vs. Control.  H p <0.05 versus 1, 5 
and 10% MVC. I, P<0.05 versus 1 and 5% MVC.  
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Figure 1.  Representative StO2 responses from a control subject (Panel A) and a patient with 
peripheral arterial disease (PAD, Panel B) in the transition from rest to exercise across all 
constant work rates.  Exercise time begins at time=0.  
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Figure 2.  Representative StO2 kinetics during 10% MVC calf plantar flexion exercise in a 
control subject (Panel A) and patient with peripheral arterial disease (Panel B). StO2b is resting 
StO2 prior to exercise onset.  Exercise begins at time=0.  Following a time delay, StO2 falls to a 
nadir with a time constant (τ1).  Dashed lines denote curve fit.   
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Figure 3.  Comparison of calf blood flow (LBF) in peripheral arterial disease (PAD) patients and 
control subjects measured at rest and immediately following the last contraction at each work rate 
(Panel A) and as a function of power output (Panel B).  Note reduced LBF/power output 
relationship at highest power outputs in PAD patients compared with controls. *, p<0.05 PAD vs. 
control.   
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Chapter 5 
Effect of Revascularization on Pulmonary Oxygen Uptake Kinetics  
in Peripheral Arterial Disease 
Abstract 
 Patients with peripheral arterial disease (PAD) have a profound reduction in 
exercise tolerance and impaired oxygen uptake ( O2) kinetics during the rest to exercise 
transition.  Previous studies have suggested that abnormalities of limb blood flow, 
impaired skeletal muscle metabolism, or both may contribute to the impaired exercise 
responses.  The present study was designed to investigate the relative contribution of 
impaired blood flow on the slowed O2 kinetics in patients with PAD by evaluating 
patients before and after revascularization.  We hypothesized that if blood flow limitation 
was the primary determinant of the slowed pulmonary O2 kinetics in PAD, 
revascularization would accelerate the pulmonary O2 kinetic response.  Eight patients 
with PAD (age 55.9±9.4 yrs.) were studied before and following revascularization 
procedures.  Peak O2 was assessed by graded treadmill exercise testing.  Limb 
hemodynamics were evaluated by ankle-brachial index (ABI), and limb blood flow at rest 
and during reactive hyperemia using venous plethysmography. Pulmonary O2 kinetics 
were evaluated from the average of three bouts of constant work rate treadmill exercise at 
2.0 mph and 4% grade.   Prior to revascularization, all PAD patients experienced 
claudication pain during exercise testing, but no patient experienced claudication during 
follow-up testing following revascularization.  Revascularization improved peak reactive 
hyperemia in patients (11.5±3.5 increased to 19.3±6.2 ml/100ml tissue/min, p<0.01) and 
the ABI of the index legs of PAD patients (from 0.66±0.12 to 0.99±0.10, p<0.01).  The 
phase 2 O2 kinetic time constant was reduced in 6 of 8 patients after revascularization 
but the magnitude of improvement was not statistically significant (from 52.0 ± 13.7 to 
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44.2 ± 11.2 sec. after revascularization, n.s.).  In contrast, the magnitude of the estimated 
O2 slow component (6-3 O2) in PAD patients was reduced (from 92 ±59 to 52 ±35 
ml/min post-revascularization, p<0.05).  Peak O2 of PAD patients improved following 
revascularization (from 14.2±3.0 to 18.5±3.6 ml/kg/min, p<0.01).  The increase in reactive 
hyperemia after revascularization was correlated with the improvement in peak O2 (r = 
0.94, p < 0.05), but no correlation was observed between RH or ABI and the phase 2 
kinetic time constant after revascularization.   In summary, revascularization resolved 
claudication symptoms, increased peak O2 and tended to improve phase 2 pulmonary 
O2 kinetics.  However, despite the significant improvement in calf blood flow responses, 
pulmonary O2 kinetics may remain abnormal in PAD patients.  These findings are 
consistent with a persistent abnormality in muscle oxygen utilization in PAD post-
revascularization and suggest that local abnormalities of the PAD-affected skeletal muscle 
may contribute to the slowed pulmonary O2 kinetics and exercise intolerance of patients 
with PAD.   
Introduction 
 
Patients with peripheral arterial disease (PAD) are characterized by a low exercise 
tolerance and reduced peak oxygen uptake ( O2) (Eldridge and Hossack 1987, Hiatt et al. 
1992).  Moreover, pulmonary oxygen uptake responses during submaximal exercise are 
abnormal in patients, and the dynamic increase of pulmonary O2 following the onset of 
exercise ( O2 kinetics) is slowed in PAD (Auchincloss et al. 1980, Haouzi et al. 1997, 
Womack et al. 1997b, Bauer et al. 1999, Barker et al. 2003, Barker et al. 2004, Bauer et al. 
2004b).  The slowing of O2 kinetics in PAD is significant and is inversely related to 
peak exercise performance, consistent with the notion that slowed O2 kinetics in PAD 
may have functional consequences (Barker et al. 2003).  Previous studies of O2 kinetics 
in PAD have attributed the abnormally slowed responses to the primary impairment in 
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lower extremity blood flow due to the arterial stenoses (Auchincloss et al. 1980, Haouzi et 
al. 1997), or alternatively in combination with the spectrum of metabolic abnormalities in 
PAD-affected skeletal muscle (Bauer et al. 1999, Barker et al. 2003).   However, the 
relative contributions of the potential muscle metabolic abnormality and primary blood 
flow impairment to the slowed pulmonary O2 kinetics and reduced exercise performance 
in PAD remains to be more fully elucidated.  
The present study was designed to investigate the relative contribution of impaired 
blood flow on the slowed O2 kinetics in patients with PAD by evaluating patients before 
and after revascularization.  We hypothesized that if blood flow limitation was the primary 
determinant of the slowed pulmonary O2 kinetics in PAD, then revascularization would 
accelerate the pulmonary O2 kinetic response.  A finding of faster O2 kinetics in PAD 
would reflect the contribution of revascularization, and presumably improvements in leg 
blood flow, on the PAD O2 kinetic response.  Additionally, we anticipated that 
revascularization would result in improvements in the symptoms of claudication and 
increase the peak exercise capacity of patients with PAD.    
Methods 
Subjects.  Eight subjects with intermittent claudication secondary to PAD were recruited.   
Subjects with PAD were enrolled that were scheduled for lower extremity angiogram as 
part of the standard care for the PAD condition.  The study was approved by the 
University of Colorado Multiple Institutional Review Board, and subjects provided 
informed consent prior to study participation.   
Peripheral arterial disease was confirmed by a resting ankle-brachial index (ABI) 
value < 0.90, that fell at least 0.10 following peak treadmill exercise.  All PAD subjects 
exhibited typical symptoms of intermittent claudication during walking, defined as 
localized discomfort or cramping in the calf muscles of the affected legs that occurred 
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only with exercise and that was completely relieved within ten minutes of rest.   Subjects 
with PAD included four subjects with unilateral occlusive disease (defined as a reduced 
ABI and claudication symptoms in one leg, but no symptoms and a resting ABI greater 
than 0.90 in the other leg) and four subjects with bilateral occlusive disease (leg 
claudication symptoms and ABI < 0.90 in both legs).  In all PAD subjects, an index leg 
was identified that was most symptomatic and for which revascularization was planned.  
Participants were excluded from study if they had: 1) a history of stroke, congestive heart 
failure, or diabetes mellitus or 2) evidence of cardiac ischemia (by Electrocardiogram) 
during baseline graded exercise testing. Additionally, subjects with ischemic rest pain or 
ulceration of the affected lower extremities were excluded from study.   
Protocol Design.  Each participant visited the Vascular Research Laboratory at the 
University of Colorado-Health Sciences Center for evaluation a total of four times: two 
visits within one-week prior to- and two visits following revascularization.   Subjects were 
instructed to avoid the consumption of alcohol, caffeine, and smoking within the 12 hours 
prior to each visit and to avoid food consumption within 4 hours before each visit.   The 
first visit was used to obtain initial screening measurements, lower extremity blood flow 
measurements, and establish baseline peak exercise capacity.  The second visit consisted 
of three constant work rate (CWR) exercise tests for the analysis of pulmonary oxygen 
uptake ( O2) kinetics as described previously (Bauer et al. 1999, Bauer et al. 2004b).  
Each participant repeated these procedures following revascularization (Table 1).   
Graded Exercise Testing.  Peak treadmill (Q-stress, Quinton Instruments, Seattle, WA, 
USA) exercise performance (peak O2) was assessed before and after revascularization as 
previously described (Bauer et al. 1999, Bauer et al. 2004b).  For assessment of baseline 
peak O2, PAD subjects performed a Gardner Protocol (speed constant at 2.0 mph with a 
2% increase in grade every 2 minutes) to maximal claudication pain that prevented any 
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further walking (Gardner et al. 1992).  In order to accommodate an expected increase in 
exercise performance following revascularization, PAD participants performed an 
incremental treadmill protocol with greater work rate increments (Astrand protocol) for 
determination of peak O2 (Astrand and Rodahl 1977).  Heart rate (HR) was measured 
continuously using 12-lead ECG monitoring during exercise testing.   
Constant Work Rate Exercise Testing.  On a separate day, subjects performed three 
treadmill exercise transitions from rest to constant work rate (CWR) walking (2.0 mph, 
4% grade) as previously described (Bauer et al. 1999).  Each CWR exercise test consisted 
of a 3-minute resting period to obtain baseline gas exchange data, followed by 6-minutes 
of CWR walking exercise, and a 30-minute period of seated rest.   Pulmonary gas 
exchange measurements and heart rate data were recorded continuously throughout the 
resting and exercise periods of each CWR test.   
Ankle Brachial Index.  The ABI was calculated in all subjects at rest as previously 
described (Bauer et al. 1999).  Prior to revascularization, a post-exercise ABI was also 
obtained within one-minute following the graded treadmill exercise.   The ratio of ankle-
to-brachial systolic pressure was determined by taking the highest brachial artery pressure 
divided into the higher of the dorsalis pedis or posterior tibialis artery pressure in each 
ankle.   
Reactive Hyperemia (RH) Blood Flow Measurements.  Calf blood flow was assessed using 
venous occlusion strain gauge plethysmography (D.E. Hokanson Inc. Issaquah, WA) at 
rest and during reactive hyperemia (RH) following release of supra-systolic cuff occlusion 
as previously described (Bauer et al. 2004b).  Blood flow was expressed as ml of 
flow/100ml of tissue/minute.  Resting blood flow was calculated as the average of 6 
separate measurements.  Peak RH was determined following a 5-minute period of limb 
ischemia induced by a proximal thigh cuff inflated to 50 mmHg above systolic blood 
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pressure.  Post-occlusion blood flow measurements were followed for 5 minutes following 
cuff release.   The highest value achieved was taken as the peak RH value.  The sum of 
peak RH values for both legs were recorded. 
Measurement of Pulmonary Gas Exchange.  For all exercise tests, oxygen consumption  
( O2), carbon dioxide production ( CO2), minute ventilation ( E), and other respiratory 
variables were measured and recorded breath-by-breath using a metabolic measurement 
system (MedGraphics CPX/D, Medical Graphics Corp., St. Paul, MN, USA).  The O2 and 
CO2 analyzers were calibrated prior to each test, and pneumotach volumes were calibrated 
using a syringe of known volume (3.0 L).  Breath-by-breath data were stored to computer 
disk for off-line analysis.  During graded exercise, the highest O2 attained from 20-
second averages was defined as peak O2.  The respiratory exchange ratio (RER) was 
calculated as the ratio of CO2/ O2.   
O2 Kinetic Analysis.  Breath-by-breath gas exchange data for each CWR exercise 
transition were processed using a software program as previously described (Bauer et al. 
1999).  Three constant work rate tests were time-aligned and averaged to provide a single, 
average O2 kinetic response for each patient before and after revascularization.   The 
averaged responses were evaluated by non-linear regression techniques (Sigmaplot 2001, 
SPSS, Inc., Chicago, IL, USA) using 2- or 3-component exponential mathematical models 
that describe the dynamic changes in pulmonary O2 as described previously (Bauer et al. 
1999, Bauer et al. 2004b).  The two component mathematical model is given as: O2(t)= 
O2(b) + A1(1 - e-(t-TD1)/τ1) + A2[1- e -(t-TD2)/τ2] and the three component exponential model 
by: O2(t)= O2(b) + A1(1 - e-(t-TD1)/τ1) + A2[1- e -(t-TD2)/τ2] + A3[1- e -(t-TD3)/τ3].  For each 
subject, best-fit modeling of the O2 kinetic response was determined by F-test. Estimates 
of the total exercise O2 increase above resting baseline (Atot) and the magnitude of the 
O2 slow component (A3′ ) were calculated from the individual model parameters as 
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described (Bauer et al. 2004b): Atot = A2 + A3′  and A3′ = A3(1-e(-(ED-TD3)/τ3)), where ED is 
the time at end-exercise (6 minutes).        
Statistical Analysis.  Two-tailed paired Student t-tests were used for comparison of 
exercise parameters before and after revascularization within PAD subjects.  Statistical 
significance was declared at p < 0.05.  A Pearson’s R product was employed to evaluate 
significant correlations using a Bonferroni correction of alpha level, p<0.016 based on 
three comparisons.   
Results 
Patient demographics and chronic medications are listed in Table 1.  Lower 
extremity arterial stenoses were localized to the iliac arteries in four subjects, three 
subjects had involvement of both iliac and femoral arteries, and one subject had an 
abdominal aortic stenosis (Table 2). Percutaneous transluminal angioplasty of the iliac 
arteries was performed in seven subjects.  A common femoral artery bypass was also 
performed in two subjects.  Seven PAD patients returned to the laboratory for evaluation 
within 33 days post-revascularization (mean 14±10 days).  However, one patient was 
unable complete follow-up evaluations until 113 days post-revascularization. 
Limb Hemodynamics.  Prior to revascularization, the resting ABI of the index and 
contralateral leg were significantly lower in PAD subjects (p<0.01, Table 3).  
Revascularization significantly improved the ABI of the index leg (p<0.01) and the 
contralateral leg (p <0.05) given that revascularization procedures treated bilateral 
symptoms in four subjects.   Resting blood flows of the index legs were not significantly 
different between pre and post-revascularization (2.9±1.2 versus 3.7±2.5 ml/100ml 
tissue/min, Figure 1).  However, following revascularization peak reactive hyperemia 
increased 69% in the index legs of PAD subjects (11.5±3.5 at baseline versus 19.4±6.2 
ml/100ml tissue/min after revascularization, p<0.01).   
  142
Peak Exercise Performance.  Prior to revascularization, all PAD patients experienced 
claudication symptoms during incremental exercise testing, and the total claudication-
limited walking time during graded treadmill exercise was approximately 344 ± 122 
seconds.   Following revascularization, peak O2 and peak HR were significantly 
increased compared with pre-revascularization findings (p<0.05, Table 4). Peak RER 
tended to be increased following revascularization but did not reach statistical significance 
(p=0.11).  No subject experienced claudication symptoms during graded treadmill exercise 
following revascularization, and incremental tests post-revascularization continued until 
patient volitional fatigue.   
Constant work rate exercise.  While all PAD subjects experienced claudication symptoms 
during CWR exercise prior to revascularization, no claudication symptoms were observed 
in PAD subjects at the same absolute treadmill work rate post-revascularization (Table 5). 
The increase in HR (∆HR) from rest to the end of CWR exercise was reduced in PAD 
subjects following revascularization (p<0.01).  End-exercise oxygen consumption and the 
RER during the same absolute treadmill CWR exercise work rate were reduced post-
revascularization (p<0.05).   Consistent with an increase in peak O2 following 
revascularization, the PAD relative intensity of the CWR treadmill exercise decreased by 
approximately 27% following revascularization (p<0.01), and the increase in O2 from 
minute 3 to minute 6 of exercise prior to revascularization (e.g. an indicator of the O2 
slow component) was reduced in PAD subjects after revascularization (p<0.05).    
O2 uptake kinetics.  Prior to revascularization, pulmonary O2 kinetic data from four PAD 
subjects were best fit using a 3-component model (to include the O2 slow component), 
and four PAD subjects were best fit by 2-component modeling (no slow component) 
(Table 6).  Following revascularization, two PAD subjects’ O2 kinetics remained best-fit 
by 3-component modeling (Figure 2), and the remaining 6 PAD subjects were best-fit 
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using the 2-component model.  No differences in phase 1 O2 kinetic responses were 
noted following revascularization.  The phase 2 time constant (τ2) (Figure 3) and time 
delay (TD2) tended to become faster following revascularization procedures, but the 
changes in these parameters did not reach statistical significance (p=0.09 and p=0.05, 
respectively).  Moreover, the amplitude of the phase 2 response were similar between pre- 
and post-revascularization.  The amplitude of the O2 slow component as modeled by a 
third exponential term comprised approximately 16% of the total O2 response pre-
revascularization (n=4) and was reduced by 6% post- revascularization (n=2).  Assessed 
from model parameters, a significant reduction of the total amplitude of O2 response 
during CWR treadmill walking was observed following revascularization within PAD 
subjects (p<0.05).   
Relationships between exercise and hemodynamic parameters.  The improvement in peak 
O2 post-revascularization in PAD subjects was significantly correlated with the increase 
in total peak reactive hyperemia (e.g. sum of both legs) (R = 0.94, p<0.01).  However, the 
improvement in hemodynamic parameters in PAD subjects was not correlated with a 
change in the phase 2 time constants (τ2) following revascularization (ABI: R = -0.06 or 
peak RH: R = -0.26, p>0.5).   
Discussion 
The primary finding of the present investigation is that revascularization of the 
lower limbs tended to speed the phase 2 time constant of pulmonary O2 kinetics in PAD 
(6 of 8 subjects), but that the faster O2 time constants were not correlated with the 
improvement in limb blood flow responses following revascularization.  In contrast, 
revascularization improved peak O2, and the magnitude of improvement was 
significantly correlated with the increase in reactive hyperemia responses following 
revascularization.  These data indicate that a primary benefit of revascularization may 
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relate to an increased peak exercise capacity in PAD.  However, revascularization may not 
normalize pulmonary O2 kinetics in PAD, suggesting that an acute improvement of leg 
blood flow may not fully address the pathophysiology of PAD.   
The dynamic increase of pulmonary O2 during the rest to exercise transition is 
dictated by the interaction between the rates of skeletal muscle mitochondrial oxygen 
consumption, oxygen delivery, circulatory transit delays, and pulmonary gas exchange 
(Whipp and Mahler M. 1980).   In healthy subjects, the time course of phase 2 pulmonary 
O2 kinetics closely reflect the dynamic increase in O2 of the exercising muscles (Grassi 
et al. 1996) and during moderate exercise is generally considered to be limited by the 
‘metabolic inertia’ intrinsic to the working skeletal muscle (Whipp and Mahler M. 1980, 
Grassi et al. 1996, Grassi et al. 1998a, Grassi et al. 1998b).  In contrast, cardiovascular 
diseases have been shown to slow pulmonary O2 kinetics presumably through 
impairment of blood flow dynamics (and thus oxygen delivery) (Sietsema et al. 1986, 
Koike et al. 1995) or in combination with peripheral impairments in peripheral skeletal 
muscle oxygen utilization (Sietsema et al. 1994, Grassi et al. 1997) .  In patients with 
PAD, lower extremity blood flow responses during exercise are limited due to the primary 
arterial stenoses.  However, PAD is also associated with skeletal muscle pathology that 
may contribute to impaired muscle oxygen utilization.  For example, there is fiber 
degeneration (Teravainen and Makitie 1977, Regensteiner et al. 1993), pathologic changes 
in mitochondrial structure (Teravainen and Makitie 1977, Sjostrom et al. 1980, Farinon et 
al. 1984), decreased electron transport chain activity (Brass et al. 2001) as well as 
derangements in capillary ultra-structure (Makitie 1977) in the affected skeletal muscle of 
PAD patients.  Thus, a fundamental question arises as to whether the slowed pulmonary 
O2 kinetics in PAD are attributable solely to the primary blood flow impairment or 
rather reflect also the metabolic dysfunction or other pathologic factors local to the 
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affected skeletal muscle.  To date, the contribution of impaired muscle blood flow to the 
slowed pulmonary O2 kinetics in PAD has not been previously addressed.   
In the present study, the patients demonstrated pulmonary O2 kinetic responses 
prior to revascularization that were quantitatively similar to the abnormally slowed 
pulmonary O2 kinetics previously reported for patients with PAD (Bauer et al. 1999, 
Barker et al. 2003, Bauer et al. 2004b).  After revascularization, the phase 2 time delay 
tended to be shorter, and the phase 2 time constant tended to be faster compared with the 
pre-procedure baseline.  Although not statistically significant, the shorter time delay of the 
primary component of pulmonary O2 kinetics following revascularization is consistent 
with the expected speeding of circulatory transit of venous blood from the exercising leg 
to the lung for gas exchange (Barstow and Mole 1987, Barstow et al. 1990) and may 
provide an indirect indication that arterial inflow dynamics were improved.  Moreover, the 
tendency to speed the phase 2 time constant after revascularization could suggest that a 
primary impairment in oxygen delivery to the exercising legs was improved, consistent 
with the early conclusions by others (Auchincloss et al. 1980, Haouzi et al. 1997).  
However, the improvement in phase 2 time constants among patients following 
revascularization was modest, accelerating the time constant by approximately 7.9 
seconds.  Thus, despite a significant improvement in blood flow responses following 
revascularization (~69%), by comparison the improvement in the phase 2 time constant 
was relatively small (~17%).  Indeed, the lack of correlation between improvements in 
limb blood flow and the phase 2 time constants with revascularization supports the notion 
that the slowed pulmonary O2 kinetics following the onset of exercise in patients with 
PAD may be predominantly determined by factors independent of the potential limb blood 
flow limitation during exercise.    
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Revascularization of the affected lower extremities in patients improved the resting 
ABI and blood flow responses during reactive hyperemia, consistent with previous 
observations of hemodynamic improvements with revascularization at rest and during 
exercise (Pernow et al. 1975).  However, the phase 2 time constants in patients remained 
slowed, consistent with the notion that accumulated changes and metabolic injury 
associated with PAD-affected skeletal muscle may persist following revascularization 
procedures.  In the present study, the phase 2 time constants improved in 6 of 8 patients, 
but on average did not normalize as compared with healthy control data collected under 
similar testing conditions (Figure 3).  This could reflect the presence of gross residual 
atherosclerotic disease in the legs in patients after revascularization. However, residual 
stenoses were less than 5% or not apparent by post-revascularization angiography.  An 
alternative explanation may be related to the skeletal muscle pathology distal to the 
primary arterial stenoses.  Using 31P-NMR, Zatina et al. observed abnormally slowed 
phosphocreatine (PCr) recovery following exercise in PAD patients that persisted for 
several months despite the hemodynamic improvement with revascularization (Zatina et 
al. 1986).  An intrinsic impairment in oxidative metabolism in PAD muscle is also 
consistent with the slowed kinetics of muscle deoxygenation (e.g. oxygen extraction) 
following the onset of exercise (Bauer et al. 2004a) (Bauer unpublished results 2005) and 
abnormal O2 kinetics previously observed in PAD patients (Auchincloss et al. 1980, 
Haouzi et al. 1997, Bauer et al. 1999, Bauer et al. 2004b).  Thus, the slowed pulmonary 
O2 kinetics after revascularization may reflect a persistent abnormality in the control of 
oxidative metabolism or other local factors limiting oxygen utilization of the affected 
lower limbs in PAD.   
An interesting finding was that revascularization appeared to reduce end-exercise 
O2 and parameters associated with the O2 slow component.  In healthy subjects, the 
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O2 slow component occurs during exercise in the heavy and severe exercise domains 
(e.g. above the lactate threshold) and describes an additional increase in oxygen 
consumption above that predicted from moderate exercise (Poole et al. 1991).  Thus, the 
O2 slow component may be considered an exercise intensity dependent phenomenon.  
The reduction in the O2 slow component in PAD patients may be clinically significant as 
less oxygen consumption may be required to perform a given submaximal exercise task, 
particularly given that low work rates can represent a large proportion of the limited peak 
O2 of PAD patients (Womack et al. 1997a, Womack et al. 1997b).  Similar changes in 
exercise O2 have been observed in PAD during treadmill walking following aerobic 
exercise training (Hiatt et al. 1994, Womack et al. 1997a). Thus, an improvement in 
exercise blood flow resulting from either revascularization or from potential 
hemodynamic and/or metabolic changes that occur with exercise training could reflect a 
common mechanism of clinical benefit between these different treatments. Further study 
will be necessary to explore the mechanisms of the O2 slow component and functional 
consequences in the treatment of claudication in PAD.   
Study limitations. 
In the present study, plethysmography could not be used to measure exercise blood 
flow or blood flow dynamics during treadmill walking.  Thus, although revascularization 
may have improved exercise blood flow we could not determine the effect of 
revascularization on this important measurement.  However, the increase in peak reactive 
hyperemia responses following revascularization was correlated with an improvement in 
peak O2, which supports the notion that reactive hyperemia provided a useful marker of 
bulk limb blood flow improvement with revascularization.  Another limitation of the study 
was in the inclusion of two PAD subjects chronically taking selective beta-1 adrenergic 
blocking agents.  Patients’ medical therapy was maintained prior to and following 
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revascularization such that the only change pre-to-post revascularization was the change in 
lower limb blood flow resulting from the revascularization procedure.  Beta-blocking 
drugs lower peak O2 by limiting cardiac output, and may slow pulmonary O2 kinetics 
in healthy subjects (Petersen et al. 1983, Hughson 1984).  Moreover, reduced reactive 
hyperemia responses in healthy and PAD subjects have also been described (Lepantalo 
1985), although lesser reductions in RH have been observed with selective beta-1 blocking 
agents (Lepantalo 1985).  Despite this potential confounding influence, prior to 
revascularization the phase 2 time constants were similar between PAD patients taking 
beta-blocking medications to those tested without these agents (56.4 vs. 50.8s, 
respectively) and were similarly affected by revascularization (48.9 vs. 42.3s, 
respectively).  Thus, in this small study of PAD patients, the changes in O2 kinetic 
responses following revascularization appear to be of similar magnitude and consistent 
among subjects.   
In conclusion, the present study demonstrated that revascularization of the lower 
limbs may speed pulmonary O2 kinetics in patients with PAD.  However, the 
improvement in the phase 2 time constant was modest consistent with a limited role for 
impaired blood flow on the abnormal pulmonary O2 kinetics in PAD patients.  
Moreover, that pulmonary O2 kinetics may not normalize following revascularization 
suggests a persistent impairment in PAD oxygen uptake dynamics following exercise 
onset.  In addition to the limitation of lower limb blood flow, factors related to the 
abnormal oxidative metabolism of PAD skeletal muscle may offer a putative mechanisms 
for the slowed pulmonary O2 kinetics of this patient population. 
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Table  1: Patient Characteristics 
Age (years) 55.9 ±9.3 
Weight (kg) 81.9 ±20.4
BMI (kg/m2) 27.4 ±6.92
Pack-years 38.3 ±5.8 
Current Smokers n=5 
  
Medications  
Aspirin n=7 
Ca2+ blocking 
agents n=5 
Beta Blocking 
agents n=2 
Statins n=3 
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    PRE POST 
Table  2: PAD Angiographic Characteristics 
 
Subject Lateralization Leg Artery % Stenosis % Stenosis procedure 
01 Uni CIA 100 0 S L 
02 Uni L CIA 61
03 Uni L EIA 100 
  L CFA 100 
  PFA 100 0 E
04 Bi L CIA 100 <5 S 
  CIA 40 0 A
05 Bi CIA 29 <5 A 
  R SFA 100 0 E 
06 Uni CIA 100 0 B 
  L EIA 100 0 B 
07 Bi L EIA 59 0 S 
  R SFA 75 <5 A
08 Bi L,R Ao 77 <5 S 
Angiograph  characteristics of PAD patients before and er revasc arization. i, unilatera
peripheral arterial disease; Bi, bilateral peripheral arterial disease.  Ao, distal Aorta, CIA, Common 
Iliac Artery; EIA, External Iliac Artery; CFA, Common femoral Artery; PFA, P da Femor
Artery; SFA, Superficial Femoral Artery.  S, stent; A, angioplasty, E, endarterectomy, B, surgical 
bypass. 
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Table  3: Ankle-Brachial Index  
 
 
 
Pre                        Post 
ABI   
Index leg resting 0.66 ± 0.12  0.99 ± 0.10**  
- post-exercise 0.29 ± 0.25  - 
   Contra-lateral leg resting 0.86 ± 0.25 1.03 ± 0.15*  
- post-exercise 0.71± 0.30 - 
Values are mean ±SD.    ABI, Ankle-Brachial Index measured at rest and immediately 
following peak treadmill exericse in patients with PAD.  Contra-lateral data include the 
revascularization of less affected legs of 3 bilateral PAD subjects. * p<0.05, ** p<0.01 Pre- vs. 
Post-revascularization.
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Table  4: Peak Exercise Characteristics Pre- and Post-Revascularization 
 
            Pre                       Post 
O2 (ml.kg-1.min-1) 14.2 ± 3.0 18.5 ± 3.6** 
RER 1.00 ± 0.09 1.12 ± 0.12 
HR (beats.min-1) 110 ± 15 128 ± 21* 
ICT (seconds) 
66 ± 34 No claudication 
ACT (seconds) 
344 ± 122 No claudication  
Values are mean ±SD.  ICT, Time to onset of claudication symptoms; ACT, Claudication 
limited total walking time on Gardner Protocol.  No subject experienced claudication pain 
during graded exercise post-revascularization (Astrand Protocol). *p<0.05, ** p<0.01 Pre- vs. 
Post-revascularization. 
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Table  5: Constant Work Rate (CWR) Exercise Characteristics Pre- and Post-
Revascularization 
 
Pre                    Post 
ICT (seconds) 75 ±34 No claudication 
∆ HR (bpm) 27 ±10 22 ±10** 
End Exercise O2 (ml.min-1) 1055 ±205 970 ±199* 
End Exercise O2 (% of peak) 94 ±13 67 ±10** 
End Exercise RER 0.96±0.06 0.90 ±0.06* 
6-3 minute O2 (ml.min-1) 92 ±59 52 ±35* 
Values are mean ±SD.   PAD patients exercised for 6-minutes at 2.0 mph, 4% grade.  All PAD 
subjects experienced typical claudication symptoms during CWR treadmill testing pre-
revascularization.  No PAD subject experienced claudication symptoms post-revascularization.  
ICT, Time to onset of claudication symptoms during CWR treadmill walking.  ∆HR, 6-minute 
heart rate minus resting baseline. * p<0.05, **p<0.01 Pre- vs. Post-revascularization.
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 Table  6: O2 Kinetic Parameters for Constant Work Rate Exercise Pre- and Post-
Revascularization 
  
 
Pre                       Post 
 
Resting O2 (ml/min) 329 ± 66 326 ±52 
   
Phase 1 N=8 N=8 
     τ1 (s) 4.9 ± 5.0 2.7 ± 2.2 
     TD1 (s) 1.9 ± 1.9 2.0 ± 2.0 
     A1 (ml/min) 297 ± 96 270 ± 103  
   
Phase 2 N=8 N=8 
     τ2 (sec) 52.0 ± 13.7 44.2 ± 11.2 
     TD2 (s) 42.8 ± 12.7 36.3 ± 9.1  
     A2 (ml/min) 381 ± 104 362 ± 81 
Phase 3 n=4 n=2 
     A3' (ml/min) 100 ± 26 60 ± 12  
     SC (%) 16 ± 6 10 ± 3 
Atot (ml/min) 724 ± 186 646 ± 155* 
Values are mean ± SD.  τ, Exponential time constant. TD, time delay. A, Amplitude of O2 
response.  Atot, total amplitude of O2 response.   Phase 3 data are presented for subjects that 
demonstrated a slow component of O2 increase. *p<0.05 Pre- vs. Post-revascularization. 
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Figure 1.  Mean ± SD. Resting blood flow and peak reactive hyperemia (RH) pre- and post-
revascularization of the index legs in PAD patients. ** p<0.01 Pre- vs. Post-revascularization.
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Figure 2.  Pulmonary O2 kinetic responses and model fit from a representative PAD patient 
before (top) and after revascularization (bottom) during treadmill constant work rate (CWR) 
exercise.  Treadmill exercise was performed at 2.0 mph, 4% grade.  Exercise was initiated at time 
0.  Note presence of O2 slow component and modeling of third component during PAD CWR 
treadmill exercise and which remains present, but reduced post-revascularization.  
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Figure 3. Pulmonary O2 kinetic phase 2 time constants of the individual PAD patients before 
and after revascularization.  Open cirlces with error bars represent group mean (±S.D.).  Phase 2 
time constants from healthy control subjects during treadmill walking provided for reference 
(mean ± S.D.) (a Bauer et al. 2004 (Bauer et al. 2004b); b Bauer et al. 1999 (Bauer et al. 1999), c 
Barker et al. 2002 (Barker et al. 2003)). 
 
 
Chapter 6.   
Synthesis and Future Directions 
Synthesis 
The transport of oxygen from the atmosphere to the skeletal muscles during 
exercise requires the tightly coupled integration of pulmonary gas exchange and 
cardiovascular function to meet the demands of oxygen utilization at the level of the 
mitochondria.  In cardiovascular diseases, the integration of these physiological systems 
becomes altered leading to slowed kinetics of pulmonary oxygen uptake following the 
onset of exercise and reduced exercise tolerance.  In peripheral arterial disease (PAD), 
arterial stenoses of the lower limbs limit blood flow increase (and oxygen delivery) 
during exercise.  However, it has been previously shown that the reduced arterial pressure 
and impaired leg blood flow do not entirely explain the abnormal oxygen uptake 
responses during exercise in PAD, consistent with the notion that alterations in 
metabolism and the microcirculation at the level of the affected skeletal muscle as well as 
systemic abnormalities in cardiovascular function may contribute to the abnormal oxygen 
uptake kinetics of this patient population.   
The present series of investigations systematically addressed key questions 
regarding the abnormal oxygen uptake responses during exercise in patients with 
peripheral arterial disease.  First, we demonstrated abnormal pulmonary oxygen uptake 
kinetics in patients with PAD during exercise of the affected lower limbs but not during 
exercise of the unaffected upper extremities, suggesting that the abnormal oxygen uptake 
responses in PAD were localized to the affected lower limbs.  Thus, the slowed 
pulmonary VO2 kinetics in peripheral arterial disease likely reflects an impairment of 
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oxygen utilization of the affected skeletal muscle and appears not to be related to the 
systemic sequelae secondary to the disease process of atherosclerosis.  In the second 
experiment, using non-invasive near infrared spectroscopy of local muscle deoxygenation 
responses during treadmill exercise, we demonstrated slowed calf muscle StO2 kinetics in 
the transition from rest to submaximal walking in patients with peripheral arterial disease 
compared with control subjects.  The slowed kinetics of the fall in calf muscle StO2 are 
consistent with the concept that the dynamic increase in muscle oxygen utilization may 
be impaired relative to local oxygen delivery during the transition from rest to exercise in 
peripheral arterial disease, forming a basis for the hypothesis that local muscle metabolic 
abnormalities in PAD may influence the adjustment of oxidative metabolism in the rest-
to-exercise transition.  In the third experiment using isolated calf exercise, we confirmed 
that the fall of muscle StO2 kinetics were abnormally slowed in the working muscle of 
patients during lower intensity exercise and extended these observations to show that the 
slowed PAD StO2 kinetic responses occurred under conditions where total increases in 
exercise blood flow were normal compared with controls.  However, the kinetic fall of 
StO2 became faster in PAD calf muscle during higher intensity exercise where the total 
increase in blood flow with exercise was significantly compromised. This dichotomous 
response is consistent with a work rate and potentially blood flow dependence of StO2 
kinetics in PAD patients, as might be predicted from the Fick principle under conditions 
where leg blood flow kinetics may be impaired.  Whether these latter data simply 
reflected a shortfall of oxygen delivery relative to oxygen utilization during the transition 
from rest-to-high intensity exercise or were the result of improved mitochondrial 
respiration in PAD muscle remains unclear.  However, even in the context of slowed 
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activation of mitochondrial oxygen utilization, the significant impairment in muscle 
oxygen delivery relative to oxygen utilization during high intensity exercise is the most 
likely explanation for the faster fall of StO2 in PAD-affected muscle.  In the final study, 
we showed that an acute improvement of leg blood flow following revascularization 
tended to speed the abnormal pulmonary oxygen uptake kinetic responses in patients with 
peripheral arterial disease.  However, an acute increase in leg blood flow capacity did not 
fully normalize the pulmonary oxygen uptake kinetic responses, consistent with a limited 
role for impaired blood flow in the abnormal oxygen uptake responses in peripheral 
arterial disease.  These findings suggest there may remain a persistent abnormality in the 
control of oxidative metabolism and/or other local factors limiting oxygen utilization at 
the level of the affected skeletal muscle even after the restoration of peripheral 
hemodynamics.  Thus, the current series of investigations present a body of work that has 
clarified and advanced our understanding of the impaired oxygen uptake responses in 
peripheral arterial disease.  Moreover, these studies have identified several key issues 
regarding the mechanisms of slowed oxygen uptake kinetics at the level of the affected 
skeletal muscle in peripheral arterial disease that may direct future research.  
Future Directions 
A key element to understanding the limitations of oxygen uptake and exercise 
intolerance in PAD is the investigation of blood flow and oxygen uptake made at the 
level of the microcirculation of the affected skeletal muscle.  The characterization of 
lower limb blood flow kinetics following the onset of exercise is paramount to further our 
understanding of the hemodynamic compromise that occurs during exercise in these 
patients.  Not to be understated, this poses a significant technical challenge as large vessel 
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arterial occlusions and collateral vessel formation complicate direct measures of conduit 
artery inflow.  Furthermore, separating the potentially normal conduit artery blood flow 
kinetics from those in the affected microcirculation in PAD will be important.  In this 
area, the measurement of blood flow using magnetic resonance imaging may prove a 
useful tool in the description of this important parameter and offer insight into the 
exercise hemodynamics of both the macro and microcirculation in PAD.   
Secondary to the blood flow impairment in PAD are many physiological changes 
in the affected skeletal muscle that may alter the transport and utilization of oxygen 
during the rest-to-exercise transition. For example, changes in capillary ultra structure 
and basement membrane alterations may impair oxygen transport from the 
microcirculation to the myocyte.  Moreover, mitochondrial irregularities and 
abnormalities in the activities of mitochondrial electron transport complexes may impair 
mitochondrial oxidative metabolism following the onset of exercise.  Understanding how 
these changes may affect oxygen utilization, particularly oxygen transport from capillary 
to muscle cell as well as the control of mitochondrial respiration at low intracellular PO2, 
are crucial to understanding the limiting factors of oxygen uptake at the level of the 
muscle and whole body in PAD.  Direct studies of skeletal muscle oxygen uptake and 
intramuscular energetics in PAD skeletal muscle will provide useful insight into the 
determinants of muscle oxygen uptake in PAD.  More broadly, these data will advance 
our understanding of the interaction between muscle metabolism and blood flow 
limitation on the local and systemic exercise responses in diseases where impaired 
oxygen delivery and muscle ischemia are critical factors.   
